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ABSTRACT

Coating of fine particles to produce tailored surface properties is currently a key
development for supercritical fluids applications, in different areas such as:
pharmaceutical, nutraceutical, cosmetic, agrochemical, electronic and specialty chemistry
industries. During the encapsulation process the particle surface can be designed with
specific properties by spreading a thin film coating material over the surface of the
particles.
Chitosan, a natural polymer, was used in this work as the encapsulant material.
Chitosan is biocompatible, biodegradable to normal body constituents, safe, non-toxic,
bacteriostatic, anticancerogen, and versatile polymer. These attributes are among the
properties that make Chitosan an attractive component of pharmaceutical products.
The main objective of this research was to encapsulate solid particles under 5 m
with a biopolymer, Chitosan, using supercritical CO2 as one of the solvents. In order to
reach this goal, some the following initial tasks were completed: the cloud point for the
system DMSO-CO2 was determined and compared with published data to validate the
experimental system. Subsequently the cloud point experiments were extended to include
the ternary system Chitosan-DMSO-CO2, and a dynamic solubility experimental set-up
was constructed and used to obtain solubility data for the same ternary system.
A novel SCF fluidized bed was used to micro encapsulate porous (TiO2) and nonporous particles (CaO) through a temperature swing with a Chitosan thin layer. DMSO
xii

was used as an entrainer to enable solubilization of Chitosan and removed within the
supercritical carbon dioxide.
Several analytical methods were used to characterize these particles; SEM-EDS
analysis was used to evaluate a group of particles, determining composition and particle
diameter on samples up to 900 particles. TEM and AFM confirmed particles of one
micron or less were encapsulated with a thickness of less than 5 nm. AFM shows particle
roughness on the nanometer range, 46 nm or more for uncoated particles and 2-4 nm for
the encapsulated ones.
FTIR, NMR and DSC-TGA analysis confirmed that the chemical structure of
Chitosan remained constant before and after processing, and the changes observed were
attributed to some DMSO and moisture adsorbed during the encapsulation process.

xiii

CHAPTER 1
INTRODUCTION

Encapsulation of fine particles to produce modified surface properties have
extensive applications in different industries, such as pharmaceutical, nutraceutical,
cosmetic, agrochemical, electronic and specialty chemistry industries. During the
encapsulation process, the particle surface can be designed with a specific physical and/or
chemical property by coating the surface of the particle with a thin film of encapsulant
material. As a result, the flow-ability, dissolution rate, controlled release, masking,
dispersability, chemical reactivity and hydrophilicity of particles can be modified to tailor
specific applications. Encapsulated particles have a significant application in targeting
and controlled release of therapeutic products, genes and other bioactive agents. This
could be attributed to the fact that controlled release systems provide the benefits of
protection from rapid degradation, targeting delivery, controlled release rate, and
prolonged duration of bioactive agents (Benita S. 2006, Onwulata C. 2005).
There are several encapsulation technologies available, which can be classified
into two categories:
-

Physical methods: vibrating nozzle, spinning disk, pan coating, fluidized bed, freezedrying, and spray drying being among the most frequently used methods.

-

Chemical methods: coacervation, phase separation, interfacial polymerization, in situ
polymerization and sol–gel methods. All of these have a common characteristic:
1

large amounts of organic solvents, surfactants, and other additives, which lead to
volatile organic compound (VOC) emissions and other waste streams. Additional
drawbacks include low encapsulation efficiency, toxic residual solvents in the end
products, what usually leads to further processing, putting in risk the fragile structure
of some chemicals or biochemical ingredients.
Spinning disk is an atomization method that involves the formation of a
suspension of core particles in the coating liquid and the passage of this suspension over
a rotating disk under conditions that generate a coating film much thinner than the core
particle size. This technology was considered very promising for particles on the micron
size range because the results were comparable to regular spray drying or freeze drying.
On the other hand, scaling up would involve the construction of multi-head small nozzles
which can certainly be a source of frequent clogging problems.
Freeze drying works under the fundamental principle of sublimation. The material
to be preserved is frozen, and then lowering the atmospheric pressure below 0.06 atm, the
ice turns directly into water vapor. The water vapor flows out of the freeze-drying
chamber. This continues for a long period of time until the material gradually dries out.
Spray drying assembly requires a feed pump, an atomizer, an air heater, an air
disperser, a drying chamber, and systems for exhaust air cleaning and powder recovery.
An aqueous solution is sprayed as fine droplets into hot air, evaporating the water, and
the dried solid is separated. This method and the regular fluidized beds have problems
when fluidizing particles smaller than 100

m, due to electrostatic forces that make

fluidization difficult. Another problem involved with these methods is the atomization of
the coating material, since droplets must be significantly smaller than the particle to be
2

coated in order to achieve uniform and complete coating while avoiding agglomeration.
Atomizing droplets at 10-100 nm is a demanding engineering problem (Gouin S. 2004).
Coacervation is a colloid phenomenon that consists of the phase separation into
colloid-rich and colloid-poor layers, which requires large amounts of solvents. It is
initiated by creating a perturbation: changing the temperature, the pH or adding a
concentrated aqueous ionic salt solution or a non-solvent. The final step for
microencapsulation is the hardening of the coacervate wall and the separation of the
microcapsules, which generally is the toughest step in the total process, requiring a long
processing period.
For many years there has been continuous interest in replacing conventional
organic solvents with environmentally friendly fluids in different chemical processes.
Supercritical carbon dioxide (SCCO2) became known as an excellent candidate due to its
characteristics and properties: it has mild critical conditions (Tc = 304.1 K, Pc= 7.38
MPa) and is low cost, non-toxic, non-flammable, highly available and easily recycled.
Finally, its most remarkable advantage is the fact that it shows gas-like diffusivities and
liquid-like densities (McHugh and Krukonis, 1994). Supercritical carbon dioxide
(SCCO2) was used initially as a solvent or in other processing areas like supercritical
extraction and separation; however, more recent applications are in particle formation and
encapsulation.
During the past decade, supercritical fluid processes such as RESS (rapid
expansion of supercritical solutions) (Tsutsumi 1995, Wang T. J. 2001, Wang Y. 2002;
Mishima K. 2000, Kim J. H. 1996, Tsutsumi A. 2003, Matsuyama K., 2003a, Sun Y. P.
1998, Matsuyama K. 2003b), gas antisolvent (GAS), and precipitation with a compressed
3

fluid antisolvent (PCA) (Falk, 1997; Young, 1999), also known as aerosol solvent
extraction system (ASES) (Bleich, 1996) or supercritical antisolvent technique (SAS)
(Wang Y., 2004; Wang Y., 2005; Elvassore, 2001; Duarte, 2006) have attracted
increasing attention for particle encapsulation.
Some of the reasons that make supercritical encapsulation techniques an attractive
option are:
-

It is an environmentally benign technology, since the supercritical solvent used can be
recovered at the end of the encapsulation process and recycled.

-

It is a one step process where the core material is enclosed by the encapsulant and
with a simple adjustment of the operation conditions; the supercritical solvent is
released obtaining a clean final product.

-

The selective solvatin power makes it possible to modulate the separation of a
particular component from a multi-component mixture.

-

The high solubility of cosolvents in the supercritical solvent make the drying of the
microparticles rapid and efficient with a low level of residual solvent, as requested by
the FDA.

-

The carbon dioxide inactivates a wide variety of bacterial organisms in the absence of
oxygen and in a slight acidic environment, generating a sanitized and sterile final
product.

-

The fact that supercritical fluids have zero surface tension and low viscosity promotes
coverage of porous materials.
It is important to emphasize that encapsulated particles have many significant

advantages, but there are some potential disadvantages that cannot be ignored: the
4

possible toxicity of the solvents used, biocompatibility of the coating material,
undesirable by-products of degradation, the chance of patient discomfort (in
pharmaceutical and cosmetic applications), and the higher cost of controlled release
systems compared with traditional formulations. These are some of the reasons that have
been driving a significant amount of interest to switch to biodegradable polymers, which
degrade as a result of natural biological processes. Most biodegradable polymers degrade
through hydrolysis of the polymer chains to biologically acceptable and progressively
smaller compounds. In some cases (i.e. poly-lactides, poly-glycolides and their copolymers), the polymers will eventually break down to lactic acid and glycolic acid,
entering the Kreb‟s cycle and break down into carbon dioxide and water.
Today the polymer industry offers a broad selection of biodegradable polymers
with unique characteristics for different applications, depending on the time delivery
range, the targeting objective (organ or cell) and the delivery pH (Brannon-Peppas 1997,
Middleton and Tipton 1998).
One of the most difficult tasks in this research was finding a natural and versatile
biopolymer, soluble on physiological pH, and non-toxic. Chitosan oligosaccharide
lactate, which is a modified carbohydrate polymer derived from chitin deacetylation,
meet all these requirements. Chitin is the second most abundant natural polysaccharide
commercially derived from crustaceous shells (Muzzarelli 1973).
Some biopolymers frequently used in particle encapsulation, such as poly-(Dlactide) (PDLA), poly-(L-lactide) (PLLA), poly-(DL-lactide-co-glycolide) (PGLA),
Dextran, Inulin and poly vinyl alcohol (PVA), are insoluble in pure SCCO2. For this
reason different authors (Bleich 1996, Mishima 2000, Reverchon 2000, Elvalssore 2001,
5

Matsuyama 2003, Perez de Diego 2004) have been studying and processing these
polymers with the assistance of a cosolvent, creating a ternary system, polymercosolvent-SCCO2.
Selecting the proper cosolvent for any solubility process is a important step, as it
can significantly influence and determine the homogeneity of the mixture, and the degree
of dissolution of the solute into the given cosolvent. DMSO was chosen as a cosolvent for
this work because it is able to solubilize the solid biopolymer Chitosan, as well as it is
soluble in supercritical carbon dioxide, a basic requirement for any supercritical
micronization or coating process (Rajasingam 2004, Kordikowski 1995, Yeo S. 1993,
Reverchon 1998).
The objective of this research was to encapsulate dry powder particles with
diameters on the micron and sub-micron range using a green, controllable and scalable
technique (Supercritical Fluid Technology) in order to obtain a uniform and controllable
coverage of particles with the chosen biopolymer.
To be able to pursue this objective, specific steps were followed in a logical and
organized sequence.
Chapter 2 provides the fundamental thermodynamic background necessary to
develop and analyze a supercritical encapsulation process. Phase equilibrium principles,
recognized experimental methods for solubility measurement in supercritical fluids,
phase diagrams for binary, ternary and polymer systems under supercritical conditions,
and a brief introduction to biopolymers are discussed here.
In Chapter 3, a broad review of different supercritical particle encapsulation
techniques published is presented. These techniques were classified based on the fact that
6

the encapsulation systems can be homogeneous or heterogeneous and that the
supercritical carbon dioxide can be used as a solvent or an antisolvent.
Chapter 4 is a compendium of the properties and specific characteristics of all the
chemicals used for this work, including the supercritical solvent, the cosolvent,
encapsulant and core material. As there is not much information available for the
encapsulant material, and having an original encapsulation technique, the selection of
well characterized and economic core material like calcium oxide (non-porous) and
titanium dioxide (porous) was a requirement. The information presented in this chapter
comes from literature data and direct experimental analysis.
In Chapter 5, all the experimental systems employed during this research are
described in full detail. In total, three different set-ups were required. The first one is a
static solubility set-up, used to establish the experimental cloud point for the binary
system DMSO-CO2 and for the ternary system Chitosan-DMSO-CO2. As there was no
data published for this particular ternary system, another set of experimental data is used
to confirm these previous results, and an extraction cell is built to obtain dynamic
solubility data. The final set-up presented is the encapsulation one, a 60 ml supercritical
fluidized bed designed and built to encapsulate micron and sub-micron particles using a
temperature perturbation technique. Diagrams and detailed experimental procedures are
presented.
Chapter 6 includes the experimental results for the solubility and cloud point for
the DMSO-SCCO2 and Chitosan-DMSO-SCCO2 system, as well as the encapsulation
results and coating characterization. In the beginning of this chapter, the cloud point data
for the binary system DMSO-SCCO2 obtained during this research is presented and
7

compared with some published information, after which some novel Chitosan-DMSOSCCO2 experimental data is shown, including cloud point and dynamic solubility results.
Based on these results, the encapsulation conditions are established, showing the T-P
effect over the encapsulant and final product. Multiple characterization techniques are
followed in order to confirm the presence of Chitosan as encapsulant material and
establish the quality of the final product. All these results are discussed in this chapter.
Techniques like FTIR and EDS are employed to confirm the presence of Chitosan on the
encapsulated sample; SEM, TEM and AFM are used to evaluate the particles before and
after the encapsulation process in order to determine the quality of the proposed method
and NMR, DSC-TGA are utilized to characterize the polymer coating before and after
being processed.
Finally, the conclusions for all the steps followed in this dissertation are presented
in Chapter 7, as well as recommendations for future work, as in all research, one door
leads to many other doors.

8

CHAPTER 2
THERMODYNAMIC BACKGROUND
FOR SUPERCRITICAL ENCAPSULATION

In this chapter, a brief introduction to supercritical fluids, measurement
techniques, and phase diagram models will be presented, as a fundamental knowledge
basis to develop a micro-encapsulation process under a supercritical environment. The
solubility measurement techniques are presented as they are usually referred to in the
literature, as well as the phase diagrams for binary and ternary systems shown. Polymers
and biopolymers in supercritical fluids will be introduced at the end of this chapter, since
they are the most commonly used coating material in particle encapsulation.

2.1. Supercritical Fluids
When talking about pure components, supercritical refers to the condition where
the temperature and pressure pass the critical point at which the phase boundaries
disappear. A supercritical fluid (SCF) is defined as a substance above its critical
temperature (TC) and critical pressure (PC). The critical point (CP) represents the highest
temperature and pressure at which the substance can exist as a vapor and liquid in
equilibrium. The phenomenon can be easily explained by looking at the phase diagram
for pure carbon dioxide (Figure 2.1).
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Figure 2.1. Phase Diagram for Carbon Dioxide

SCF technology has been in commercial use for more than 40 years as an
environmentally benign, and energy-cost effective tool in a variety of industries, such as
the decaffeination of coffee and tea (Vitzthum 1975) and for the extraction of flavors and
essential oils from natural sources (Rizvi 1994, Grandison 1996). SCF technology is
building its path in several pharmaceutical industrial operations, including product
sterilization, crystallization, particle size reduction, coating, encapsulation and the
preparation of drug delivery systems. It has also been shown to be a feasible option in the
production of granular drug delivery systems, such as microparticles and nanoparticles,
liposomes and encapsulated complexes, which control drug delivery and/or enhance drug
stability.
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There are advantages when working with supercritical fluids, for example:
-

The fact that the critical temperature of carbon dioxide is close to ambient
temperature makes it possible and safe to process heat-labile compounds.

-

SCF functions as solvent for aliphatic hydrocarbons with chains of 20 carbons or less
and for nearly all aromatic hydrocarbons.

-

It can be used with cosolvents, such as methanol and acetone to enhance the solubility
of polar solutes.

-

Organic solvents, such halocarbons, aldehydes, esters, ketones, and alcohols are
freely soluble in supercritical CO2, facilitating the extraction of organic solvents.
Carbon dioxide can be used in two different ways: as a solvent or an antisolvent,

depending on if the purpose is to coat particles or just to make particles by precipitation.
For coating purposes, coverage of porous particles benefits from this particular solvent,
since the diffusion coefficients of organic solvents in supercritical CO2 are typically one
or two orders of magnitude higher than in conventional organic solvents, making porous
impregnation with controlled morphology and narrow particle size distribution (Table
2.1).
Carbon dioxide is non-toxic, non-flammable, inexpensive and recyclable. After
finishing the chemical process, it can be separated completely from the final product by
expanding it, and then liquefied for recycling purposes.
Supercritical fluids (SCF) can be applied on the production of pure active
ingredient particles or a mixture of active ingredients and excipients (polymer or lipid
carrier). The density and the solvent power of SCF could be adjusted significantly
through a small perturbation of temperature and/or pressure around the critical region to
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tailor the product characteristics. SCF can even be used to coat therapeutic particles with
single or multiple layers of polymers or lipids, by preparing a coating solution in SCF and
choosing the adequate temperature and pressure conditions that do not solubilize the core
material being coated.

Table 2.1. Fluid Properties for Different Pure Components Phases
Supercritical
Medium
Properties

g / ml

Density,
Diffusivity, D

cm 2 / s

Fluids
Gases(1)

Liquids(1)
Tc, Pc

Tc, 4 Pc

2

(0.6-2.0) x 10-3

0.6 – 1.6

0.2 – 0.5

0.4 – 0.9

(1.0-4.0) x 10-1

(0.2-2.0) x 10-5

0.7 x 10-3

0.2 x 10-3

(1.0-3.0) x 10-4

(0.2-3.0) x 10-2

(1.0-3.0) x 10-4

(3.0-9.0) x 10-4

-

10-400

-

-

10-2

10-1

10-1

10-1

Dynamic viscosity,

g / cm s
Surface tension,
(dynes/cm)
Thermal conductivity, k
(W/m K)

(1) Ambient conditions, (2) Conditions where pressure is four times higher than the critical pressure.
(Bruce E. Poling, John M. Prausnitz, John O' Connell, 2000)

2.2. Solubility in Supercritical Fluids
The solvent power of supercritical fluids is a function of pressure and
temperature. For this reason, the solubility power can be adjusted to solubilize or separate
solutes and solvents by manipulating the operation conditions. Usually, the solvent power
of a supercritical fluid increases with density and vice versa. Density can be reduced by
decreasing the pressure or increasing the temperature.
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For extraction or desorption purposes, different authors (Tan and Liou 1988 and
1989, Modell 1978) found that higher pressures at fixed temperatures promote these
phenomena. The solvency power of supercritical fluids is enhanced as the fluid density
increases with pressure increments at a given temperature, which is favorable for
desorption, extraction or regeneration processes.
Pressure reduction at constant temperature leads to lower concentrations of the
dissolved substances, causing precipitation of dissolved substances due to the lower
density. In the same order of ideas but now considering the temperature effect, the
density is reduced by temperature augmentation at constant pressure.
When working with mixtures of multiple solutes at supercritical conditions, the
isotherms will intersect at the crossover points due to pressure adjustments, as illustrated
in Figure 2.2 (Chimowitz 1986). For that reason, separation processes for solid mixtures
can be designed in which the separation conditions will be located between the crossover
points of the two species. For example, in Figure 2.2, consider a gas phase at a pressure
Po, intermediate to crossover points P1* and P2*, which is cooled from temperature TH
(High Temperature) to TL (Low Temperature). Note that the solubility of component 2
increases, while solubility of component 1 decreases. As an example, consider a process
in which a mixture of components 1 and 2 are extracted at Po and TH, and separated by a
simple temperature decrease to TL. This approach can be extended to multicomponent
mixtures.
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Figure 2.2. Crossover Phenomena for Multiple Solutes Mixtures. (Chimowitz, 1986)

The observed retrograde behavior for solubility of multicomponent solute
mixtures is similar to the retrograde effects of pressure and temperature observed in
sorption processes (Figure 2.3). As was presented by Tan and Liou 1990a and 1990b, the
system Toluene-CO2-Activated Carbon and Benzene-CO2-Activated Carbon show
crossover of the equilibrium loadings at different temperatures and relatively high
pressure. The pressure at which the crossover occurred increased with the supercritical
phase concentration for both components. This behavior was modeled by Akman and
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Sunol 1991, by coupling supercritical sorption isotherms with a conventional fixed bed
desorber model, where a high-density favored desorption was predicted.

Figure 2.3. Crossover Phenomena in a Desorption Process. (Akman and Sunol, 1991)

2.3. Experimental Techniques for Solubility Measurements in Supercritical Fluids
The solubility of a solute in a supercritical fluid (SCF) is probably one of the most
important thermo-physical mixture properties. The solubility information is desirable for
the determination of Equation of State (EOS) interaction coefficients to allow prediction
of the phase distribution of the solute. This information is used to understand the
temperature-pressure dependence of the solubility in order to determine the appropriate
operation conditions for process components such as extractors and separators.
To determine the feasibility of an encapsulation process, it is necessary to have
the solubility of the encapsulant and the core material in the SCF. This data is not always
available and some experimental determination of the data could be required. There have
been a number of different approaches developed for the measurement of solute solubility
for pure or multicomponent SCFs. These techniques are either dynamic, where the solute
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is continually removed within SCF at equilibrium conditions, or static, where known
amounts of solute and solvents are preloaded into a cell where the pressure, temperature
and/or volume can be adjusted to obtain the cloud point or equilibrium condition.

2.3.1. Dynamic Solubility Measurements for Supercritical Fluids
The diagram of a flow apparatus similar to the one used to determine the
solubility of Chitosan in SCF is shown in Figure 2.4. In this system, the SCF is loaded to
the system with a high pressure pump and compressed to the desired operating pressure.

Figure 2.4. General Diagram of a Dynamic Flow Set-Up.

After leaving the pump, the SCF flows through a preheater within the constant
temperature bath; this ensures that it reaches the required temperature before it contacts
the heavy solute carefully preloaded into the equilibrium cell.
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After the saturated SCF-rich phase exits the column, it is expanded at atmospheric
pressure. The heavy component falls out of the solution and is collected in a cold trap.
The advantages and disadvantages of using a dynamic flow system are listed in Table 2.2.

Table 2.2. Evaluation of Dynamic Solubility System.
Advantages
Off-the-shelf equipment is used
Large amounts of solubility data can be obtained
Equilibrium, stripping, or fractionation data can be obtained
A simple sampling procedure can be used
Disadvantages
At high pressure the density of the SCF-rich phase can become greater than the density of the
solute-rich liquid phase, pushing out the liquid phase and causing inaccurate solubility data
Undetected phase changes can occur in the column, such as: solid liquid, liquid1

liquid1+

liquid2
Cannot be used to determine solubility of liquid solutes
When running multi-component mixtures, extra care should be taken to avoid completely
depleting one or more of the components.
A heavy solute can clog the system and cause erroneous solubility data.

2.3.2. Static Solubility Measurements for Supercritical Fluids
Figure 2.5 shows a diagram of a typical static view cell apparatus used to obtain
solubility information (McHugh 1984 and 1985, Seckner 1988). The main component of
this system is a high-pressure, variable-volume, view cell. This cell allows visual
determination of the phases present at equilibrium.
The cell is initially loaded with a measured amount of solute (liquid or solid),
after which a known amount of SCF is pumped into the cell. Then, keeping the
temperature constant, the mixture in the cell is compressed to a single phase by adjusting
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the volume. The reported solubility data point is the pressure interval between the twophase state and the single fluid-phase state.
The mixture critical point is defined by the pressure and temperature at which
critical opalescence is observed for a slight change in either pressure or temperature.

Figure 2.5. General Diagram of a Static View Cell Set-Up.

The advantages and disadvantages of a variable volume view cell apparatus are
presented in Table 2.3.
Table 2.3. Evaluation of Static Solubility System.
Advantages
The phase transitions are also determined visually, and phase inversions are easily detected.
The solubility of solids and liquids in binary mixtures are obtained without sampling.
Heavy solids, liquids and polymers can be studied.
Minimum amounts of chemical components or SCF are used in an experiment.
The pressure of the mixture can be continuously adjusted at a fixed composition and temperature.
Disadvantages
SCF fractionation data are not easily obtained.
Just one sample mix can be studied per loading
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2.4. Phase Equilibria
An understanding of the phase equilibrium of mixtures is fundamental for the
design of supercritical fluid processes. Accurate high pressure equilibrium data for multicomponent systems are difficult to obtain and time consuming; therefore it would be
ideal to be able to predict it from pure component properties. However, it is possible to
make such predictions in all cases, so it is useful to correlate and extrapolate limited
experimental data.
Before describing the characteristics of the phase diagrams, it is helpful to
remember the Phase Rule. The Phase Rule describes the possible number of degrees of
freedom in a (closed) system at equilibrium, in terms of the number of separate phases
and the number of chemical constituents in the system. The phase rule not only gives the
number of independent variables that should be fixed to define a multiphase, multicomponent mixture, it also specifies the topology of the phase diagrams used to represent
that behavior. This explanation is represented in Table 2.4 (McHugh and Krukonis,
1994).
Table 2.4. Summary of the Geometrical Features
of Phase Diagrams for One and Two Components.
Number of Equilibrium Phases
Degrees of

Geometrical

Freedom

Features

One Component

Two Component

System

System

3

4

0

Points

2

3

1

Lines

1

2

2

Surfaces

-

1

3

Volumes
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Phase diagrams are essential instruments for the study of supercritical mixtures,
due to the high level of complexity of the intermolecular interactions in dense fluids that
makes solubility calculations difficult and not always reliable. This is why understanding
the possible types of phase diagrams applicable for the mixture of interest, can help
minimize the amount of experimental work needed to determine the solubility levels over
wide ranges of temperature and pressure.
Before describing the possible phase diagrams for supercritical systems, some
phase transition definitions commonly used are presented in Table 2.5.

Table 2.5. Definitions of Phase Transitions Occurring at High Pressures.
Abbreviation

Transition

Description
a)

LCST

Temperature at which two liquids merge to form a single

Lower Critical

liquid phase as the system temperature decreases at constant

Solution

pressure.

Temperature

b) Temperature at which the transition described in (a) takes
place in the presence of a gas phase.

UCST

Upper Critical

Temperature at which two liquids merge forming a single liquid

Solution

phase when the system temperature is ramping up; the UCST takes

Temperature

place at a lower temperature than the LCST.
a)

For systems solid-SCF, the UCEP is the point at which the
liquid and the gas phase merge to form a single fluid phase in
the presence of a noncritical solid phase.

UCEP

Upper Critical
End Point

b) For systems liquid-SCF, the UCEP takes place at the
intersection of the UCST curve and a three-phase liquidliquid-vapor; the UCEP is also the intersection of the LLV
line with the lower temperature branch of the critical mixture
curve.

LCEP

Lower Critical
End Point

For systems solid-SCF, the LCEP takes place when a liquid and a
gas phase merge to form a single fluid phase in the presence of a
noncritical solid phase.

(McHugh and Krukonis, 1994)
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When operating at supercritical conditions, it is recommended to keep away from
regions of multiple phases in pressure-temperature-composition space, such as: liquidliquid-vapor (LLV), solid-liquid-vapor (SLV) or solid-solid-vapor (SSV) equilibrium;
because when these regions of multiple phases are projected onto a two dimensional P-T
diagram, their geometrical representations are simplified, since the pressure and
temperature (field properties) are the same in each of the equilibrium phases.

2.5. Phase Diagrams for Binary Mixtures
McHugh and Krukonis have found that many of the behaviors observed in phase
diagrams for multi-component mixtures are very similar to the phase diagrams for binary
mixtures, even if the components vary in molecular size, shape, structure and/or attractive
potential. Following their classification, a description of the phase diagrams for a
supercritical solvent and a single solute are presented in this section.

2.5.1. Type I
The phase diagram for a Type I system is shown in Figure 2.6, which illustrates
the behavior of a binary system with respect to temperature, pressure and composition by
using three-and two-dimensional plots. This phase equilibrium is characteristic for binary
systems conformed by a supercritical component and a compound of medium volatility,
or components with similar molecular diameter and/or similar interaction forces.
The light component (lower molecular weight) will be identified with number 1,
while the heavy component (higher molecular weight) will be identified with the number
2. When evaluating the interval where the molar fraction of the heavy compound (2)
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varies from x=0 to x=1, the vapor-pressure curves for components 1 and 2, they separate
into gas and liquid regions. The vapor pressure curves end at the critical point of each
component, TC1 and TC2. The critical curve, symbolized by the broken line in Figures
2.6a and 2.6b, connects the critical points and limits the two-phase region.
The molar composition of the heavy compound is denoted by x, T1 is a
temperature below the critical temperature of the components and T2 is a temperature
above the critical temperature of the light component (1).
Figure 2.6c shows that a single vapor phase will exist at very low pressures with
an equilibrium composition x* at a temperature T1 <TC1. As the pressure is isothermally
increased a two-phase vapor-liquid envelope is formed and the liquid phase becomes
visible. The equilibrium composition of the vapor and liquid phases will be given by the
horizontal tie lines in the envelope. As the pressure is increased continuously while
keeping the temperature constant at a fixed composition (x*), the amount of the liquid
phase increases while the amount of the vapor phase decreases until only a small bubble
of vapor remains, and finally the bubble of vapor disappears, turning into a single liquid
phase.

22

Figure 2.6. Phase Diagram Type I for a Binary Mixture. (a) P-T-x, (b) P-T, (c, d) P-x.

Next, as the temperature is raised to T2, where T2 >TC1, just the right end of the
molar composition x will be observed, as showing in Figure 2.6d. In this plot the lefthand side of the vapor-liquid does not touch the pressure axis; at the equilibrium
composition x* in Figure 2.6d, the vapor-liquid envelope is intersected along the dew
point curve at low pressures. As the pressure is raised, the vapor-liquid envelope is
intersected at its highest pressure, which corresponds to the mixture critical point at T2
and x*. This mixture critical point is identified with the intersection of the dashed curve
in Figure 2.6b and the vertical isotherm at T2. At the critical mixture point, the dew point
and bubble point curves concur and all the properties at each of the phases becomes the
same.
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2.5.2. Type II
This type of behavior is presented in Figure 2.7. It is similar to the Type I system,
in that the critical mixture curve is a continuous curve between the critical points of the
two pure components (1 and 2). However, at low temperatures, liquid-liquid phase
separation occurs, resulting in a liquid-liquid-vapor (LLV) line in Figure 2.7a. This LLV
equilibrium line intersects the liquid-liquid critical line (Figure 2.7b) at an UCEP (upper
critical end point). At this point, the two liquid phases become identical in the presence of
a vapor phase. Only liquid-liquid equilibria exist at pressures higher than the colored
surface, representing equilibrium of the three phases (Figure 2.7b).
The P-T group of liquid-liquid critical points is known as upper critical solution
temperature (UCST) and is not affected by pressure changes; it is just a function of
temperature for a given composition.

Figure 2.7. Phase Diagram Type II for a Binary Mixture. (a) P-T, (b) P-T-x.
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2.5.3. Type III
This type of diagrams corresponds to a system in which the critical properties of
the two mixture components are significantly different, as a result of a different
molecular weight, structure and/or intermolecular forces between the molecules.
The Type III diagram (Figure 2.8b) differentiates from Types I and II in that it has
a LLV region very close to TC1. The Te branch of the critical line that starts at TC2,
symbolized as usual as a dotted line, intersects the LLV line at the low-temperature end
known as Lower Critical Solution Temperature (LCST).

Figure 2.8. Phase Diagram Type III for a Binary Mixture.
(a) P-T-x , (b) P-T , (c) P-x , (d) P-x , (e) P-x.
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The other branch of the critical mixture temperature, which starts at TC1, intersects
the LLV line at the high temperature end known as Upper Critical End Point (UCEP), as
can be observed in the P-T diagram of Figure 2.8b.
From Figure 2.8a, it can be seen that the P-T diagram at T1, a temperature below
the LCST, is similar to the one described for the Type I system in Figure 2.6c. When the
temperature is raised to T2, where T2 < LCST, the isotherm drawn at this specific
temperature just misses the LLV line. Then in Figures 2.8a and 2.8c, a particular
envelope shape is observed, where the single liquid phase is almost divided into two
liquids to form a three phase LLV system.
When the temperature is slightly incremented to T3, the LLV line will be
intersected, as shown in Figures 2.8b and 2.8d, indicating that two liquids have been
formed in the presence of a vapor phase. At low pressures, a single vapor phase exists. As
pressure is raised, the dew point line of the liquid-vapor envelope is intersected and a
liquid phase is formed. If the pressure is increased and the overall mixture composition is
less than x*, a vapor-liquid envelope is obtained. If the overall mixture composition is
greater than x*, a liquid-liquid envelope is observed. At T3, two critical points are
observed, one at the top of the vapor-liquid envelope (TClv) and the other at the top of the
liquid-liquid envelope (TCll).
When temperature is raised to T4 = UCEP, Figure 2.8e shows the P-x diagram
expected. This isotherm intersects the vapor pressure curve for the less volatile
component, the high-temperature end of the LLV line (UCEP) and the critical mixture
curve. At low pressure, a single vapor phase exists. As the pressure is isothermally
increased the dew point curve is intersected, revealing a single liquid-vapor phase.
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2.5.4. Type IV
This type of system (Figure 2.9) is obtained when the differences in size, structure
or strength of the intermolecular forces between the two mixture components are
remarkably larger than in the Type III system.

Figure 2.9. Phase Diagram Type IV for a Binary Mixture.
(a) P-T-x , (b) P-T , (c) P-x , (d) P-x , (e) P-x.
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At T1, the LLV line and the pressure curve of the component 1 are intersected, but
at T2, the LLV line is intersected and not the pressure curve of the more volatile
component (Figure 2.9b). At pressures higher than the LLV pressure Figures 2.9c and
2.9d show that at concentrations greater than x* the liquid-liquid envelope does not
exhibit a closed dome with a mixture critical point.
The diagram is presented in Figure 2.9e shows the phase behavior when the
temperature is higher than the UCEP temperature (T3). Two phases exist as the pressure
increase. The two branches of the vapor liquid phase envelope start getting closer in
composition at an intermediate pressure, as a mixture critical point may occur; but as the
pressure increases, the two curves begin to diverge.
When the temperature is raised towards T4 the vapor-liquid envelope gets closed,
resulting in a mixture critical point (CP) at a moderate pressure. If the pressure values
become greater than the mixture critical pressure then a single fluid phase will exist at T4.
If the pressure is increased further than the mixture critical pressure, a single fluid phase
splits into two phases. Figure 2.9f shows the two-phase regions with their tie lines and
two mixture critical points (CP) at T4, depending on the overall composition of the
mixture. One critical point occurs at the maximum of the vapor-liquid envelope as the
pressure is increased isothermally from low to a moderate value, while the other mixture
critical point (CP) occurs at the minimum of the fluid-liquid envelope at higher pressures.
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2.5.5. Type V
As shown in Figure 2.10, this phase behavior is very similar to the previously
described Type III system; but in Type V phase behavior, there is no region of liquid
immiscibility at temperatures below LCST.

Figure 2.10. Type V P-T Phase Diagram.

2.5.6. Type VI
This type of equilibria is the only one that cannot be described by van der Waals
equation of state, since the components involved in these systems develop hydrogen
bonding. In these particular systems a continuous, gas-liquid critical curve and a liquidliquid critical curve intersects the LLV line at UCEP and LCEP points (Figure 2.11).
This phase behavior is found in systems with specific chemical interactions, like
water-alcohol. It consists of a liquid-vapor critical line connecting the two critical points
of the pure components TC1 and TC2, and a LL immiscibility critical line with a maximum
pressure connecting both UCEP and LCEP of the same three-phase line. Another
possibility is the existence of a second LL critical curve at high pressure with a pressure
minimum; this phenomenon is called high pressure immiscibility. Also, the low-pressure
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immiscibility region and the high-pressure immiscibility region can be combined in one
uninterrupted LL region (Andreas Bolz 1998).

Figure 2.11. Type VI P-T Phase Diagram.

2.6. Phase Diagrams for Solid-Supercritical Fluid
Solid-SCF mixtures constitute a large and important subset of binary mixes, as
was presented by Thomas J. Bruno and James F. Ely 1991. For these types of mixtures,
usually the melting point of the solid is greater than the critical temperature of the SCF.
The vapor pressure curves of both components are shown in Figure 2.12a, as well
as the melting and sublimation curves for the pure solid. A solid-liquid-vapor (SLV) line
that starts at the triple point (TP) of the pure solid and ends on the upper branch of the
gas-liquid critical curve at the UCEP, indicates that the melting point of the solid is
decreased in the presence of the supercritical fluid. This behavior can be attributed to the
fact that the SCF dissolves the solid in the equilibrium liquid phase, lowering the melting
point of the heavy component.
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In Figure 2.12b, the phase diagram for a temperature in-between the SCF critical
point and LCEP (T1) is presented. At low pressures, a solid-vapor equilibrium is
observed, for a high solid concentration. As the pressure increases, the system comes
across the SLV line. At high solid concentration, a solid–liquid equilibrium will be
reached, merging continuously into a solid-fluid equilibrium with further pressure
increments. At lower solid concentrations and pressures, a liquid–vapor equilibria
envelope is obtained with a critical point (CP) at the top of it.

Figure 2.12. Phase Diagram for a Solid-SCF System
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As the temperature increases to T2, the liquid-vapor envelope disappears at the
LCEP, becoming a single solid-SCF equilibrium region. As can be inferred from Figure
2.12c, the LCEP is a crucial point when using SCF as solvents, since small pressure
changes around it can turn the binary system Solid-SCF into a one phase system, a SCF
system. Continuing with temperature increases to T3, shown in Figure 2.12d, the
inflection point at LCEP vanishes.

2.7. Phase Diagrams for Ternary Mixtures
The phase behavior diagrams used for ternary systems consist of a supercritical
fluid and two other components that are liquids at room temperature, following the
classification suggested by Elgin J. C. 1959. The ternary phase diagrams were organized
into three different classes, based on the appearance of liquid-liquid-vapor (LLV)
regions. The diagrams are presented as three binary pairs, where each of the three
diagram axes represents a single tie line for a binary pair at a certain temperature and
pressure.
In order to be able to study a ternary system, it is required to fix three degrees of
freedom, such as P, T and overall mixture composition. The ternary diagrams shown set
the SCF in the lower left-hand corner, the least soluble component (A) in the lower righthand corner and the third component (B) is placed at the top of the triangle phase
diagram.
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2.7.1. Type I
The three diagrams in Figure 2.13 represent mixtures at a fixed temperature,
somewhat higher than the critical temperature of the SCF, and three different pressures.

Figure 2.13. Phase Diagram for a Type I Ternary Mixture

A particular characteristic of Type I systems is the absence of liquid-liquid-vapor
(LLV) immiscibility regions within the ternary diagram. Figure 2.13a shows that at
atmospheric pressure (P1), component A is miscible in all proportions with component B,
while the SCF is almost immiscible in A and slightly soluble in component B. The solid
curve in the diagram separates the one-phase liquid (L) region from the two-phase liquidvapor (L-V) region.
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In Figure 2.13b, the pressure of the system has been increased to a point slightly
below the critical pressure of the SCF (P=P2<Pc). At this pressure the SCF still remains
practically insoluble in component A but its solubility in B has increased; the tie line for
the SCF-B mixture became smaller too, reflecting that the solubility of component B and
SCF-rich phase has increased.
In Figure 2.13c the pressure is increased to a value greater than the critical
pressure for the SCF-B mix (P=P3>Pc). The SCF is now miscible in all proportions with
B, and the binodal curve does not intersect the SCF-B binary axis, while the SCF remains
insoluble in A. The binodal curve intersects the SCF-A binary axis in two places,
indicating that a liquid phase, mostly a mixture of A and B, is in equilibrium with a fluid
phase, mainly the SCF with component B.

2.7.2. Type II
This phase diagram is presented in Figure 2.14. What distinguishes this ternary
mix from other systems is that liquid-liquid-vapor (LLV) regions appear within the
pressure-composition prism but do not extend to the SCF-B face of the prism.
Figure 2.14a shows that the phase diagram at atmospheric pressure (P=P1=Patm)
is identical to the one described previously for the Type I mixture.
If the pressure is increased to P2, a pressure below the critical pressure of the SCF
(P=P2<Pc), a miscibility break appears for various SCF-A-B compositions where liquidliquid (LL) and liquid-liquid-vapor (LLV) regions are generated, as shown in Figure
2.14b.
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In Figure 2.14c, the pressure is increased to P3, where (P=P3=Pc), and the LL and
LLV regions expand considerably. If the tie lines in the LL region become parallel to the
A-B binary axis, the selectivity yA / xA / yB / xB approaches values greater than 1.0,
indicating that a very good separation of A from B could be obtained at this condition.

Figure 2.14. Phase Diagram for a Type II Ternary Mixture.
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If the pressure is further increased above the critical pressure for the SCF-B
mixture (P= P4>Pc), the LLV miscibility gap disappears and the phase behavior becomes
identical to that described for a Type I ternary system (Figure 2.13d), where at most two
phases exist.

2.7.3. Type III
The distinguishing feature of Type III ternary phase behavior is that the binary AB mixture is immiscible at very low pressures, as can be seen in Figure 2.15a. As SCF is
added to the A-B mixture (Figure 2.15b), a very large LLV region appears in this
diagram, then by increasing the pressure, the LL region close to the A-B axis expands. If
the pressure value is greater than the critical pressure for the SCF-B mix (P=P3>Pc), a
single liquid-fluid solubility curve is formed. In Figure 2.15c, the liquid-fluid solubility
curve intersects the A-B axis at the end of the binary A-B tie line, indicating that, even at
an elevated pressure, a miscibility region still exists in the A-B binary system.
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Figure 2.15. Phase Diagram for a Type III Ternary Mixture.

For Type III ternary systems, the liquid-liquid region increases with increasing
SCF content (Figure 2.15b). Even if B is only slightly miscible with A at low pressures
and in the absence of SCF, it is possible to use the SCF to separate even more A from B.
Although the classification for ternary systems is described here at a fixed
temperature, it is important to remember that any single binary system can exhibit all
three types of phase behaviors as the temperature of the system changes. This implies that
a Type I ternary system may behave as a Type II or Type III ternary system if the
operating temperature and pressure are adjusted to values near the critical point of the
SCF solvent.
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2.8. Phase Diagrams for Polymers
An important subset of high-pressure phase diagrams is the one for polymer-SCF
mixtures. The scientific interest in the high-pressure phase behavior of polymer solutions
was initially motivated by the technology required to make polyethylene.
In order to facilitate the study of this system, the polymer is considered as a
pseudo-single component, describing the phase behavior by using the same diagrams
presented before.

Figure 2.16. P-T Diagram for a Polymer-SCF System.

Figure 2.16a shows the schematic P-T diagram for a Type III (small polymer
molecules) system where the vapor-liquid equilibrium curves for two pure components
end in their respective critical points, C1 and C2. The steep dashed line in Figure 2.16a at
the lower temperature is the P-T trace of the UCST curve. The other critical mixture
curve shown in Figure 2.16a starts at the critical point of the less volatile component,
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shows a pressure maximum, and intersects an LLV region at conditions usually close to
the critical point of the more volatile component. The portion of the curve named LCST
is where the two phases (liquid-liquid) coalesce into a single phase when the temperature
is lowered at a constant pressure.
Figure 2.16b shows the P-T diagram for a pseudo-binary polymer-solvent mixture
that is similar to the diagram given in Figure 2.16a. It this case the large difference in the
molecular size of the mixture components (polymer and carbon dioxide) suppress many
of the features of the phase diagram shown in Figure 2.16a. A pure polymer does not
have a critical point or vapor pressure curve, so the high temperature portion of the
critical mixture curve does not exist in Figure 2.16b.
Both the UCST and the LCST branches of the chemical mixture curve are usually
referred to as cloud point curves. For polymer-solvent systems, the pressure or
temperature interval for a clear to totally opaque fluid to liquid-liquid transition along the
UCST or LCST curves can be one hundred times greater than the interval for small
molecule systems. The phase transition is not very distinct; it just progressively gets
cloudier and cloudier, and so the name cloud point.
UCST curve for a polymer-solvent system is usually attributed to enthalpy
interactions between the mixture components, which are not affected by small pressure
changes. However the LCST curve is usually attributed to the large difference in the
thermal expansion or free volume of the polymer and solvent. As the mixture is heated,
the solvent expands at a much faster rate than the polymer, so that the dissolution of the
polymer in the solvent is associated with a large decrease in the change of entropy of
mixing. This entropy decrease occurs as solvent molecules are forced to condense around
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the polymer to dissolve it. At the end the amount of entropy released while forming a
single phase is so great that the free energy of mixing becomes positive and the solution
splits into two phases.
Figure 2.16c shows a Type IV P-T diagram that could take place with small
molecule mixtures if the difference in size and/or the intermolecular potentials of the
mixture components becomes very large. The occurrence of the phase behavior shown in
Figure 2.16c can be tracked back to Figure 2.16a. As the disparity in the properties of the
two components increases, the temperature range between the UCST and the critical
mixture curves shown in Figure 2.16a becomes smaller and smaller. Eventually the
difference in properties of the mixture components becomes so large that the UCST and
critical mixture curves merge into a single critical mixture curve, exhibiting a pressure
minimum at low temperatures.
Figure 2.16d shows how Figure 2.16c is transformed into a polymer-solvent
system where the cloud point curve is the result of combining the LCST-type transitions
at high temperatures and the UCST-type transitions at lower temperatures.
The molecular weight distribution of the polymer also has another effect on the
phase diagram; Figure 2.16b shows that at pressures below the LLV line, the vapor and
the liquid phases exist in equilibrium, but if the molecular weight distribution of the
polymer is large, the LLV line becomes an area. This is because the system is now truly a
multi-component system and the LLV line shown in Figure 2.16b in fact represents the
highest pressure at which three phases exist for a highly poly-disperse polymer.
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2.9. Modeling Supercritical Fluid Equilibria
In order to be able to design and evaluate supercritical fluid processes, it is
essentially useful to have accurate models. Unfortunately, the properties that make SCF
so useful such as: the high compressibility, the asymmetry of the system and the
mathematical singularity of the critical point itself make modeling it difficult.
There are quite a few models for supercritical phase equilibriun most of them the
SCF phase is treated as a dense gas and an equation of state (EOS) is used to calculate the
fugacity coefficient.
When a supercritical solvent and a solute i are in equilibrium, the fugacity of the
component i in the supercritical fluid phase can be determined with the following
equation:
(1)
In this approach the results are susceptible to the composition dependence of the
interaction energies and size factors, making mixing rules extremely important. Another
difficulty in this approach is that to estimate the fugacity coefficient in a supercritical
phase requires the integration through the critical region where most EOSs are less
accurate.
Another approach considers the SCF phase as an expanded liquid, and as a result
the fugacity is given by:

(2)
where:
i

: Is the composition dependent activity coefficient at the reference pressure.
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Po: Reference pressure.
foL: Is the fugacity of the pure reference liquid.

v i : Is the partial molar volume of component i.

If the reference pressure is supercritical, it is not necessary to make the integration
on the critical region; however, an EOS should be used to calculate the partial molar
volume and a reference activity coefficient will be required.
When working with solids, the cubic equations cannot predict the fugacity, and
for this reason it will be determined by modeling i as a pure component, and the fugacity
equation obtained will be:

(3)
where:
f iS : Fugacity of a component i as a pure solid phase.

Pisat T : Sublimation pressure of the pure component at the same temperature.
S
i

: Molar volume of the pure solid.

sat
i

T : Fugacity coefficient at T and Pisat (correction factor for high pressure).

: Pointing correction factor.

The volume of the solid can be considered constant for a given temperature (T),
so the pointing correction factor is simplified to:
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.

Following the same analysis the fugacity coefficient for a pure solid

sat
i

T at a

given temperature can be considered one (1) since the saturation pressure for a solid is
less than 1 bar. Then considering all these simplifications in equations 1 and 3, the
solubility for a heavy solid in supercritical fluid can be determined with the following
equation:

(4)
The fugacity coefficient of the solid in the SCF phase is the most important
variable in this equation, representing the solubility increase as the gas is compressed into
the critical region. The fugacity coefficient describes the non-ideal behavior observed
when the gas density increases from ideal gas values at very low pressures, where the
molecular interaction is much lower compared to liquid-like densities at high pressures.
At a fixed temperature, the solubility increases in the supercritical fluid solvent with
pressure increments, as

SCF
i

decreases much more rapidly than the pressure increases or

than the exponential term in the numerator increases, particularly near the critical point.
The most widely used method of analysis for supercritical equilibrium systems
are Equations of State (EOSs). Cubic EOSs are easily extended to multi-component
systems by using mixing rules. They can be derived by considering a first order
perturbation with a hard sphere reference system and making some simplifications and
assumptions. The most basic EOS known is the van der Waals (vdW), obtained by
considering that the integral of the perturbing intermolecular potential for a pair of
molecules is constant. The vdW EOS can predict almost all types of phase behaviors
43

qualitatively, but not necessarily quantitatively. Other EOSs like Redlich-Kwong (RK)
(1949), the Soave modification of Redlich-Kwong (SRK) (1972) and the Peng-Robinson
(PR) equation (1976) incorporated some improvements, like the assumption that the
perturbing intermolecular potential is temperature and density dependent, calculating the
parameters from critical properties and optimizing the parameters by fitting pure
component vapor pressure or liquid molar volume data.
Another model successfully used to describe liquid phase behavior in highly
asymmetric polymer solutions is the Lattice-Gas EOS. The lattice-gas model is based on
the distribution of molecules and holes, or vacant lattice sites, in a three dimensional
lattice. Lattice models have been used to address the fact that the behavior in the
immediate vicinity of the critical point is non-classical and cannot be described by
classical EOS like vdW. Non-analytical lattice-gas models have been developed that are
accurate in the critical region. Wheeler (1972) developed an equation able to describe the
limiting behavior of dilute solutions near the critical point. Gilbert (1986, 1987) described
a lattice-gas model able to fit molar volume and solubility data for highly asymmetric
SCF-solid mixtures using two adjustable parameters.
When working with polymers and SCF at high pressures, a lattice-gas model is
recommended, as the pure component properties are calculated assuming that each
component can be broken into small parts (mers), and these parts will each have their
own particular hole or space (lattice), generating a specific density for system. Flory‟s
research group developed the theory of solutions (1964-1970) known as Flory‟s theory,
where they were able to demonstrate that the thermodynamic properties of a mixture
depends in the thermodynamic properties of the pure components. For example, the
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LCST behavior normally observed of polymers phase diagrams, is a consequence of the
differences on the thermodynamic properties of the polymers and solvent components in
the mixture. Flory‟s model does not apply for systems where there are strong specific
interactions; to dilute solutions and it neglects the free volume effect.
In 1977 Sanchez-Lacombe developed a lattice-fluid theory, in which the
vacancies or empty lattice sites are accounted for the compressibility and density
changes. This model does not require separation of internal and external degrees of
freedom, as in Flory‟s theory. External degrees of freedom are attributed only to
intermolecular forces, and internal degrees of freedom are related to intra-molecular
chemical bond forces.
Perturbation models such us the Statistical Associated Fluid Theory (SAFT)
developed by Chapman et al. (1990) are more sophisticated than the lattice-fluid models.
This theory has a wider range of applicability, since the mixture density is considered a
function of pressure, temperature and composition. This EOS considers the association
between resembling molecules and solvation between contrasting molecules. This makes
the theory more accurate, but at the same time more complicated, since additional
equations and parameters are required.
SAFT is an EOS that incorporates terms to describe the molecular size and shape
(including chain length and branches), association energy (like hydrogen bonds) and
dispersion. The reference part of SAFT includes hard-sphere, chain and association
terms, while the perturbation part of SAFT accounts for mean-field dispersion effects.
The characteristic parameters for the pure substances involved in a mixture can be
determined from vapor-liquid equilibrium data (VLE), vapor-pressure-temperature data
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(VPT) or from the molecular weight. All this makes SAFT an attractive method to use,
when using well known and characterized components. However when working with
substances like the one required for this research, Chitosan Oligosaccharide Lactate, this
model is difficult to use, since no molecular properties, VPT or VLE data are published.
A technique that complements all the methods already mentioned are computer
simulations, which are not yet effective tools for modeling SCF phase equilibria due to
the non-analytic nature of the results and the time consuming computing calculations.
Still, the calculations may provide a good approach on the molecular level to outline the
basis for improved mathematical models. Monte Carlo simulation has been used to
predict SCF equilibria with an isobaric-isothermal assembly which accounts for density
fluctuations to calculate solid solubility in SCF. Qualitative and quantitative agreement
were obtained using Lennar-Jones potentials, plus quadrupole interactions for the system
naphthalene-SCCO2.
Working with polymers in a multicomponent supercritical mixture is a complex
problem, where most of the theoretical approaches cannot accurately predict the
thermodynamic interaction of such a different conglomeration of molecules. The use of
global phase diagrams provides a logical method to investigate the phase behavior of
simple and complex mixtures. Initially this technique was applied for simple binary
mixtures (Deiters and Pegg 1989, Lamm and Hall 2001, Patel 2008, Patel and Sunol
2009), while lately the interest has turned to more complex systems like polar substances
and polymer mixtures (Kraska 1996, Yelash and Kraska 1999, Polishuk et al. 2000).
When generating a global phase equilibrium diagram from EOS, the boundaries
between the different types of phase behavior can be obtained by calculating high order
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thermodynamic states, which represent transition states between different types of phase
behavior. In order to work with multicomponent mixtures, sub-systems of binaries can be
studied separately and used as pseudo pure substances.
As presented in this section, there are different approaches to model phase
equilibria for SCF, and no single model will work for all situations. The compromise
between accuracy and convenience will always exist.
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CHAPTER 3
SUPERCRITICAL ENCAPSULATION TECHNIQUES

In this chapter, a review of published papers and patents on particle encapsulation
using different supercritical techniques and their classification according to the different
concepts currently used is made. Encapsulation methods using supercritical fluids
basically follow two tracks: the homogeneous supercritical solution track or the
heterogeneous multi-phase track. In addition, the heterogeneous track contains a subclassification where the carbon dioxide possibly combines with a cosolvent, or can be
used as a solvent or antisolvent for the encapsulant material. A set of tables are presented
in Appendices A and B contain summarized information (Papers and Patents) for the
different SCF techniques used to encapsulate particles in the size range from 0.5 to 500
m for different industrial applications. For this work, the term particle encapsulation
indicates that a core solid material is covered by a shell or coating material. This term can
be used for single core encapsulation (Encapsulated Single Particle) or multiple core
encapsulations (Encapsulated Particles).
At this point it is helpful to recap some information introduced in Chapter I.
Encapsulation of fine particles to produce tailored surface properties is currently a key
development of supercritical fluids applications, in areas like: pharmaceutical,
nutraceutical, cosmetic, agrochemical, electronic and specialty chemistry industries. A
direct result of the industrial application is that a considerable number of publications and
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patents are filed every year. This chapter presents a review of published information
classified according to the different concepts currently used to encapsulate particles, and
is as comprehensive as possible.
During the encapsulation process, the particle surface can be engineered with
specific physical, chemical, and/or biochemical properties by spreading a thin film of
material on the surface of the particles. As a result, the flow-ability, dissolution rate,
controlled release or masking, dispersability, chemical reactivity, bio-efficacy, and
hydrophilicity of particles can be modified for a variety of applications.
Several traditional encapsulation processes are used at industrial levels. These can
be classified into two broad categories with possible hybrid mechanisms: physical
methods (vibrating nozzle, rotating disk, pan coating, fluidized bed, freeze-drying, spray
drying, etc.) and chemical methods (coacervation, phase separation, interfacial
polymerization, in situ polymerization, sol–gel methods, etc.). Usually these
encapsulation methods require large amounts of organic solvents, surfactants, and other
additives, leading to volatile organic compound (VOC) emissions and other waste
streams. Other drawbacks include low encapsulation efficiency and further processing of
the products such as downstream drying, milling, and sieving, which are usually
necessary. In addition, residual toxic solvent in the end products, temperature and pH
requirements, and strong shear forces are overwhelming challenges for maintaining the
delicate structure of some chemical and biochemical ingredients.
Micronization and recrystallization of pharmaceutical compounds using
supercritical fluids has many advantages over other traditional methods like spray drying,
jet milling, grinding, and liquid antisolvent techniques. There has been growing interest
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in replacing conventional organic solvents with environmentally friendly supercritical
fluids in chemical processes. Supercritical carbon dioxide (SCCO2) became an excellent
candidate due to its characteristics and properties: it has mild critical conditions (Tc =
304.1 K, Pc= 7.38 MPa), and is low cost, non-toxic, non-flammable, readily available,
easily recycled, and as a solvent, it possesses a unique combination of gas-like diffusivity
and liquid-like density and solvency (Krukonis 1985). At this point of time, SCCO2 has
been used as solvent or processing medium demonstrating successful results in numerous
areas, initially with supercritical extraction and separation, and more recently with
particle formation, coating and encapsulation (Yeo 1993, Reverchon 1998).
During the past decade, supercritical fluid processes have attracted increasing
attention for particle engineering, including fine particle formation, coating, and
encapsulation (Jung 2001). These have included Rapid Expansion of Supercritical
Solutions (RESS), (Tsutsumi 1995, Wang T. J. 2001, Wang Y. 2002, Mishima K. 2000,
Kim J. H. 1996, Tsutsumi A. 2003, Matsuyama K. 2003, Sun Y. P. 1998, Matsuyama
2003), Gas Antisolvent (GAS), and Precipitation with a Compressed fluid Antisolvent
(PCA) (Falk 1997, Young 1999), also known as Aerosol Solvent Extraction System
(ASES) (Bleich 1996) or Supercritical Antisolvent method (SAS) (Wang Y. 2005,
Elvassore 2001, Wang Y. 2004, Duarte 2006).
Pressure or temperature changes can produce regions of supersaturation, which
result in the formation of fine and uniform solid particles. The term supersaturation refers
to a solution that contains more of the dissolved material than could be dissolved by the
solvent under normal circumstances. Supersaturated solutions are prepared or result when
the temperature increases at constant pressure, or the pressure increases at constant
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temperature of a saturated solution. Small particles (seeds) can trigger the separation of
the dissolved material from the solvent.
When using supercritical fluids to produce solid materials independent of the
technique used, two basic mechanisms of phase separation occur: nucleation or spinodal
decomposition. If the initial condition from which the new phase is formed is metastable,
the phase transition occurs by nucleation. If the starting condition is unstable, the phase
transition occurs by spinodal decomposition.
Nucleation is an activated process where a free energy barrier must be eliminated
in order to form a nucleus of the new phase within the metastable mother phase, while
spinodal decomposition is a spontaneous process. The height of the nucleation free
energy barrier is the result of the competition between the formation of an interface,
which involves an energy cost, and the formation of a bulk stable phase, which is
energetically favorable. The formation of a new phase by nucleation is the result of the
activated growth of localized fluctuations of large amplitude. Nucleation normally occurs
at nucleation sites provided by suspended particles or small bubbles; this is called
heterogeneous nucleation. Nucleation without preferential nucleation sites is known as
homogeneous nucleation (Debenedetti 1998).
In contrast, spinodal decomposition involves fluctuations of any amplitude that
grow spontaneously, exceeding the critical wavelength. Spinodal decomposition is the
preliminary procedure by which an unstable phase settles down to equilibrium. The type
of perturbation considered in thermodynamic stability theory is large in extent but small
in intensity, like a small density (or any intensive property) change occurring over a
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large-scale volume. In the thermodynamic viewpoint, loss of stability with respect to such
perturbations occurs at a precisely specified condition: the spinodal (Figure 3.1).
In Figure 3.1, the binodal and spinodal curves merge at the critical concentration.
Inside the binodal curve, the system is unstable and undergoes a spontaneous phase
separation. Between the binodal and spinodal curves (shaded region), the system is
metastable. Outside the binodal curve the system is fully miscible (one phase).

Figure 3.1. Phase Transition by Nucleation and Spinodal Decomposition.

In polymer systems the nucleation kinetics is significantly slower, leading usually
to spinodal decomposition. The critical polymer concentration corresponds to the
condition where

, where the curvature of the free energy function is

zero, at the spinodal point. The shape of the free energy function can be changed by
adjusting temperature or pressure conditions. If the pressure is kept constant and the
temperature is adjusted, two general polymer systems can be differentiated. Polymer
systems that become miscible upon increasing the temperature are known as UCST
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(Upper Critical Solution Temperature). Polymer systems that become miscible upon
decreasing the temperature are known as LCST (Lower Critical Solution Temperature).
These concepts, that are well known for polymer solutions at ambient pressures, are valid
as well for solutions near and at supercritical conditions. At any pressure, depending on
the nature of the combination polymer-solvent, the solution could display UCST or LCST
or some combination of these (Kiran 1998).
In Figure 3.2, curve a represents a complete miscible system, and curves b, c and
d represent the variation in shape of the free energy function which occurs when
temperature is increased or decreased.
The route for particle synthesis and encapsulation using supercritical fluids
basically follows two tracks: the homogeneous supercritical solution track or the
heterogeneous track (Sunol 2001). On the heterogeneous track a sub-classification is
suggested, where the CO2 can be a solvent or an antisolvent for the coating material. The
schematic explanation for each of these tracks is presented in Figure 3.3.
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a)

b)

Figure 3.2. Binodal and Spinodal Curves in Polymer Systems. a) LCST and b) UCST
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The morphology of the resulting solid material depends on the material structure
(crystalline or amorphous, composite or pure, etc.) and of the RESS parameters
(temperature, pressure drop, distance of impact of the jet against the surface, dimensions
of the atomization vessel, nozzle geometry, etc.) (Tsutsumi 1995, Wang T. J. 2001, Wang
Y. 2002; Mishima K. 2000; Kim J. H. 1996; Tsutsumi A. 2003; Matsuyama K. 2003; Sun
Y. P. 1998; Matsuyama 2003).
Different methods have been described for the encapsulation of powders using
RESS (Kim J. H. 1996) and its derived processes (Wang Y. 2002) obtained by coupling
with a non-solvent (RESS-N) (Mishima K. 2000, Matsuyama K. 2003) or with a fluidized
bed (Tsutsumi 1995, Wang T. J. 2001). All of them will be described in this review.
a)

Figure 3.3. Route for Particle Encapsulation. a) Homogeneous track.
b) Heterogeneous track (CO2 as a solvent). c) Heterogeneous track (CO2 as antisolvent).
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b)

c)

Figure 3.3. (Continued)
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GAS (Gas Antisolvent) is also referred to as SAS (Supercritical Antisolvent).
SEDS or Solution Enhanced Dispersion by Supercritical Fluids is a particular
modification of this process, where the supercritical fluid is used as an anti-solvent that
causes precipitation of the substrate(s) dissolved initially in a liquid solvent.
This method is based on the principle that a batch of solution is expanded several
times by mixing with a supercritical fluid in a vessel, causing the solute precipitation.
Due to the dissolution of the supercritical fluid, the expanded solvent has a lower solvent
strength than the pure solvent. The mixture becomes supersaturated and the solute
precipitates (Wang Y. 2005, Elvassore 2001, Wang Y. 2004, Duarte 2006).
An important feature of the SAS process is that the organic solvent can be almost
completely removed by simply washing it out with pure CO2 and as a result, dry particles
are produced. Compared to RESS, the SAS process offers much more flexibility in terms
of choosing suitable solvents. Furthermore, SAS has advantages over RESS because SAS
is usually operated under mild conditions compared with those of RESS, which is
associated with relatively high temperature and high pressure (Chang 1989, Matson 1987,
Tom 1991).
ASES or PCA (Precipitation with a Compressed Antisolvent) is used when microor nano-particles are expected. The process consists of pulverizing a solution of the
substrate(s) in an organic solvent into a vessel swept by a supercritical fluid, then
spraying the solution through an atomization nozzle as fine droplets into compressed
carbon dioxide. The dissolution of the supercritical fluid into the liquid droplets is
accompanied by a large volume expansion, which leads to a reduction in the liquid
solvent power. The weaker liquid solvent power causes a quick rise in the super57

saturation within the liquid mixture and the consequent formation of small and uniform
particles (Falk 1997, Young 1999, Bleich 1996).
PCA enables production of relatively monodispersed, sub-micron sized particles
of biodegradable polymers. This process is quite flexible in terms of solvent choice, as
well as for polymer and drug also. The only stipulations on solvent choice are that the
compressed antisolvent can readily dissolve in it and expand it. Nearly all organic
solvents meet these criteria.
Recent studies with PCA applied to drug processing have shown difficulties in
incorporating the drug into the release matrix, as well as undesirable conformational
modification of proteins. A process of dissolving ionic species in non-aqueous
environments, Hydrophobic Ion-Pairing (HIP), was developed and successfully applied
to these problems.
HIP is a technique whereby ionic pharmaceutical agents and proteins can be
directly solubilized in organic solvents. It consists of pairing charged halves of the
molecule with oppositely charged surfactants possessing some hydrophobic character,
effectively increasing the molecule‟s solubility in low-dielectric organic solvents by
orders of magnitude. Anionic surfactants have been used exclusively for this work due to
their low toxicity, while the cationic sites on the pharmaceutical compound or protein are
masked with detergent molecules. The drug, surfactant, and residual water of hydration
form what is referred to as a HIP complex. This technique makes it possible to obtain true
homogeneous solutions of ionic compounds in neat organic solvents, with the only
requirement being an accessible positive charge (Falk R. 1997).
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Microencapsulation of pharmaceutical compounds in biodegradable polymer
particles is of great interest for the development of new controlled drug-delivery systems.
Several medical methods, depending on the required particle morphology, can be used for
this purpose including, aerosol, inhalation, and systemic and subcutaneous injections.
Typically, particles in to the range of 5-100 μm are subcutaneously injectable, 1-5 μm
particles are suitable for aerosol delivery and inhalation therapy to the lungs, while
nanoparticles can be directly injected in the systemic circulation. Even with a
considerable number of studies of the preparation of pharmaceuticals coated with
polymers for controlled release applications, the development of a micro-encapsulation
method with environmentally benign solvents still remains a challenge. Solvent
impurities are often toxic and also may degrade pharmaceuticals within a polymer matrix.
Polymers in general have very limited solubility in SCCO2 at temperatures below
80°C (Lele 1992 and 1994, Tom 1994, O‟Neill 1998). However, solubility can increase
significantly at higher temperatures and very high pressures, often above 300 bar (Lele
1994, Tom 1991, Mawson 1995).
Another encapsulation method, well adapted for batch operation, involves
polymerization on the particle surface in SCCO2. This method is equivalent to the
emulsion polymerization route in aqueous media, except that SCCO2 is used as the
polymerization solvent (Cooper 2000).

SCCO2 is a classical solvent used for

polymerization reactions of methyl methacrylate, MMA (Wang W. 2002, Shiho 2000).
More recently, encapsulation in SCCO2 has been found to be of particular interest for
recovering and processing metal oxide nanoparticles (Liu 2003). Metal powders are
common components of pyrotechnic and solid propellants. Coating of metal powders
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reduces their deterioration through corrosion and aggregation caused by moisture or other
aggressive surroundings. Coating of metal nanoparticles with polymers also reduces their
flammability and makes them safe to handle. The technologies currently used in the
industry for coating of solid substrates, such as the Wurster coating process or fluidizedbed coating, employ common organic solvents. Replacement of organic solvents with
SCCO2 could result in an alternative, environmentally friendly approach.

3.1. Homogeneous Pathway
Particle encapsulation using the homogeneous track is not very easy, since all the
components (including coating material, core and cosolvent (if required)) should be
soluble in SCCO2, and after that they have to be precipitated following an appropriate
sequence.
Kim Jong-Hyun (1996) used the rapid expansion of supercritical solutions (RESS)
process to make polymeric microparticles or microspheres of poly-(L-lactic acid) (LPLA) loaded with pharmaceuticals (naproxen) for drug delivery applications.
The liquid solvent carbon dioxide was compressed to the desired pressure by a
high-pressure syringe pump. Before it entered the extraction vessel, the solvent was
preheated up to the extraction temperature. The solvent entered the extraction vessel,
loaded with L-PLA and naproxen mixture. Next, the saturated solution flowed to the preexpansion unit wrapped with double-insulated heating tape to prevent phase changes
upon expansion and choking problems in the capillary tube caused by premature
precipitation of solute or solid CO2. After that, the supercritical fluid solution was
expanded through a capillary tube serving as the expansion device.
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Several process variables were studied (L/D nozzle ratio, pre-expansion
temperature, and extraction pressure) that could affect the morphology of the processed
naproxen and L-PLA particles. Microspheres and some microspherical agglomerates
dominated the morphology, L-PLA microspheres (10-90 μm) loaded with naproxen and
some free naproxen microparticles (1-5 μm) were observed.
From the results presented, the presence of agglomeration is constant in almost all
the experiments. This indicates that this is not a simple system, and an enhancement in
the precipitation conditions (T-P) is required to make this step smoother. It is important
to mention that all the precipitation methods presented in this chapter were initially used
to make particles with a supercritical technique, and they have been adjusted for coating
purposes, due to all the advantages that SCF offers.
From the information reviewed and following the classification used, the SCF
precipitation methods are heterogeneous or homogeneous. In the heterogeneous ones
there is a sub-classification where the CO2 can be a solvent or an antisolvent for the
coating material.
Homogeneous systems are less frequently used because solubility in CO2 is
limited to low-polarity substances. In addition to this, a homogeneous systems requires
very fine control of the operation variables in order to be able to obtain the right
deposition order. However, if all the conditions are given, this could be a powerful
method where the deposition order, the particle size and the coating thickness would be
tunable parameters.
In RESS processes, the nucleation phenomena is straightforward: as soon as the
pressure decreases, the dissolved solute precipitates. However, it is not easy to control
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the thickness and uniformity of the coating, because this precipitation phenomena can
happen in just 10-5 s. Another difficulty with a RESS process is the elimination of the
cosolvent to trace levels, which sometimes can be a problem. However, this process is
usually considered because the implementation costs are lower than in an antisolvent
process and deposition will always occur.
Antisolvent processes are recommended for systems where the coating material is
not soluble on the SCF. In this case an entrainer will be used, and the use of this
technique will allow reducing the amount of cosolvent or entrainer to trace levels in the
final product just by flushing it with pure CO2. Rapid expansion techniques show better
results when working with particles between 10-90 m, and antisolvent methods work
reasonably well with particles under 10 m.
Using the data presented by authors cited in this paper, we see that the use of SCF
in a fluidized bed improves the quality of the coating, but still when working with
particles under 100 m, agglomeration is a common factor.
When temperature is used as the perturbation condition to initiate the
precipitation, a better control and uniformity of the coating is obtained.

This was

confirmed in Sunol (1998), where an antisolvent process was described in which the
precipitation was induced by a temperature change, allowing the formation of a coating
film as thin as 0.2 m. Another author that used temperature adjustments in SCF to
precipitate a coating over small particles (2-3 m) was Pessey (2000), who obtained a
thickness of 0.2-1 m.
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3.2. Heterogeneous Pathway
On the heterogeneous track, the ternary system integrated by a core substance, a
coating material, an optional co-solvent and the supercritical solvent form the
heterogeneous mixture. The supercritical fluid can be used as a solvent for the coating
material, and a pressure or temperature perturbation is introduced to cause the
precipitation. Another option can be using the supercritical fluid as antisolvent, where the
mixture becomes supersaturated, thus precipitating the coating material.

3.2.1. Carbon Dioxide as a Solvent
What characterizes this particular coating track is that the coating material is
completely soluble in pure SCCO2, or in the system cosolvent-SCCO2.
One of the first supercritical fluidized-bed coating processes with the rapid
expansion of fluid solutions (RESS) was presented by Tsutsumi Atsushi (1995).
Spherical catalyst particles (average particle size of 56 μm) were coated with paraffin by
expanding a supercritical carbon dioxide solution of paraffin through a nozzle into a bed
that was fluidized by air. Tsutsumi reported no significant agglomeration during coating
and, using a gravimetric method, estimated the thickness of paraffin layer coated on the
core particles to be below 0.5 m.
A new method for coating polymeric thin films on particles was achieved via
simultaneous nucleation of polymeric material, by encapsulating the fluidized particles in
the supercritical fluid, and further curing and binding the material coated on the particles,
Sunol et al. (1998). A schematic description of the multi-purpose pilot plant used is
shown in Figure 3.4.
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Figure 3.4. The Supercritical Fluid Aided Materials Processing Pilot Plant. (Sunol 1998)

The prototype system used carbon dioxide as the supercritical solvent and
hydroxyl terminated poly butadiene (HTPB) as the polymer. The particles coated were
sodium chloride crystals and ammonium nitrate, with a particle size range of 30-500 m
and film thickness as low as 0.2 m.
The particles were fluidized with supercritical fluid recirculated through a
recirculation pump in a closed loop. The loop was maintained at a low but supercritical
temperature, while the fluidized bed was controlled at a higher temperature, in order to
decrease the solubility, precipitating the coating material and promoting the
polymerization. In order to achieve successful fluidization, the liquid feed containing
monomer/polymer, catalyst, and the curative were introduced into the recirculation loop,
which operated at a temperature that maximized solubility. The operation continued in
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the recycle mode until satisfactory level of coating and curing was achieved. Then, the
system was shut down through a procedure that avoided further polymerization and
precipitation of the polymer.
The surface characteristics of the polymer encapsulant were quite uniform. SEM
and AFM both confirmed the deposition of a defect free, self-planarizing, encapsulating
layer on the selected particulate materials.
This particular coating method can be distinguished from regular coating
processes, since the precipitation is a consequence of a temperature increment instead of
depressurization; this suggests a better control on the coating, given that the precipitation
process is slower, providing more time for thermodynamic stabilization of the system.
In 2000, Pessey et al. presented particular “core-shell structures,” Ni/Cu and
SmCo5/Cu, by thermal decomposition of bis(hexafluoroacetylacetonate)-copper(II) in the
supercritical mixture CO2/ethanol. Ni particles with an average diameter 3

m and

thickness of 0.2 to 1 m were obtained.
The experimental system required a high-pressure reactor made of stainless steel
and the internal walls covered with poly(tetrafluoroethylene) film (PTFE; thickness 0.25
mm) to avoid contamination of the cell‟s wall. An external heating resistor allowed the
precursor to reach the decomposition temperature. The temperature of the cell‟s bottom
was TA, while the temperature of the cell‟s top was maintained constant at TB (with TB >
TA), creating a convective movement produced by the temperature gradient (TB - TA). At
the same time, the precursor decomposition occurred and released atomic copper, which
coated the in-movement particles. The experimental set-up is shown in Figure 3.5.
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Figure 3.5. Apparatus for Particle Encapsulation by Thermal Decomposition.

A strong point of this process is that after the decomposition stage the organic part
of the precursor is still soluble in the supercritical fluid and is easily removed when the
vessel is vented and easily trapped at the outlet of the installation. After the return to
ambient conditions, the coated particles are directly obtained free of solvent and organic
contamination.
Mishima et al. (2000, 2001 and 2003) presented a rapid expansion method they
named RESS-N, since they used a cosolvent (methanol, ethanol, propanol) that as pure
component was a non-solvent for the coating material (poly ethylene glycol (PEG),
poly(methyl methacrylate) (PMMA), poly(L-lactic acid) (PLA), poly(DL-lactide-coglycolide) (PGLA) and PEG-poly(propylene glycol) (PPG-PEG) triblock copolymer).
The solubilities of these polymers in CO2 increased significantly with low-molecular
weight alcohols as cosolvents. Particles of lysozyme (24
acetamidophenol,

acetylsalicylic

acid,

m), lipase (19

1,3-dimethylxanthine,
66

flavone,

m), p
and

3-

hydroxyflavone (15 m) and TiO2 (35 and 320 nm) were coated following the procedure
presented in Figure 3.6.

Figure 3.6. Formation of Polymeric Microcapsules by RESS-N.

With this work, the authors made a great contribution in the coating arena, since
particles between 6 and 62 m were coated with different polymers and the SEM results
showed they got good coverage. The most important contribution was the development
of a technique where the cosolvent could be easily removed from the final product, as
evidenced by the amount of residual cosolvent in the microcapsules, which was less than
1 wt. %.
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Glebov (2001) used SCCO2 to apply polymeric films on fused silica plates and
metal (Al, Mg) powders (20 μm). The polymers used were poly (vinylidene fluoride) and
poly (4-vinylbiphenyl) (PVB).
Solutions of polymers in SCCO2 were prepared in a batch stirred high-pressure
temperature-controlled reactor, and samples of metal powders and/or of fused silica
substrates were placed in an auxiliary vessel (sampling volume) connected to the reactor
through a sampling valve. After the desirable reactor temperature was achieved, the
sampling valve was opened and the auxiliary volume was connected to the reactor. After
10 min the sampling valve was closed, and the reactor was discharged to the atmosphere.
The sampling volume was allowed to cool and then discharged. The thicknesses of the
films reported were in the range of 1-30 nm.
In 2001, Wang Ting-Jie used a rapid expansion of supercritical fluid solution
(RESS) process for the coating granulation of fine particles in a fluidized bed. He used
CO2 as a solvent, paraffin as a binder, fine particles of SiO2 (d= 1μm) as coating material
and glass beads as core particle (d=130 μm). What makes this process different is that
core particles and fine particles were employed to simulate the drug-carrier and the drug
in pharmaceuticals. The core particles carried the drug of fine particles to the human
body and dispersed them. The releasing control of the fine particles was determined by
the surface coating on the fine particles. The core particles and fine particles were mixed
and fluidized before the rapid expansion of the supercritical fluid solution.
Like in other RESS processes, the paraffin was heated and extracted with SCCO2.
After extraction, the SCCO2 solution of paraffin was expanded into the fluidized bed
through the nozzle. Liquefied carbon dioxide was fed into the extraction column at a
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constant flow rate to keep the pressure constant in the column during the coating
granulation process. The temperature at the nozzle inlet was found to be an important
factor affecting the coating granulation process.
The rapid expansion of the supercritical solution caused a high supersaturating
ratio of solute in the spraying flow, forming a large number of superfine nuclei. The
superfine nuclei deposited on the surface of the particles formed a thin film. It was found
that the fine particles were all covered with the thin film. The granules with fine particles
attached were circulated through the spraying region and were covered with the binder or
coating material in the region in the form of a film, resulting in the fine particles being
cumulatively coated on core particles layer by layer.
Ribeiro Dos Santos (2002 and 2003) implemented a batch process to create
solvent-free microparticles of bovine serum albumin (BSA) for sustained release using
Gelucire 50/02 (which is a mixture of glycerides and fatty acid esters), Dynasan 114 or
Trimyristin as coating materials.
The coating material and the BSA crystals were placed in an autoclave equipped
with an impeller. The autoclave was sealed, heated and pressurized with CO2 until the
desired supercritical conditions were reached. Cooling the autoclave induced a pressure
decrease and a phase change from supercritical to liquid state, thereby insolubilizing the
coating material precipitated upon the insoluble BSA crystals dispersed in the medium.
Afterwards, the autoclave was vented to ambient conditions and the coated particles were
collected from the bottom of the autoclave.
The stability of BSA was evaluated by performing capillary electrophoresis and
there was no apparent effect of the encapsulation conditions on the structural integrity of
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the protein. Gelucire 50/02 appeared to be a good coating material, since it did not
crystallize such as Dynasan 114 and Trimyristin did. The coating was not found to be
perfectly uniform: the outer surface of the coated particles exhibits some discontinuities
and defects, with an average of two BSA crystals contained in each particle and a mean
coated particle size of 500 m.
One of the advantages of this process, compared to the homogeneous SCF
process, is that the active material to be coated stays in its solid state during the whole
process; consequently, biomolecules such as proteins used as drugs are less prone to
denaturalization in process like this.
A modified RESS process for particle coating with a solution of polymer in
supercritical CO2 was studied by Wang Yulu (2002). This technique involved extracting
the polymer (polyvinyl chloride-co-vinyl acetate (PVCVA) and hydroxypropyl cellulose
(HPC)) with supercritical CO2, with or without a co-solvent in an extraction vessel. Next,
the polymer was precipitated onto the surface of host particles (glass beads, 315 and 500
m) in a second precipitation vessel by slowly adjusting the pressure and temperature
inside the precipitator to lower its solubility. The author reported an average coating
thickness of 0.8 μm, with some agglomeration and uneven coating.
A rapid expansion of supercritical suspensions in impinging-stream reactors was
presented by Tsutsumi (2003) for the coating of ultra fine particles with the coating layer
(paraffin) in nanoscale. Silica particles with an average diameter of 1μm and titanium
dioxide with the average diameter of 20 nm were used as core particles.
Measured amounts of ultra fine core particles and paraffin were loaded in the
extraction column, then CO2 was injected, and P and T were adjusted to get a SC
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mixture. After mixing, the supercritical suspensions were allowed to expand into the
coating chamber through two capillary nozzles. The nozzles were heated to prevent
clogging. During the expansion process, supercritical carbon dioxide was fed into the
supercritical extraction column continuously to keep the pressure constant.
The impinging distance was observed to influence the coating rate of the ultra fine
particles. The coating layer on the core particles was detected by the SEM observation.
Thickness of the paraffin layer was around 50–60 nm. It was found that uniform film
coating was successfully achieved in the single core silica particle and agglomeration was
observed for titanium dioxide.
Another way to encapsulate particles is by dispersion polymerization in SCCO2 ,
as Yuea (2004) proposed. Dechlorane PlusR 515 (DCR) particles, with an average size of
12 μm were chosen as model host particles and were successfully encapsulated with
poly(methyl methacrylate) (PMMA) and poly(1-vinyl-2-pyrrolidone) (PVP) polymers via
in situ dispersion polymerization in supercritical carbon dioxide (Figure 3.7).
During polymerization, AIBN acted as free-radical initiator and PDMS-MA
functioned as a surfactant. All components were premixed and charged into the reactor
with CO2 at room temperature until an appropriate pressure was reached.
AIBN free radical
PDMS-MA

DCR

DCR

DCR
Surfactant

Monomer

Polymerization

DCR

Coated particle

Figure 3.7. Radical Polymerization Mechanism.
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Before the reaction started, the monomer, surfactant, and initiator were all
dissolved in CO2 and the heavy DCR particles stayed at the bottom of the vessel during
the reaction. The vessel was then heated to initiate the free radical polymerization and the
pressure reached its desired final value. Most of the experiments were run for 48 h
(reaction time), after which CO2 was released and the reactor was cooled down to room
temperature followed by sample collection.
Results showed that the average particle size of 12

m and the particle

agglomeration observed was minor. As the authors stated, the polymer coagulation and
the coating thickness could be controlled adjusting the Monomer/Core Material ratio and
by adequate T-P operation conditions.
Kröber H. (2005) made a great contribution by using a fluidized-bed coating
process with a rapid expansion of supercritical solutions (RESS) on the encapsulation of
different diameters of glass beads (7.39 – 124.6 μm). He showed that it was possible to
fluidize particles with a mean diameter of 7.4 m, and he proved that the fluidization of
particles under sub- or supercritical conditions was different from that under atmospheric
pressure. With increasing pressure, the minimum fluid velocity necessary to start the
fluidization decreased as the density of the SCF increased.
Supercritical carbon dioxide was used as solvent as well as carrier fluid for the
core material creating the fluidized-bed.

The coating material was stearyl alcohol

(C18H38O). The apparatus consisted essentially of three subsections: the CO2 supply, the
extractor (in which the CO2 becomes saturated with coating) and the high pressure
reactor (where the coating takes place). The fluidized-bed reactor was filled with the core
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material and the bed was fluidized by adding pure carbon dioxide as “carrier fluid.” The
reactor floor consisted of a perforated plate.
When the reactor reached thermal stability, the micro-encapsulation process was
initiated. Carbon dioxide flowed through the extractor, saturated by the coating material,
and then expanded through a nozzle into the fluidized-bed reactor.

The expansion

produced a fine aerosol of droplets that deposited onto the core particles, spreading out as
a film and then hardening, yielding a solid layer of coating on the particles. Complete
coatings with a layer thickness between 1 and 8 m were achieved.
Another work in encapsulation based on an in situ polymerization for coating
ceramic particles was presented by Hertz (2006). The YSZ powder (particle size 30 to
300 nm), the MMA monomer, the surfactant (PDMS-g-PA or FOMBLIN) and the
initiator were introduced in the reactor containing pentane. The reactor was closed and
the mixture stirred. CO2 is non-polar whereas the oxide surface is polar; therefore, the
surfactant molecules tended to assemble spontaneously at the surface of the particles with
the polar or CO2-phobe part anchored on the particles and the non-polar or CO2-phile part
dissolved in SCCO2 under specific conditions (Calvo 2000, DeSimone 2001, Johnston
2000). Polymerization was carried out in SCCO2 during 4 h at 30MPa and 150 °C.
(Figure 3.8).
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Figure 3.8. Schematic Description of the Proposed Mechanism for the Encapsulation of
YSZ Powder by in Situ Polymerization in SCCO2.
A number of attractive results were obtained from this preliminary study. The
calculated thicknesses for the polymer shell were about 4.3 nm.

3.2.2. Carbon Dioxide as an Antisolvent
What characterizes this particular coating track is that the coating material is not
soluble or has a low solubility in pure SCCO2.
The aerosol solvent extraction system (ASES) used by Bleich (1996) exploited
the fact that a supercritical gas was acting as non-solvent for an organic solution of the
drug (hyoscine butylbromide, indomethacin, piroxican and thymopentin) and polymer
(PLA) in order to form microparticles by a flocculation process. Due to the miscibility of
the organic solvent used, methylene chloride, and the supercritical gas phase,
microparticles with residual organic solvents below 30 ppm were formed.
The drug polymer solution (2%, w/w) was sprayed through a nozzle into the
supercritical carbon dioxide phase. The spraying of the drug/polymer solution was
followed by a drying process where CO2 was pumped continuously. The microparticle
size for all products was smaller than 50 m. Therefore, drugs with low solubility in
supercritical carbon dioxide were preferable for this microparticle production technique.
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Hydrophobic ion pairing (HIP) is a technique whereby ionic pharmaceutical
agents and proteins can be directly solubilized in organic solvents while maintaining
biological activity. It consists of pairing a charge on the molecule with oppositely
charged surfactants possessing some hydrophobic character, effectively increasing the
molecule‟s solubility in low dielectric organic solvents. Falk (1997) used this technique
to coat low molecular weight pharmaceuticals like gentamycin, naloxone, and naltrexone,
using supercritical carbon dioxide as the antisolvent, methylene chloride as a cosolvent
and PLA as the polymer coating, in a compressed antisolvent (PCA) process.
In this process, carbon dioxide, the solvent containing the pharmaceutical
compound and the polymer were pumped concurrently through an ultrasonic spray nozzle
into a view cell containing carbon dioxide, at constant pressure and temperature. The cell
was vented from the top so the precipitated particles could settle and be recovered
directly from the chamber. The drug/polymer particles were spherical in shape and
between 0.2 and 1.0 m in diameter, as determined by scanning electron microscopy.
Drug incorporation efficiencies were determined and in vitro release profiles measured.
Young (1999) produced encapsulated Lysozyme (1-10 μm) by PCA method with
some particular modifications that allowed him to avoid earlier limitations of massive
polymer agglomeration and limited protein solubility in organic solvents.
The protein was encapsulated in biodegradable polymer, either poly-(l-lactide) (lPLA) or poly(DL-lactide-co-glycolide) (PGLA) microspheres, which were precipitated
from a dichloromethane solution after being sprayed into a CO2 vapor phase through a
capillary nozzle to form droplets which solidified after falling into a CO2 liquid phase. By
delaying precipitation in the vapor phase, the primary particles became sufficiently large,
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from 5 to 70 μm, such that they could encapsulate the lysozyme. At an optimal
temperature of -20 °C, the polymer solution mixed rapidly with CO2, and the precipitated
primary particles were hard enough that agglomeration was markedly reduced compared
with higher temperatures.
Upon completion of solution injection, the cell was filled with liquid CO2. Liquid
CO2 was swept through the cell to remove the dichloromethane and further dry the
particles. After drying, the cell was depressurized.
Elvassore (2001) achieved the microencapsulation of insulin with PLA using a
mixture of cosolvents, dichloromethane and dimethyl sulfoxide, in order to ensure the
solubility of both the polymer and the protein, to which the supercritical antisolvent was
added.
In the SAS method, the liquid solution and the supercritical antisolvent were
continuously added to the precipitation unit in concurrent or countercurrent mode and the
particles formed were collected in the vessel. In the final step, supercritical CO2 flowed
into the vessel to wash and dry the precipitated products and after the cosolvents were
extracted, the CO2 was vented through an expansion valve.
It was found that the use of mixed solvents gave a suitable solution for the
application of the SAS process. Submicron particles with no flocculation and
agglomeration phenomena were obtained. The results showed that microspheres of PLA
charged with insulin that were produced had average diameters ranging from 0.5 to 2 μm.
In the majority of the encapsulation procedures the common problem is
agglomeration. In order to solve this problem, Wang (2004) used an ultrasonicator to
break the nanoparticles agglomeration. Silica nanoparticles (hydrophobic and
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hydrophilic) were employed as host particles, Eudragit polymer as the coating material,
acetone as cosolvent and supercritical CO2 as the anti-solvent (SAS).
Eudragit was dissolved in acetone and the silica nanoparticles were suspended in
the polymer solution, and an ultra-sonicator was used to break up the nanoparticles
agglomerated in the silica–acetone suspension. When steady state conditions were
reached in the high-pressure vessel, the polymer-silica–acetone suspension was delivered
by a high-pressure pump and was sprayed through a stainless steel capillary nozzle into
the high-pressure vessel containing SCCO2. Thereafter, CO2 was supplied to remove any
residual organic solvent. When the cleaning step was completed, the high-pressure vessel
was slowly depressurized and samples were collected for characterization.
The results revealed that 16–20 nm nanoparticles were successfully coated or
encapsulated in polymer by the SAS coating process. The thickness of the polymer film
was estimated to be around 10–40 nm, and appeared to be independent of surface
hydrophilicity.
One year later Wang attempted to encapsulate fine submicron silica particles (0.5
μm) with a polymer for controlled release of drugs, poly(lactide-co-glycolide) (PLGA),
using the same supercritical antisolvent (SAS) technique reported in Wang 2004.
The results showed that submicron silica particles were successfully encapsulated
by PLGA in the form of loose agglomerates. It was found that the polymer weight
fraction and the polymer concentration played critical roles in the agglomeration of the
coated particles. A high polymer weight fraction favored the agglomeration of the coated
particles and the uneven distribution of the polymer coating. A low polymer
concentration appeared to prevent agglomeration among the coated particles. The
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operating pressure and temperature were also found to influence agglomeration. A higher
pressure facilitated the agglomeration of coated particles as a result of sintering because
the glass-transition temperature of the polymer, Tg, was depressed. The operating
temperature appeared to have little effect on the agglomeration of the coated particles
when the temperature was below the glass-transition temperature; however, when the
operating temperature was above Tg, the polymer coating on the surface of particle
appeared to be sintered, causing strong agglomeration. The flow rate of the polymer
suspension was found to have little effect on the agglomeration.

78

CHAPTER 4
ENCAPSULATED PROTOTYPE SYSTEMS

Controlled release systems provide the benefits of protection from rapid
degradation, targeted delivery, control of the release rate, and prolonged duration of
bioactive agents. Controlled drug delivery systems have received considerable attention
in recent years and they are providing in general a more controlled rate of uptake of the
drug by the body. In this way, their therapeutic action is prolonged without increasing the
dosage. One common way of controlling the release is by incorporating the drug in a
polymeric carrier, and then the drug is released in the affected site by diffusion or surface
erosion.
In conventional pharmaceutical applications, the active compound is rapidly and
totally released in the body in a single burst. The concentration of the drug inside the
body decreases with time (Figure 4.1a). At the beginning a peak is observed, and then as
a function of time the concentration decays. One of the main problems in the traditional
system is the possibility that the concentration–time curve crosses the toxicity limit for
the active component. Every active substance presents two concentration limits: a lower
limit, that represents the minimum concentration to obtain therapeutic effects, and the
upper or toxicity limit, that represents the maximum concentration for which the
undesirable effects are more important than therapeutic drug action.
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The purpose of controlling the drug delivery is to achieve more effective therapies
while eliminating the potential for both under and over dosing. Other advantages of using
controlled delivery systems can include the maintenance of drug levels within a desired
range, the need for fewer administrations, optimal use of the drug, and patient compliance
(Figure 4.1b).
While these advantages can be significant, the potential disadvantages cannot be
ignored.

The possible toxicity or biocompatibility of the polymer coatings used,

undesirable by-products of degradation, the chance of patient discomfort, and the higher
cost of controlled release systems compared with traditional pharmaceutical formulations.
For these reasons, research with biodegradable polymers has expanded considerably.
These materials degrade within the body as a result of natural biological processes. Most
biodegradable polymers degrade as a result of the hydrolysis of the polymer chains into
biologically acceptable, and progressively smaller, compounds. In some cases (e.g.
polylactides, polyglicolides and their copolymers) the polymers will eventually break
down to lactic acid and glycolic acid, enter the Kreb‟s cycle, further break down into
carbon dioxide and water, and finally, are excreted through normal processes.
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Figure 4.1. Drug Levels in the Blood.
(a) Traditional drug dosing, (b) Controlled delivery dosing.

The objective of this research was to develop a tunable and mild encapsulation
technique capable of coating dried powder particles with a final size between 1 to 5 m,
since there are still a lot of room for improvement in this particle size range, as was
shown in Chapter 3.
The particle should contain one core or active ingredient and a protective coating.
Since the encapsulation method is in development, the simplest model was suggested
(Figure 4.2).
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In this chapter, the chemicals used in the encapsulation process will be described,
including the rationale for their selection, their pertinent physical and chemical properties
and their molecular structures.

Figure 4.2. Coated Dry Powder Prototype.

4.1. Chitosan
Chitosan is a modified carbohydrate polymer derived from chitin deacetylation, as
can be seen in Figure 4.3.

Figure 4.3. Preparation of Chitosan from Chitin.

Chitosan is used for nasal, ocular and oral drug delivery. Its use prolongs contact
time and improves drug absorption. Furthermore, Chitosan is useful for gene delivery,
due to its permanent cationic charge. It interacts electrostatically with negatively charged
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molecules like DNA to form complexes which are very stable and therefore it is able to
condense DNA molecules, protecting the DNA against nuclease degradation.
In acidic mediums, the amine groups will be positively charged, conferring to the
polysaccharide a high charge density which results in a strong electrostatic interaction
with mucus and negatively charged mucosal surfaces, thereby increasing the permeability
of an epithelium (Mansouri, 2004).
In addition to the properties mentioned in Table 4.1, Chitosan has the ability to
cause tight junction disruption at the molecular level, enhancing drug delivery through
tissues (Smith et al. 2004).
Table 4.1. Chitosan Properties.
Chemical properties

Biological properties

Cationic polyamine

Natural polymer biocompatible

High charge density at pH<6.5

Biodegradable to normal body constituents

Adheres to negatively charged surfaces

Safe and non-toxic

Amiable to chemical modifications

Hemostatic, bacteriostatic and fungistatic

High molecular weight linear polyelectrolyte.

Anticancenogenic

Viscosity, high to low (depending on Mn)

Versatile

Reactive amino/hydroxyl groups

Reasonable cost

Chitosan is a weak base and is insoluble in water at neutral and alkaline pH.
Cancer or tumor cells have an acidic pH, making the amine groups in the Chitosan to be
positively charged. As mentioned above, this confers to the polysaccharide a high charge
density which results in a strong electrostatic interaction, which increases the
permeability of the cell.
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The versatility and tune-ability of this polymer is given by the combination of
degree of deacetylation and molecular weight (Table 4.2), which promotes solubility in
different environments (Köping-Höggård, 2003).
Table 4.2. Chitosan Classification (Sigma Aldrich)
Polymer

Average Mn

% Deacetylation

Viscosity (cps)

Oligosaccharide

< 5000

> 90

6

Low Mw

50,000-190,000

75-85

20-200

Medium Mw

190,000-310,000

75-85

200-800

High Mw

310,000-375,000

>75

800-2000

The specific polymer used in this research was Chitosan Oligosaccharide Lactate,
(with a number average molecular weight Mn<5000, Sigma Aldrich 523682), as it is
soluble at regular mucus pH 6.5, water and DMSO, which confirms a promising future
application in pharmaceutical and food fields. Table 4.3 contains some physical
properties of this polymer.
Table 4.3. Chitosan Oligosaccharide Lactate Physical Properties.
Property

Value

Source of Information

Physical form

Yellow powder
> 90% deacetylation

Sigma Aldrich

Average MW

< 5000

Sigma Aldrich

MW
(amu)

340.3

Sigma Aldrich

Density
(g/cc)

1.4532 (22.6 C)
1.4657 (28.6 C)
1.4763 (35.3 C)

Quantachrome
Ulatrapicnometer 1000

Viscosity
(cP)

6

In 1 % acetic acid, Sigma
Aldrich

Soluble in

H2O, DMSO, Acetic acid
solutions (6-6.5 pH)

Determined experimentally
(Chapter 5)
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4.2. Carbon Dioxide (CO2)
Carbon dioxide is a colorless, odorless gas. At standard temperature and pressure,
the density of carbon dioxide is about 1.5 times that of air. The carbon dioxide molecule
(O=C=O) contains two double bonds and has a linear shape. It has no electrical dipole,
and as it is fully oxidized, it is moderately reactive and is non-flammable.
Supercritical carbon dioxide refers to carbon dioxide that is in a fluid state while
also being at or above both its critical temperature and pressure, allowing for rather
unique properties. Carbon dioxide usually behaves as a gas in air at standard conditions
for temperature and pressure (STP) or as a solid called dry ice when frozen.
If the temperature and pressure are both increased from STP to be at or above the
critical point for carbon dioxide, its properties are midway between a gas and a liquid.
More specifically, it behaves as a supercritical fluid above its critical temperature
(31.1°C) and critical pressure (72.8 atm), expanding to fill its container like a gas but
with a density like that of a liquid (Figure 4.4).

Figure 4.4. Supercritical Fluid Phase Diagram.
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Supercritical CO2 has become an important commercial and industrial solvent due
to its role in chemical extraction, in addition to its low toxicity and environmental impact.
It is a non-flammable solvent with low viscosity, high diffusion rate and no surface
tension. The relatively low temperature of the process and the stability of CO2 also allow
most compounds to be extracted or dissolved with little damage or denaturing. The
selective solvating power of carbon dioxide makes it possible to separate a particular
component from a multi component mixture. Another big advantage for food and
pharmaceutical applications is that CO2 inactivates a wide variety of bacterial organisms,
enabling the final product to be sterilized.
A drawback of CO2 as a solvent, however, is that only volatile or relatively non
polar compounds are soluble, as CO2 is non-polar, and has low polarizability and a low
dielectric constant. For this reason, a cosolvent is usually employed in the cases where
the solute of interest is not soluble or has a very low solubility in pure supercritical
carbon dioxide. Some of the properties of carbon dioxide are presented in Table 4.4.
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Table 4.4. Properties of Carbon Dioxide (CO2).
Properties
Molecular weight

44.0095(14) g/mol

Appearance

colorless gas

Density

1,600 kg/m³, solid; 1.98 kg/m³, gas

Melting point

−78 °C (194.7 K) (sublimes)

Boiling point

-57 °C (216.6 K) at 5.185 bar

Critical temperature, Tc

31.03°C

Critical pressure, Pc

7.38MPa
(1-9) x10-4 g/cm -s

Dynamic viscosity,
Surface tension,

4.34 dyn/cm at 20°C

Solubility in water

1.45 kg/m³

Acidity (pKa)

6.35 and 10.33
0.113x10-6 m2/s at -10 °C

Kinematic viscosity,
Dipole moment

zero

Heat capacity, cp

183.1 J/mol K at 38°C, 8653 kPa

Enthalpy of vaporization ( H vap)

15.326kJ/mol at -57.5°C

Enthropy of vaporization ( S vap)

70.8 J/mol K at -57.5°C

4.3. Dimethyl Sulfoxide (DMSO)
Dimethyl sulfoxide, whose chemical formula is (CH3)2SO, is a by-product of
wood pulping. This colorless liquid is an important polar aprotic solvent that dissolves
both polar and non-polar compounds and is miscible in a wide range of organic solvents
as well as water. It has a distinctive property of penetrating the skin readily, allowing the
handler to taste it. Its taste has been described as oyster- or garlic-like. Some of the
properties of the dimethyl sulfoxide are presented in Table 4.5.
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Table 4.5. Properties of DMSO
Properties
C2H6OS

Molecular formula
Molar mass

78.13 g/mol

Appearance

Clear, colorless liquid

Density,

1.1004 g/cm3, liquid

Melting point

18.5 °C (291.65 K)

Boiling point

189 °C (462.15 K)
Miscible

Solubility in water
Critical temperature, Tc

447°C
57.1atm

Critical pressure, Pc

1.996 cP at 20 °C

Viscosity,

3.96

Dipole moment
Heat capacity, cp

153 J/mol K

Entropy, S

188.78 J/mol K

Enthalpy of formation, Hf

-203.4 kJ/mol

DMSO is an important polar aprotic solvent, since it is able to dissolve a variety
of organic substances, including carbohydrates, polymers, peptides, as well as many
inorganic salts and gases, and is less toxic than other members of this family. Loading
levels of 50-60 wt % are often observed vs 10-20 wt % with typical solvents.
Use of DMSO in medicine dates from around 1963 (Parcell 2002), when a
University of Oregon Medical School team, headed by Stanley Jacob, discovered it could
penetrate the skin and other membranes without damaging them and could carry other
compounds into a biological system. In addition, because DMSO increases the rate of
absorption of some compounds through organic tissues including skin, it can be used as a
drug delivery system.
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DMSO was selected for this research as an entrainer since the polymer (Chitosan)
is highly soluble in it but not in pure carbon dioxide. Second, the fact that the liquid is
transferred into the CO2 under some specific P, T conditions and the non-solubility of the
Chitosan in the mixture (CO2 + DMSO) at that conditions were considered in order to
design this new encapsulation method.

4.4. Calcium Oxide (CaO)
Calcium oxide is a white, caustic and alkaline crystalline solid commonly known
as burnt lime, lime or quicklime; it is a widely used chemical compound, as a softener
and pH regulator for water treatment, fertilizer, food industry, petroleum additives, glass,
fiberglass and steel industry. On the food and pharmaceutical industry this chemical is
used on the manufacture of antacid, dairy basic drinks, food complement, cheese,
condensed milk, powder milk, cereals, pasta, protein products, and animal nutrition
products, etc.
In this present work calcium oxide was used as it is readily available in a wide
particle size range (less than one micron to 250 microns), low cost, non soluble in DMSO
or SCCO2, non porous and well characterized. There is also value in micro-encapsulated
calcium oxide products. Some of the properties of the calcium oxide are presented in
Table 4.6.

89

Table 4.6. Properties of Calcium Oxide (CaO).
Properties
Molecular formula

CaO

Molar mass

56.077g/mol

Appearance

White solid

Density

3350 kg/m3, solid

Melting point

2572 C (2845.15 K)

Boiling point

2850 C (3123.15 K)

Thermal conductivity k, (cal/cm s K)
Porosity ssa, (m2/gr)
Solubility in water

0.019
2-5
reacts

Enthalpy of formation, Hf

-635.09 kJ/mol

Entropy, S

38.19 J/mol K

Heat capacity, cp

49.954 kJ/ mol K

4.5. Titanium Dioxide (TiO2)
In terms of volume, Titanium Dioxide is one of the top fifty chemicals produced
worldwide. It is a white, opaque and naturally-occurring mineral found in two main
forms: rutile and anatase. Titanium dioxide has a variety of uses, as it is odorless and
absorbent. From medicine to make-up and plastics to paper, hardly a day goes by when
we do not use titanium dioxide. In powder form, titanium dioxide (TiO2) is widely used
as an intensely white pigment to brighten everyday products such as paint, paper, plastics,
food, medicines, ceramics, cosmetics, and even toothpaste. Its excellent UV ray
absorption qualities make it perfect for sunscreen lotions, too. It is also inert and
biocompatible, making it suitable for medical devices and artificial implants. Titanium
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dioxide is what allows osteo-integration between an artificial medical implant and bone.
Some of the properties of the titanium dioxide are presented in Table 4.7.

Table 4.7. Properties of Titanium Dioxide (TiO2).
Properties
TiO2

Molecular formula
Molar mass

79.87 g/mol

Appearance

White solid

Density

4230 kg/m3, solid

Melting point

1870 C (2143 K)

Boiling point

2972 C (3245 K)

Porosity ssa, (m2/gr)

10-200
insoluble

Solubility in water

Like calcium oxide, titanium dioxide is widely available and well characterized. It
is low cost, insoluble in DMSO or SCCO2, and the particle size used is less than one
micron and is porous. Experiments with TiO2 allowed evaluating the effect of porosity on
the encapsulation process.
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CHAPTER 5
EXPERIMENTAL SYSTEMS AND PROCEDURES

In this chapter a description of all the experimental set-ups used during this
research will be presented. This section includes set-up diagrams and the experimental
procedures. Start up procedures, how to run the experiments, clean up and shut down
protocols are included in the Appendices.

5.1. Solubility Systems
In determination of phase behavior of multi-component systems at high pressure,
there are static and dynamic methods; these methods were reviewed in Chapter 2. Both
techniques were used in this research and the experimental set-ups are presented next.
Even though when using static systems just one sample mixture can be studied per
loading, it requires minimum amounts of components and allows visualization of the
phase transitions. Dynamic systems allow collection of large amounts of solubility and
equilibrium data, but they require good handling of the operation conditions to avoid
inaccurate solubility data.
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5.1.1. Static Cloud Point (Phase Analyzer)
The experimental system used is shown in Figure 5.1. One of the most important
components of the system was the Phase Monitor SPM20 (Thar Technologies), which
consists of a high pressure variable–volume cell (5 – 15 ml) made in stainless steel where
the mixture to be studied was placed. The temperature was controlled automatically
between room temperature and 150±0.1 ºC. The pressure was adjusted manually using a
mechanical syringe pump (Ruska 2200), and by decreasing the vessel volume the
pressure was increased and vice versa. The pressure and temperature signals in the vessel
were transferred to a portable PLC controller and the mixture behavior could be
visualized on a video monitor.
A stirrer was used to obtain a homogeneous mix of Chitosan-DMSO-SCCO2
inside the vessel. The phase behavior phenomena occurring inside the cell were
visualized on a video monitor using a camera placed directly over a sapphire window.
The carbon dioxide used in this system was pumped with a syringe pump (ISCO
100DX) equipped with a cooling jacket to assure that the CO2 withdrawn from cylinder
tank remained in the liquid phase.
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Figure 5.1. Cloud Point Experimental Set-Up Diagram.
This experimental procedure is described step by step in the flow diagram
presented in Figure 5.2.
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Figure 5.2. Flowchart for the Static Solubility Procedure.

Different solutions of Chitosan-DMSO (0.1, 0.5 and 1 mg/ml) were prepared by
weighing 0.01g; 0.05g and 0.1g of Chitosan respectively using an analytical balance,
measurable to ± 0.0001 g, and mixing this powder with 100ml of DMSO measured with a
pipette, measurable to ± 0.001 ml.
After the solution was prepared, the liquid Chitosan-DMSO mixture was loaded
into the cell using a pipette. Then the mixer assembly was screwed, closing the vessel. At
this stage, the volume of the vessel was adjusted to 5 ml and the remaining air was
purged out slowly with carbon dioxide. When the purging was completed, the outlet
valve was closed, and the vessel was filled with CO2 at a constant flow rate of 1ml/min,
using the automatic syringe pump, until the desired pressure was reached. When the
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desired pressure was obtained, the inlet valve of the vessel was closed. At this point
pressure, temperature, and CO2 volumes that had been fed into the vessel were recorded
as initial operation conditions.
Next, the vessel assembly was tilted into a horizontal position where the interface
between Chitosan-DMSO and SCCO2 phases in the cell could be visualized in the
monitor. Then the desired temperature of the vessel was adjusted with the controller, and
a period of 2 h is given for the system stabilization. The stirrer was activated and once the
pressure and the temperature in the vessel were constant, the contents of the vessel were
compressed by reducing its volume by moving the piston with the mechanical syringe
pump, until a cloudy phase was formed. Once in the one-phase region, the pressure was
lowered rapidly by moving the piston backwards until two phases were visualized. The
pressure was raised slowly until a cloudy phase was formed again. This procedure was
repeated five times for each sample in order to obtain repeatability. Next, the temperature
of the system was changed (308, 313, 318 K) and the entire procedure was repeated to
obtain more solubility data with the same load. (The step by step procedure is presented
in Appendix C).

5.1.2. Dynamic Solubility
Figure 5.3 shows a diagram of the system used in this research. The set-up was
built with off-the-shelf equipment and is similar to ones used by several investigators
including Johnston and Ecker 1981, and Krukonis and Kurnik 1985.
The basic structure of this system consisted of two pumps (one syringe pump
(ISCO 500) for the supercritical fluid and a HPLC pump (Waters 600E) for the liquid
96

cosolvent), a preheater coil, an inline mixer and the extraction cell where the solid solute
was placed. The solute extracted with the supercritical mixture was accumulated in a
collection vessel and analyzed with an UV (HP 1050), while the expanded supercritical
flow was measured with a Digital Wet Test Meter (Model 63135 PAC).

Figure 5.3. Dynamic Solubility Set-Up Diagram.
(1) ISCO pump, (2) ISCO pump controller, (3) pump chiller, (4) HPLC pump, (5, 6)
check valves, (7) water tank, (8) coil heat exchanger, (9) inline mixer, (10) extraction
vessel, (11, 12) thermocouples, (13) Immersion circulator, (14) bypass line, (15) back
pressure regulator, (16) pressure gauge, (17) collection vessel, (18) wet test meter.
The experimental procedure to study the ternary system Chitosan-DMSO-SCCO2
dynamic solubility has different steps and operation conditions that can be easily
visualized in the flow chart presented in Figure 5.4. Liquid carbon dioxide (CO2) was
charged to the system using the syringe pump, which was kept at -3 C with the help of a
chiller, to ensure the CO2 was at liquid phase while it was pumped into the system. This
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guaranteed a constant flow rate. The co-solvent used in this particular case was DMSO,
which was pumped into the system by the HPLC pump.
After leaving the pumps, the CO2 and the DMSO flowed through a 10 m stainless
steel coil submerged into a water bath at constant temperature (the pre-heater stage).
Then the DMSO-CO2 flow passed through an inline mixer, ensuring a homogeneous
mixture at the bath temperature before it contacted the heavy solute. The supercritical
solution was then fed to the extraction vessel, where the heavy solid (Chitosan) was
carefully packed to ensure proper contacting, to maintain the solute in the column even if
it liquefied at operating conditions, and to allow sufficient room for the heavy liquid to
expand as the supercritical fluid dissolved in it.
Temperature controlled environment
Liquid CO2
Preheater

Inline mixer

Extraction vessel
loaded w/Chitosan

Liquid DMSO

Gas CO2

Back Pressure
Regulator (BPR)

Wet Test Meter
DMSO-Chitosan
collected in a fixed
amount of water

Figure 5.4. Flowchart for the Dynamic Solubility Procedure.

The column was packed with a stainless steel mesh, followed by a layer of glass
wool at the bottom, then the solute was added, and finally another layer of glass wool at
the top and the stainless steel mesh. For this research the glass wool and all the glassware
used were pretreated with 5% hexamethyldisilazane (HMDS) solution and heated in the
98

oven at 70 C for 12 h, creating a chemical bond with the silanol groups (Si-OH), which
could capture the Chitosan producing wrong solubility data.
After the mixture left the extraction vessel, it was expanded through a mechanical
back pressure regulator and collected over water into a glass collection vessel. To avoid
clogging, the back pressure regulator was wrapped with a heating tape, keeping it at a
temperature greater than the bath temperature, to compensate any Joule-Thomson cooling
during the expansion of the CO2. The Chitosan required for this research was soluble in
water. Therefore, a measured amount of water was used to collect the extracted solute,
and the concentration of Chitosan in the resulting solution was determined through UV
analysis. The flow rate of the expanded CO2 was measured with a Wet Test Meter
connected to the glass collection vessel and DMSO amounts were determined from mass
balance. The step by step procedure is presented in Appendix D.

5.2. Encapsulation Set-up
As is the case in the development of most new methods, the encapsulation set-up
presented in Figure 5.5 was built with off-the-shelf equipment in order to minimize
delivery time and maximize flexibility in design as well its retrofit.
The major pieces of equipment that were integrated within this system were a
high pressure pump (P-200A THAR) used to feed the supercritical carbon dioxide, an
HPLC pump for the Chitosan-DMSO mixture, a constant temperature air box where the
encapsulation cell was placed, a heating bath connected to a heat exchanger placed inside
the box to ensure constant temperature environment, three thermocouples (used to read
the temperature inside the box and at the entrance and outlet of the cell), a lamp, a video
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camera/recorder system, heating tape elements over the encapsulation cell and the back
pressure regulator, a back pressure regulator, a collection vessel and Wet Test Meter. The
high pressure pump was connected to a chiller to ensure carbon dioxide will be at the
liquid phase at the pump all the time, avoiding cavitation problems.
The insulation box was used to keep the stainless steel coil that carries the carbon
dioxide and the coating solution (Chitosan-DMSO) injection system at the same
temperature, ensuring supercritical conditions before reaching the encapsulation vessel.
The encapsulation vessel used was a modified Jerguson flat glass gauge,
consisting of three parts. The solid central body or chamber was machined from a
stainless steel bar, where one stainless steel sintered distributor plate with 0.5 m holes
was placed at the bottom of the cell and another stainless steel sintered frit plate with 0.2
m holes was located at the top, acting as a filter to stop solid particles from leaving the
vessel. The frit at the bottom has a 1/16” hole in the center for the coating solution
injection tubing to pass through (Figure 5.5). The other two parts were the side bar covers
that held one tempered glass each, and steel bolt ant nuts to keep all the three pieces
together (Figure 5.6), even at high pressure and temperature (2220 psig, 600 F).
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Figure 5.5. Encapsulation Set-Up Diagram.
(1) High pressure pump (P-200A THAR), (2) Pump controller, (3) Pump chiller
(Refrigerator Recirculator, PolyScience), (4) HPLC pump (Waters 600E), (5, 6) Check
valves, (7) Circulator bath (Haake B81), (8) Radiator, (9) Stainless steel coil, (10)
Insulation box, (11) Windowed encapsulating vessel (Jerguson gauge), (12,13,14) K
thermocouples, (15,16,17) Pressure gauges, (18) Back pressure regulator, (19) Camera,
(20) Collection vessel, (21) Digital wet test meter (PAC), (22) Coating system detail: (a)
½ in SS Tee, (b) 1/16 in SS tubing, (c) ¼ in SS tubing, (d) SS distributor 0.5 m holes.

Figure 5.6. Flat Glass Gauge. (Jerguson gauge)
(a) Front view includes window, (b) Side view.
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To start the encapsulation procedure, the vessel was preloaded with the solid
sample to be encapsulated and sealed following a specific procedure included in
Appendix E. Then the heating bath was activated six hours before the start of the
experiment, to guarantee a stable temperature inside and outside the cell. Carbon dioxide
was charged to the system using a continuous pump, which was kept at 0 C with the
help of a chiller to be sure the CO2 was at liquid phase while it was pumped into the
system. The pump was operated in the continuous flow rate mode (Mode E), and the
system pressure was controlled with a back pressure regulator. After leaving the pump,
the CO2 flowed through a coil located in a constant temperature air bath, where the CO2
was pre-heated in order to reach supercritical conditions before reaching the
encapsulating vessel.
In order to fluidize the particles, the supercritical CO2 flow rate determination was
required. After reviewing different equations like Wen & Yu 1966, Riba 1978 and
Baeyens 1981, the first one was chosen following the recommendations of Carsten Vogt,
2005. There were two imperative numbers to estimate before starting the experiments:
the minimum fluidization velocity required to fluidize the particles (umf) and terminal
velocity (ut).

102

Fluidization Velocity for CaO particles with SCCO2 at constant pressure P=100bar
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Figure 5.7. Carbon
Dioxide Flow Required to Fluidize CaO Particles at 100 Bar.
Fluidization Velocity for TiO particles with SCCO at constant pressure P=100bar
2

2

0.08
0.07

SCCO2 Flowrate (cm/s)

0.06
0.05
0.04
0.03
0.02
0.01
0
0.00

1.00

2.00

3.00

4.00

5.00

6.00

Particle size (micron)
Umf (T=310K)

Ut (T=310K)

Umf (T=315K)

Ut (T=315K)

Umf (T=320K)

Ut (T=320K)

Figure 5.8. Carbon Dioxide Flow Required to Fluidize TiO2 Particles at 100 Bar.

As can be seen in Figures 5.7 and 5.8, operating at constant pressure of 100 bar
even a T of 10 K did not cause major adjustments on the CO2 flow rate required to
fluidize the particles, compared to the effect of particle size. The CaO and TiO2 samples
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used were made up of different particle sizes between 0.1 m to 7 m, which promoted a
uniform fluidization. The best results were obtained for 2-5 g CO2/min. Sample
calculations and tabulated results are shown in Appendix F.
Once the system reaches the required operation conditions (T and P), and the
particles are fluidizing properly, the coating solution, a DMSO-Chitosan mix, was
pumped into the system by the HPLC pump, and the supercritical ternary system
(Chitosan-DMSO-CO2) stayed in contact with the solid particles for at least 30 minutes.
The system was considered stable when the temperature difference registered at the inlet
and outlet of the encapsulation cell was no more than 1 C. The heating tape located over
the cell was turned on and the temperature was controlled with an on/off controller. The
coating material started to precipitate over the solid particles or core material, keeping the
temperature constant to avoid re-dissolution of the polymer. The carbon dioxide flow
was increased and the DMSO left the encapsulation vessel with the carbon dioxide.
After the DMSO-CO2 mix left the coating vessel, it was expanded through a
mechanical back pressure regulator and collected over a known amount of water into a
glass collection vessel. To avoid clogging, the back pressure regulator was maintained at
a temperature greater than the system temperature to compensate any Joule-Thomson
cooling during the expansion of the CO2. In order to establish when all the DMSO had
been extracted to avoid the coating to be re-dissolved, a measured amount of water was
used to collect the DMSO-SCCO2 mix, and the DMSO concentration was determined
through UV analysis using a quartz cuvette. The flow rate of the expanded CO2 was
measured with a Wet Test Meter connected to the glass collection vessel. The step by
step procedure is presented in Appendix E.
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5.3. Sample Analysis
Different characterization analysis methods were used to study the particles
before and after encapsulation, as well as the encapsulant material itself.
5.3.1. Fourier Transform Spectroscopy (FTIR)
FTIR is an analysis technique that provides information about the chemical
bonding or molecular structure of materials. This technique works on the fact that bonds
and groups of bonds vibrate at characteristic frequencies. A molecule that is exposed to
infrared rays absorbs infrared energy at frequencies that are characteristic to that
molecule. During FTIR analysis, the sample is subjected to a modulated IR beam, and the
sample‟s transmittance and reflectance of the infrared rays at different frequencies is
translated into an IR absorption plot. The resulting FTIR spectra pattern is then analyzed
and matched with known materials in the FTIR library of the computer processor.
FTIR spectroscopy does not require a vacuum, since neither oxygen nor nitrogen
absorb infrared rays. FTIR can be used with very small quantities of sample, whether
solid, liquid or gaseous.
For this research, all the samples analyzed were in the solid state: calcium oxide,
titanium dioxide and Chitosan. The solid samples were milled with potassium bromide
(KBr) to form a very fine powder. This powder was then compressed into a thin pellet
which could be analyzed, as KBr is also transparent in the Perkin Elmer 4000 FTIR.

5.3.2. Ultraviolet Visible Absorption Spectroscopy (UV)
This analysis uses light in the ultraviolet and visible range. In this region of the
electromagnetic spectrum, the molecules experience rotational and vibrational transitions,
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creating a complex and unique combination used to identify and differentiate chemical
components.
UV spectroscopy is used for quantitative determinations. The Beer-Lambert law
states that the absorbance of a solution is directly proportional to the concentration of the
absorbing species in the solution and the path length. Therefore for a fixed path length,
UV can be used to determine the concentration of the absorber in a solution by using a set
of known concentration solutions to create a calibration curve that will show how the
absorbance changes with the concentration.
The concentration of Chitosan was determined quantitatively by measuring the
UV-Vis absorbance of the carbonyl and amino groups. This peak absorbance was
analyzed using a V-530 UV-Vis spectrophotometer.

5.3.3. Scanning Electron Microscopy-Energy Dispersive Spectroscopy (SEM-EDS)
SEM is one of the most useful instruments in the study of solid materials. It is
easy to operate, requires minimal sample preparation, is a non-destructive analysis
system and enables rapid data acquisition. The SEM is used to generate high-resolution
images and to show chemical composition of sampling areas from 1cm to 5 microns with
magnification ranges from 20X to 30,000X. The equipment used for this research was the
Hitachi 800.
The electron scanning microscope uses a focused beam of high energy electrons
to generate a variety of signals at the surface of solid specimens. These signals include
secondary electrons that produce SEM images, backscattered electrons, diffracted
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backscattered electrons used to determine crystal structures, photons that are used for
elemental analysis (EDS), and visible light and heat.
Samples must be solid and they must fit into the microscope chamber. Samples
must be stable in a vacuum on the order of 10-5 to 10-6 torr and dry; in this particular
research all the samples were dry particles, coated and uncoated. Sample preparation was
minimal. All the samples were dried under vacuum and kept in a desiccator and sprinkled
over a carbon tape. In order to prevent charge buildup, the samples were coated with a
thin layer of conductive material (gold), obtaining high resolution images.
Another application used extensively with the Hitachi 800 was the Automated
Particle Analysis tool. This application is designed to characterize hundreds of particles
by size, shape and chemical composition.

5.3.4. Transmission Electron Microscopy (TEM)
This is a microscopic technique whereby a beam of electrons is transmitted
through a sample, interacting with it as it passes through. An image is formed as a result
of this interaction between the electrons and the sample components; then the image is
magnified and focused onto an imaging device (screen, photographic film or CCD
camera).
A TEM was used in this research to visualize and measure the Chitosan coating
over the CaO and TiO2 particles, based on the structural difference (organic or inorganic)
of the coated particles. The sample was prepared by placing a drop of the solution made
with Ethanol and coated particles on a Formvar-coated Cu TEM grid that was dried under
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a lamp in ambient conditions. The grid was then placed within the TEM vacuum chamber
(model FEI Morgagni 268D) and examined.

5.3.5. Atomic Force Microscopy (AFM)
This is a high resolution scanning microscopy technique that offers tridimensional
particle visualization with proved resolution on the order of fractions of nanometers. The
AFM consists of a cantilever with a sharp tip at the end that is used to scan the specimen
surface.
This analysis technique was useful to obtain topographic imaging of the uncoated
and coated particles, including surface roughness. The sample preparation for this
analysis was simple and basic: double-sided sticky tape was used to attach the loose
particles over a thin flat piece of glass.
There are two basic operation modes for the AFM: static and dynamic. The static
mode was used in this research. In this approach, the cantilever was dragged across the
surface of the sample and the contours of the surface, and uncoated and coated particles
were measured directly using the deflection of the cantilever.

5.3.6. Differential Scanning Calorimeter with Thermal Gravimetric Analysis (DSCTGA)
Thermal analyses are useful techniques to determine properties of materials as
they change with temperature. To determine the inorganic-organic composition of the
encapsulated particles, two methods were used in this research: differential scanning
calorimetry and thermal gravimetric analysis with a TA SDT Q600 DSC-TGA system.
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These two features were utilized for two different reasons. Differential scanning
calorimeter measures the heat flow and the glass transition temperature of the polymer
coating (Chitosan). Thermogravimetric analysis (TGA) measures the weight changes in
material, determining the composition (organic coating-inorganic core) of the samples.
Samples were heated in air at a rate of 5 C/min from room temperature to 700 C.
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CHAPTER 6
EXPERIMENTAL RESULTS

The objective of this research had been to encapsulate small solid particles using a
biopolymer, Chitosan, with supercritical CO2 as a solvent and DMSO as a cosolvent. In
order to accomplish this goal some initial steps had to be accomplished. First, a set of
experiments was performed to determine the cloud point for the system DMSO-CO2, in
order to validate the experimental set-up and the procedures with published data. The
next step was determining the cloud point for the ternary system Chitosan-DMSO-CO2
system. There is no such published polymer solubility data. In order to obtain data at the
operation conditions for the encapsulation system, a dynamic solubility experimental
system was developed and used to obtain solubility data. Finally, CaO and TiO2 particles
were encapsulated with Chitosan in a fluidized bed using a temperature swing to initiate
dissolution. These experimental results and characterization will be presented in this
chapter.

6.1. Density Experiments
Some of the models used to calculate thermodynamic properties of polymerssolvents solutions require that the concentration should be expressed in terms of volume
fractions. For this reason, binary solution characterization information was required. To
calculate volume fraction accurately, the partial molar volumes should be known, and as
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a consequence it was important to have accurate density data for different compositions
of the binary mixture. In this particular case, DMSO-Chitosan, the solution was prepared
by mass using an analytical balance with ± 0.0001g accuracy (OHAUS, Adventurer-Pro).
The density measurements were made with a certified density meter with 0.0001g/cm3
accuracy (DMA 4000, Anton Paar). Six different solutions were prepared by dissolving
Chitosan powder in DMSO at room temperature. The concentrations expressed in weight
percentage of Chitosan were: 0.15, 0.88, 1, 2.57, 4.73 and 17.36 w/w %. The density
measurements were made in a temperature range of 298.15-358.15ºK. The experimental
data obtained was as follows.

Table 6.1. Density Data for the Mixture DMSO-Chitosan.
(Chitosan concentration w/w%)
T ( K)
(g/cm3)
Chitosan
0%
STD
0.15%
STD
0.88%
STD
1%
STD
2.57%
STD
4.73%
STD
17.36%
STD

298.15

308.15

318.15

328.15

338.15

343.15

348.15

358.15

1.0966
-

1.0852
-

1.0752
-

1.0652
-

1.0551
-

1.0501
-

1.0451
-

1.0350
-

1.0967

1.0967

1.0967

1.0967

1.0967

1.0967

1.0967

1.0967

0.0003

0.0003

0.0003

0.0003

0.0003

0.0003

0.0003

0.0003

1.0968

1.0876

1.0777

1.0677

1.0572

1.0522

1.0472

1.0372

0.0007

0.0006

0.0006

0.0006

0.0001

0.0001

0.0001

0.0001

1.0974

1.0890

1.0792

1.0695

1.0594

1.0544

1.0493

1.0386

0.0016

0.0006

0.0008

0.0008

0.0005

0.0002

0.0001

0.0001

1.1014

1.0940

1.0845

1.0741

1.0611

1.0591

1.0544

1.0450

0.0007

0.0007

0.0007

0.0007

0.0007

0.0007

0.0007

0.0007

1.1095

1.1046

1.0897

1.0800

1.0702

1.0653

1.0604

1.0505

0.0072

0.0000

0.0000

0.0000

0.0000

0.0000

0.0000

0.0000

1.1417

1.1335

1.1226

1.1129

1.1021

1.0971

1.0947

1.0826

0.0005

0.0000

0.0000

0.0000

0.0002

0.0001

0.0021

0.0009
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In order to be able to appreciate the effect that temperature and concentration had
over the density of the mixture, the data offered in Table 6.1 is plotted in Figure 6.1. It
was seen that under isothermal conditions, the density of the mixture increased
proportionally as Chitosan concentration rose, and for a fixed concentration the density of
the mixture decreased as the temperature increased.

Figure 6.1. Density Isotherms as a Function of Chitosan Concentration
for Different DMSO-Chitosan Solutions.

6.2. Cloud Point Experiments
The cloud point experiments were performed with the static set-up for the solvent
system DMSO-SCCO2 and then for the ternary system Chitosan-DMSO-SCCO2.

6.2.1. DMSO-CO2 System
Polymer solubility in CO2 was very low, so a cosolvent was used. As has been
found in this particular case, Chitosan is only soluble in water, so DMSO (dimethyl
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sulfoxide) was the only option, since water solubility in SCCO2 is very low and other
researchers like Rajasingam 2004, Gonzalez 2002 and Kordikowski 1995 studied the
solubility of DMSO in supercritical dioxide for antisolvent process.
The experimental set-up used was presented in Chapter 5 section 5.1.1. One of
the most important characteristics of this system was the ability to adjust pressure and
temperature for a fixed concentration. This translated into data repeatability and multiple
data points (P, T) for a given concentration. Pressure and temperature inside the vessel
were tracked continuously in conjunction with phase behavior by having all the
information projected live on the video monitor.
A stirrer was used to obtain a homogeneous mixture of DMSO-SCCO2 inside the
vessel. The phase behavior phenomena occurring inside the cell were visualized on a
video monitor using a camera placed directly over a sapphire window.
The carbon dioxide used in this system was pumped with a syringe pump (ISCO
100DX) equipped with a cooling jacket to assure that the CO2 withdrawn from cylinder
tank remained in the liquid phase.
The first step of this experimental procedure was to load the liquid DMSO into
the cell using a pipette (measurable to ± 0.01 ml), then the mixer assemble was screwed,
closing the vessel. At this point, the volume of the vessel was adjusted to 5 ml and the
remaining air was purged slowly with carbon dioxide. When the purging was completed,
the outlet valve was closed, and the vessel filled with CO2, at a 1ml/min constant flow
rate, using the syringe pump until the desired pressure was reached. At this point, the
inlet valve of the vessel was closed. The temperature in the cell was adjusted and the
stirrer was activated. When the pressure and the temperature in the vessel were constant,
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the contents of the vessel were compressed by moving the piston with the mechanical
syringe pump. Once a turbid or cloud-phase was observed, the temperature and pressure
values were recorded, then the pressure was lowered by moving the piston backwards
until the turbidity disappeared, and then raised slowly until the turbidity appeared. This
procedure was repeated five times for each sample in order to obtain repeatability. Next,
the temperature of the system was changed and the entire procedure was repeated to
obtain more solubility data with the same load. The experimental data obtained is
presented in the next figure with the existing published data.
The temperature selected for these experiments (314.2, 318.2 and 328.2 K) was
based on the published data and the requirements for the encapsulation of natural or
pharmaceutical products (thermal liable compounds). The results obtained were used to
validate the method and at the same time to obtain temperature operation ranges for the
coming experiments.
The DMSO molar fraction selected for this set of experiments was based on the
envisioned coating method, where a small quantity of cosolvent was used, in order to
avoid high concentration of DMSO on the encapsulated particle that could cause the
coating to re-dissolve.
As can be seen in Table 6.2, experimental cloud point for the system DMSO-CO2
was collected in a temperature range of 314.2 K to 328.2 K and pressures from 89 to
133.5 bars. The standard deviation based on the five readings made for each data point is
less than one bar, indicating the experimental method is accurate.
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Table 6.2. Experimental Cloud Point Data DMSO-CO2
T ( K)
1 K

314.2

318.2

328.2

XCO2

Pave (bar)

STD(bar)

0.90
0.91
0.95
0.96
0.97
0.98
0.90
0.91
0.94
0.95
0.97
0.90
0.94
0.95

89.0
90.3
91.0
91.2
92.2
92.1
103.0
104.3
105.0
105.8
106.2
129.0
132.9
133.5

0.51
0.50
0.34
0.52
0.57
0.48
0.62
0.60
0.75
0.46
0.59
0.60
0.37
0.45

The isotherms presented in Figure 6.2 are consistent with those reported by
Rajasingam 2004, Gonzalez 2002 and Kordikowski 1995.
Cloud Point DMSO-CO2
140
120

Pressure (bar)

100
80
60
40
20
0
0.0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

x (CO2 mole fraction)
Rajasingam, 298.2K
Gonzalez, 309.41K
Gonzalez, 328.94K

Kordikowski, 298.2K
Gonzalez, 314.49K
Exp. Cloud Point 314.2K

Kordikowski, 303.2K
Rajasingam, 318.2K
Exp. Cloud Point 318.2K

Rajasingam, 308.2K
Gonzalez, 321.28K
Exp. Cloud Point 328.2

Figure 6.2. Cloud Point Experimental Data for the System DMSO- CO2
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1.0

Cloud Point DMSO-CO2
93
92

Pressure (bar)

91
90
89
88
87
86
85
0.85

0.90

0.95

1.00

x (CO2 mole fraction)
Gonzalez, 314.49K

Exp. Cloud Point 314.2K

Figure 6.3. Detail Cloud Point Experimental Data for the System DMSO-CO2 at 314 K.
Shows Standard Deviation Presented in Table 6.1.

Figure 6.3 is used to show the error bars on a small section of the cloud point plot
presented in Figure 6.2. Since the standard deviation is low and varies between 0.34 to
0.75 bars, it is not possible to see it on the original scale. The variation observed in Figure
6.2 can be attributed to the different experimental methods.

Rajasingam and

Kordikowski used a sampling method where pressure drops of 1 bar were reported as
well as 10% uncertainty of their measurements. Gonzalez used a set-up similar to the one
presented in this research, but the DMSO volume required was higher since this
information would be applied for anti-solvent processes, and this value was measured by
the number of rotations of the handle on a manual pump.
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6.2.2. Chitosan-DMSO-CO2 System
Some biopolymers frequently used in pharmaceutical applications such as poly(D-lactide) (PDLA), poly-(L-lactide) (PLLA), poly-(DL-lactide-co-glycolide) (PGLA),
Dextran, Inulin and poly vinyl alcohol (PVA), are insoluble in SCCO2, for this reason
different authors have been studying and processing them on a ternary system, polymerDMSO- SCCO2 (Reverchon 2000, Perez de Diego 2004). However, no data on the
system Chitosan-DMSO- SCCO2 has been published.
The next logical step was to obtain cloud point experimental data for this ternary
system, since the binary data cosolvent-solvent (DMSO-CO2) was already obtained.
For this purpose, the exact same set-up was used, Phase Monitor SPM20 (made
by Thar Technologies), but in this case different solutions Chitosan-DMSO (0.1, 0.5 and
1 mg/ml) were prepared by measuring the amount of Chitosan using an analytical
balance, measurable to ± 0.0001 g, and mixing this powder with the corresponding
volume of DMSO measured with a pipette, measurable to ± 0.001 ml.
The temperature selected for these experiments (308.2, 313.2 and 318.2 F) was
based on the requirements for the encapsulation of natural or pharmaceutical products
(thermally labile compounds).
The DMSO molar fraction used was 10% or less in order to be consistent with the
set of experiments performed for the system DMSO-CO2.
In Table 6.3, the experimental cloud point data for the system Chitosan-DMSOCO2 was collected in a temperature range of 308.2 K to 318.2 K and pressures from
92.4 to 156.7 bars were presented, (solubility was expressed on mass basis in Table 6.3,
and Figures 6.4, 6.5 and 6.6). The standard deviation value presented in this table was on
117

average less than one bar. It was based on five readings made for each experimental
condition, indicating that the experimental method is accurate. In total, for every
temperature, 35 data points were collected, distributed on seven compositions and five
readings for each pressure.

Table 6.3. Experimental Cloud Point Data Chitosan-DMSO-CO2. (Mass fraction)
T ( K)
1 K

308.2

313.2

318.2

wCO2

wDMSO
0.93
0.92
0.92
0.86
0.93
0.94
0.93
0.93
0.92
0.92
0.86
0.93
0.94
0.93
0.93
0.92
0.92
0.86
0.93
0.90
0.94
0.93

wChitosan

7.29E-02
7.84E-02
8.22E-02
1.42E-01
7.28E-02
6.45E-02
7.34E-02
7.29E-02
7.84E-02
8.22E-02
1.42E-01
7.28E-02
6.45E-02
7.34E-02
7.29E-02
7.84E-02
8.22E-02
1.42E-01
7.28E-02
9.50E-02
6.45E-02
7.34E-02

6.65E-06
7.15E-06
7.50E-06
1.29E-05
3.32E-05
5.89E-05
6.70E-05
6.65E-06
7.15E-06
7.50E-06
1.29E-05
3.32E-05
5.89E-05
6.70E-05
6.65E-06
7.15E-06
7.50E-06
1.29E-05
3.32E-05
4.34E-05
5.89E-05
6.70E-05

Pave (bar)
109.0
92.4
96.1
100.8
109.9
119.8
121.8
122.7
95.3
103.1
113.9
126.9
138.0
146.5
128.1
103.7
115.1
121.8
136.4
145.5
154.0
156.7

STD (bar)
0.6
0.5
0.4
0.4
0.6
0.7
0.2
0.1
0.8
0.6
0.6
0.6
0.5
0.5
0.5
0.7
0.2
1.1
0.8
0.3
0.4
0.3

As shown in Figure 6.4, Chitosan solubility increased proportionally with the
pressure at constant temperature, and solubility decreased with temperature increments at
constant pressure. This was a general effect that was suitable to the short-range attractive
forces between solvent and solute. The solubility of a low-volatile solute like Chitosan,
was enhanced as the density of the volatile solvent (CO2) increased, as a consequence of
temperature drop in an isobaric process or a pressure rise in an isothermal process.
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Figure 6.4. Cloud Point Experimental Data for Chitosan-DMSO- CO2 (80-160 Bar).

Figure 6.5. Cloud Point Experimental Data for Chitosan-DMSO- CO2 (100-115 Bar).
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In Figure 6.5, the error bars from a small section on the cloud point plot data in
Figure 6.4 is presented, since the standard deviation was low and varied between 0.2 to
1.1 bars, it was not possible to show it on the original scale.
A drastic change of slope was observed when collecting the cloud point data and
this is presented in Figure 6.6. This particular change of the solubility values could be
attributed to the fact that as this was a low solubility system. The critical point of the
solvent was close to the lower critical endpoint of the mixture. This means that the
behavior of the fluid phase in the proximity of the critical endpoint was strongly
influenced by the proximity of the critical point of the solvent.
At the critical endpoint, the solubility did change with infinite slope in the isobar
as a function of temperature, or in the isotherm as a function of pressure, and this infinite
slope was caused by the high vulnerability of the solution at the critical endpoint.

Figure 6.6. Slope Change at the Proximity of the CO2 Critical Point
for the System Chitosan-DMSO-CO2.
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In general, this cloud point experimental data confirms the hypothesis that the
solubility of this polymer (Chitosan) is low, compared to the solubility of the cosolvent
(DMSO). This suggests that an antisolvent or a perturbation coating method should be
used when a solution of DMSO-Chitosan will be used as the coating mix and the CO2
will be used to extract the DMSO. The Chitosan will be precipitated over the particles to
be encapsulated either by saturating and expanding the DMSO with CO2 or by
temperature perturbation.

6.3. Solubility Experiments
With the cloud point information available for the binary and ternary system, next
a dynamic solubility data for the system Chitosan-DMSO-CO2 was required in order to
establish the operation conditions for the encapsulation process.
The dynamic solubility system was useful to reproduce the solubility data
obtained in the static set-up, this time having a continuous process under supercritical
conditions. This experiment was considered as the first stage for the encapsulation
process, since it was possible to establish proper sampling procedures, ascertain
experimental difficulties and determine settings like temperature, pressure and flow rates.
In order to get the solubility information for the ternary system, the concentration
of each component needs to be determined or calculated. The UV system was used to
establish the Chitosan concentration in water-DMSO solutions, and the first step was to
ensure that the DMSO presence in the water solution would not interfere with the
Chitosan determination.
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After the UV calibration procedure, which is presented in full detail in Appendix
G, it was established that disposable PMMA cuvettes could be used to determine
Chitosan concentration in Water –DMSO solutions at a wavelength of 294 nm.
The UV spectra in Figure 6.7 shows the absorbance of the Chitosan collected in
200 ml of DI water when the supercritical solution Chitosan-DMSO-CO2 leaving the
extraction cell was bubbled into an Erlenmeyer flask containing the water.
Chitosan Absorbance Experimental Data

0.09
0.08
0.07

Absorbance

0.06
0.05
0.04
0.03
0.02
0.01
0
250

270

290

310

330

350

370

390

410

430

450

Wavelength (nm)
34.1 C, 109.3 bar
36.10 C, 118.9 bar

33.1 C, 104.4 bar
33.9 C, 103.4 bar

36 C, 97.4 bar
35.7 C, 98.8 bar

35.0 C, 110.5 bar
34.8 C, 105.4 bar

Figure 6.7. UV Spectra for Chitosan-DMSO-Water Solutions.

Using the linear relation presented in Appendix G and the UV results at
absorption band of 294 nm from Figure 6.7, the Chitosan concentration was determined
as presented in Table 6.4.
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Table 6.4. Chitosan Molar Concentration in 200 ml of Sample Solution.
Absorbance

C (mg/ml)

Mol Chitosan

0.0078
0.0138
0.0169
0.0211
0.0225
0.0847
0.0205
0.0529

0.01
0.02
0.03
0.04
0.04
0.11
0.03
0.06

2.78E-07
8.00E-07
1.07E-06
1.43E-06
1.56E-06
4.20E-06
1.38E-06
2.32E-06

The DMSO concentration was determined as a function of the operation time and
the flow rate of the HPLC pump, which was calibrated before operating the system to
ensure accurate values. The UV was not an option in this case, since Chitosan-DMSO
peaks overlapped in the region 195-245 nm and they could not be de-convoluted.

Table 6.5. DMSO Molar Concentration in 200 ml of Sample Solution.
Operation

Flow

Time (min)

(ml/min)

278.00
295.00
299.15
288.18
315.00
360.28
235.00
365.00

0.16
0.17
0.17
0.17
0.17
0.17
0.17
0.17

Mol DMSO
0.63
0.71
0.72
0.69
0.75
0.86
0.56
0.87

The amount of carbon dioxide used to extract the Chitosan was determined in two
different ways: using the Improved Rackett Equation (IRE) to determine the number of
moles of liquid CO2 at -3.0 C pumped by the ISCO syringe pump through the extraction
cell, and from the volume of expanded CO2 registered by the Wet Test Meter (WTM)
located at the end of the system (Appendix H). The results obtained were similar, since
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the error of the IRE at this low temperature was less than 0.2% compared to the IUPAC
Tables (Smeltzer, 2006).

Table 6.6. Moles of CO2 Used to Extract DMSO-Chitosan
T WTM

Mol CO2

T pump

Mol CO2

( C)

(WTM)

( C)

(IRE)

24.50
24.00
24.20
25.00
25.40
24.40
26.20
25.20

5.93
6.43
6.26
6.19
6.94
7.70
5.04
7.74

-3.00
-3.00
-3.00
-3.00
-3.00
-3.00
-3.00
-3.00

5.93
6.29
6.38
6.14
6.72
7.68
5.01
7.78

% Diff
0.14
2.27
-1.82
0.81
3.20
0.22
0.57
-0.47

To conclude, the information was put together and translated as solubility data,
including Chitosan, DMSO and CO2 fractions in Table 6.7. Usually, this information is
required for modeling or simply as guidance when studying the solubility of a multiple
component system for extraction or encapsulation purposes. However, in this particular
case, the information was not available and is a contribution of this research. It is
important to mention that every operation condition was evaluated twice and T and P
were registered at three different points of the system. The accuracy of these readings is
confirmed with the STD values presented in Table 6.7.
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Table 6.7. Solubility Data for the System Chitosan-DMSO-CO2
T ( C)

STD ( C)

P (bar)

STD (bar)

XChitosan

XCO2

XDMSO

36.0
35.7
33.9
33.1
34.8
34.1
35.0
36.1

0.50
0.15
0.20
0.34
0.23
0.17
0.21
0.11

97.3
98.8
103.4
104.4
105.4
109.3
110.5
118.9

0.7
0.5
0.4
0.4
0.7
0.8
0.2
0.5

4.25E-08
1.14E-07
1.50E-07
2.09E-07
2.08E-07
2.72E-07
2.47E-07
4.88E-07

0.9045
0.8990
0.8991
0.8990
0.8991
0.8990
0.8990
0.8985

0.0955
0.1010
0.1009
0.1010
0.1009
0.1010
0.1010
0.1015

Once all the dynamic solubility data was obtained, the next step was to compare
these results with the cloud point experimental data for the ternary system.

This

information is presented as a plot in Figure 6.4.
It is important to note that the cloud point data obtained from the static set-up or
solubility cell corresponded to the unique points where the components of the chemical
system co-existed in equilibrium, the mixture became opaque and it was no longer
possible to see the stirrer or the polished internal surface of the high pressure cell. The
dynamic set-up provided solubility data through leaching of the solid at a rate where the
extract phase was saturated. These results are interrelated and they should be similar, but
not necessarily exact matches, since the measurement methods were different, even
though (as confirmed in Figure 6.8) for a temperature of 35 C both results presented the
same behavior: as the pressure increased for an isothermal system, the solubility
increased.
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Solubility Data Chitosan 5000 in DMSO and SCCO2 at 35C

125
120

Pressure (bar)

115
110
105
100
95
90
0.E+00

1.E-07

2.E-07

3.E-07

4.E-07

5.E-07

6.E-07

7.E-07

x (Chitosan mol fraction)
Cloud Point 35 C (308 K)

Solubility 35 C (308 K)

Figure 6.8. Solubility and Cloud Point Data for the Ternary System
Chitosan-DMSO-CO2 at 35 C (308 K).
6.4. Encapsulation Experiments
The static and dynamic solubility data obtained for the ternary system, helped
establish that the pressure and temperature operation conditions for the encapsulation
process were 92-156 bar and 308-318 K respectively.
The encapsulation set-up was built with off-the-shelf equipment, which makes it
affordable and in this particular case we were able to build a system with a visualization
window. This window made it possible to follow the encapsulation process, since the
fluidization model for this ternary system was not available. In this particular experiment,
the limitations were temperatures on the encapsulation cell no higher than 50 C (323 K)
(to avoid the polymerization of the Chitosan in the lines) and pressures no higher than
130 bar (to avoid leaks on the encapsulation cell).
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The materials to be encapsulated were titanium dioxide (TiO2) and calcium oxide
(CaO), and they are insoluble in DMSO. Figure 6.9 shows a diagram of the operation
conditions during the encapsulation process.
Several encapsulation experiments were performed in the pressure range of 110120 bars and a temperature range of 41-50 C (314-323 K), using different contact
periods and particles (CaO and TiO2). Figure 6.9 describes graphically the encapsulation
process step by step, considering each factor separately: pressure, temperature and carbon
dioxide flow rate as a function of time. As shown in these diagrams, when the particles
were getting covered by the encapsulants, all the conditions were kept constant in order
to achieve a better coverage, followed by a temperature increase, which caused further
Chitosan precipitation. For the given pressure range, temperature increase reduced
Chitosan solubility and subsequently period allowed removal of DMSO in the system.
In an effort to show the effect of each of the operation conditions by itself, three
plots are presented: Figure 6.10 (coating thickness as a function of pressure), Figure 6.11
(coating thickness as a function of temperature) and Figure 6.12 (coating thickness as a
function of process time). At first glance these plots might cause some confusion,
because of the complexity of the behavior shown. However, going back to the definition
of solubility under supercritical conditions, it is obvious that these plots confirm the fact
that solubility is a function of density and for this reason pressure and temperature effect
cannot be analyzed independently.
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Figure 6.9. Coating Process Diagram.
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The thickness of the encapsulant material deposited over the particles was given
by a combination of factors: feed composition (DMSO-Chitosan), chemical composition
of the mixture (Chitosan-DMSO-CO2) in the cell, pressure, temperature and processing
time. This means that even having the same feed composition, the thickness of the
polymer deposited over the core material changed depending on the operation conditions
(Appendix I).
Results presented in Figure 6.10 show that when pressure was raised at constant
temperature, the coating thickness increased and coverage improved, which was a logical
consequence of solubility enhancement.
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Figure 6.10. Coating Thickness as a Function of Cell Pressure
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As the temperature increased at constant pressure the solubility of the polymer
decreased, causing its rapid precipitation which was desirable, since this encapsulation
method was based on temperature perturbation (Figure 6.11). However, if not controlled,
the polymer precipitated too fast, producing agglomeration and a poor encapsulation
process.
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Figure 6.11. Coating Thickness as a Function of Cell Temperature.

Comparing Figures 6.10 and 6.11, it can be observed that the highest thickness
was obtained for the combination high pressure-low temperature (120bar, 42ºC), which
was the condition that enhanced solubility and consequently promoted better
encapsulation.
The other factor considered in this encapsulation process was the process time,
including precipitation and extraction of DMSO, as presented in Figure 6.12.
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We would expect to get higher thickness for longer contact time, but as explained
previously, solubility is a function of density, and as shown in detail in Figure 6.12, the
lower thickness corresponds to a point with highest contact time at 120 bar and 42ºC,
which could be an indication that the coating material was re-dissolved in the DMSOCO2 mixture and removed.
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Figure 6.12. Coating Thickness as a Function of Process Time.

Table 6.8 includes all experimental conditions that resulted in encapsulated
particles. When the contact period was 20 min or less, there was no conclusive
information to affirm that any encapsulation was performed.
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After micro-encapsulation, each sample was characterized. To establish the
presence of Chitosan on the processed sample, FTIR was used. The concentration of each
element in the sample was determined with the EDS. SEM was used to obtain the
particle size distribution, the coating thickness was measured with TEM and finally the
coating morphology was evaluated with AFM.

Table 6.8. Coating Experiments Chitosan-DMSO-Core Material
Core
Material
CaO
CaO
CaO
TiO2

Contact

Thickness*

Time (min)

( m)

P (bar)

T( C)

111.0

48.6

Low pressure (12h)

0.0254

119.0

41.9

50

0.0528

119.8

44.8

45

0.1420

110.0

44.0

73

0.0265

TiO2

120.0
45.0
60
0.0368
*These are average values, for 8-24 samples per experiment.

Figure 6.13 depicts FTIR results of transmittances of CaO samples before and
after the encapsulation process. The plot in black (above) represents the CaO before
coating and the only peaks observed correspond to traces of elements present on the
quicklime sample: 875.99 cm-1 (SiO2), 1432.41 cm-1 (Sulfate), 3676.53cm-1
probably Ca-OH), which is caused by moisture exposure of the sample.
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(OH

Figure 6.13. FTIR CaO Before Coating (Above),
CaO-Chitosan After Processing (Below).

The plot in red (below) represents the CaO coated with Chitosan, where the
absorbance peaks obtained were compared with some published data available (Rout
2001, Cardenas 2004). The NH2 deformations are in the range 1559-1583 cm-1, C=O
bond 1646-1655 cm-1, C-H 2920-2945 cm-1 and N-H 3366-3450 cm-1, similar to the ones
found in literature reviewed.
These results confirm the Chitosan was precipitated during the encapsulation
process, but do not necessarily prove its presence as an encapsulant. The same analysis
was performed on all the TiO2 and CaO samples, to verify the presence of Chitosan
before proceeding with further analysis.
The next set of analyses performed was Energy Dispersive Spectroscopy (EDS)
to determine the weight percentage of each chemical elements present in the samples
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after the coating process, in order to compare these values with the weight percentages of
the same elements in the feed. In Tables 6.9 and 6.10 Calcium (Ca) was used for calcium
oxide (CaO), Nitrogen (N) was used for Chitosan (C12H24N2O9)n, sulfur (S) was used for
DMSO (C2H6OS), titanium (Ti) was used for titanium dioxide (TiO2), and oxygen (O)
was used as a reference element to validate the accuracy of the EDS analysis. The
difference (percentage basis) between the two values are presented in the last column on
both tables.

Table 6.9. Feed Mass Balance vs SEM-EDS Analysis for Processed CaO Samples
Material

Feed Mass Balance

SEM-EDS

Dif.

(Weight %)

(Weight %)

(Oxygen)

Ca

N

O

Ca

N

O

S

70.72

0.09

28.68

61.03

3.46

27.78

0.60

3.14

67.39

0.49

29.21

60.10

3.50

28.95

0.64

0.89

42.64

3.51

33.13

31.82

2.24

34.82

0.27

-1.74

48.26

2.83

32.24

40.80

3.96

33.40

0.72

-0.82

35.72 4.36 34.23 28.83
* This experiment did not produce encapsulated particles

4.01

31.90

1.31

1.05

CaO, Chitosan, DMSO*
CaO, Chitosan, DMSO
CaO, Chitosan, DMSO
CaO, Chitosan, DMSO
CaO, Chitosan, DMSO

%

Table 6.10. Feed Mass Balance vs SEM-EDS Analysis for Processed TiO2 Samples
Material

Feed Mass Balance

SEM-EDS

Dif.

(Weight %)

(Weight %)

(Oxygen)

Ti

N

%

Ti

N

O

S

TiO2, Chitosan, DMSO

%

41.34

2.71

39.00

37.5

4.03

38.93

0.39

0.19

TiO2, Chitosan, DMSO

29.24

4.47

38.68

20.28

7.86

38.98

0.31

-0.78

Visually it was easy to determine the presence of Chitosan in the processed
samples just by observing the yellowish color of the dry powder, and SEM-EDS results
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confirmed the presence of Chitosan and DMSO in the processed samples (the last one
(DMSO) in very small amounts), verifying that it was extracted with the supercritical
CO2 from the encapsulation cell. Another result obtained by using the SEM-EDS analysis
is that even when the samples presented a yellowish color and no encapsulation was
produced, having a higher percentage of N for the processed samples compared to the
feed calculations was an indication of a high concentration of Chitosan. This particular
sample was analyzed with TEM (Figure 6.14).

Figure 6.14. CaO-Chitosan TEM Image.

However, again these results were not conclusive, since the Chitosan could be
present as coating or simply as precipitated material, and for this reason TEM and AFM
analysis were required.
One of the characterization techniques employed to estimate the particle sizes
(before and after the encapsulation process) and the coating thickness was a Scanning
Electron Microscopy (SEM). This SEM system (Hitachi 800) has a feature that allows
users to analyze a group of particles, reporting the total number of particles in the picture
and the estimated diameter for each of them. Therefore, pictures of the samples were
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taken before and after the coating, with particle populations in the order of hundreds,
establishing a particle size distribution for coated and uncoated CaO and TiO2.
These results were essential in order to establish how the particle size was
affected by the coating process and how significant the TEM results were. These results
are summarized on Table 6.11, and the particle size distribution plots for the coated and
uncoated CaO and TiO2 are shown in Figures 6.15 through 6.18.
Table 6.11. Average Particle Size from SEM Analysis.
Particle
Uncoated TiO2
Coated TiO2
Coated CaO
Uncoated CaO

# Measurements
957
543
477
806

DoAverage ( m)
0.39
0.40
0.20
0.25

The results obtained from the particle size distribution does not show much
difference between the particle before and after processing. This indicates that the
coating thickness is on the nanometer order, which is confirmed by the TEM data as well.
(a)
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40
35

25
20
15
10
5

98
1.
1
1.
22
1.
46
1.
68
1.
99
2.
25
2.
75
4.
77

91

0.

83

0.

69

0.

63

0.

56

0.

46
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0.
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27
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21
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0.

11

0.
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0
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Particle Size (micron)
Uncoated CaO

Figure 6.15. Particle Size Distribution for Uncoated CaO. (806 data points).
136

(b)
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Figure 6.16. Particle Size Distribution for Encapsulated CaO. (477 data points).
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Figure 6.17. Particle Size Distribution for Uncoated TiO2. (957 data points).
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Figure 6.18. Particle Size Distribution for Encapsulated TiO2. (543 data points).
Another factor that had to be considered with the SEM was that samples
contained encapsulated, non-encapsulated and polymer particles. Therefore, precise
particle size and coating thickness required TEM analysis of the particles.
TEM analysis of the processed CaO and TiO2 samples confirmed the fact that the
particles were encapsulated, providing the shape of the encapsulated particles and the
coating thickness. Transmission electron microscopy (TEM) is an imaging technique
whereby a beam of electrons is transmitted through a specimen, then an image is formed,
magnified and directed to appear on a CCD camera (CCDs are used in digital
photography). The materials interact with the electron beam and the intensity of the
transmitted beam is affected by the volume and density of the material through which it
passes, for this reason in the following pictures it is possible to distinguish between the
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dark solid dense core made of inorganic material, CaO or TiO2, and the organic polymer
coating that is almost transparent to the electron beam.

(a)

(b)

Figure 6.19. TEM for Chitosan Encapsulated Particle.
(a) CaO Particles, (b) TiO2 Particles.
Using several pictures taken for each of the processed samples, similar to the ones
shown in Figure 6.19, average information about particle size and coating thickness were
obtained and presented in Tables 6.12 and 6.13. The external diameter (Do) and internal
diameter (Di) were calculated from measurements done by using Microsoft Office Visio
2003 when analyzing the digital TEM images for each particle. The bold numbers in
each column represent the average values.
The experimental data showed that pressure, temperature and contact time are
related: when pressure increased, the coating thickness and coverage increased as a
logical consequence of solubility enhancement. As the temperature increased, the
solubility of the polymer decreased, causing its rapid precipitation. This was desirable,
139

since this encapsulation method was based on temperature perturbation, but if not
controlled the polymer precipitated too fast and there was not enough time for the
supercritical mixture to be absorbed over the particles‟ surface, producing agglomeration
and a poor encapsulation process. The other factor considered in this encapsulation
process was the contact time. In theory, the longer the exposure or contact time, the
thicker the coating should be, but the experimental results did not back up this premise.
One encapsulation test where the CaO particles were stirred overnight at room
temperature in the liquid mixture Chitosan-DMSO and then pressurized at 111 bar and
48.6ºC for 120 min was the experiment that showed the thinner coating and the inferior
coverage.
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Table 6.12. TEM Thickness Measurements for Encapsulated CaO Particles.
Do ( m)

Di ( m)

Thickness

P

T

Contact

( m)

(bar)

( C)

Time (min)

2.2208
1.3839
0.4185
120
45
45
0.5132
0.4095
0.0519
120
45
45
0.1736
0.1410
0.0163
120
45
45
1.3670
0.8970
0.2350
120
45
45
0.3430
0.2750
0.0340
120
45
45
0.9690
0.6450
0.1620
120
45
45
2.1648
1.8734
0.1457
120
45
45
0.3100
0.1650
0.0725
120
45
45
1.0077
0.7237
0.1420
120
45
45
0.2045
0.1372
0.0337
109
42
50
0.3577
0.1925
0.0826
109
42
50
0.2621
0.1376
0.0623
109
42
50
0.1193
0.0770
0.0212
109
42
50
0.1236
0.0817
0.0210
109
42
50
0.2464
0.1429
0.0518
109
42
50
0.2510
0.1019
0.0746
109
42
50
0.2862
0.1349
0.0757
109
42
50
0.2314
0.1257
0.0528
109
42
50
0.1725
0.0971
0.0377
111
49
30*
0.1081
0.0806
0.0138
111
49
30*
0.1639
0.1156
0.0242
111
49
30*
0.1400
0.0890
0.0255
111
49
30*
0.1360
0.0980
0.0190
111
49
30*
0.1480
0.0950
0.0265
111
49
30*
0.1682
0.1064
0.0309
111
49
30*
0.1480
0.0970
0.0255
111
49
30*
0.1481
0.0973
0.0254
111
49
30*
*The system chitosan-DMSO-CaO was kept at room conditions
for 12h with constant stirring before pressurization for 30 min.
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Table 6.13. TEM Thickness Measurements for Encapsulated TiO2 Particles.
Do ( m)

Di ( m)

0.1513
0.1531
0.3329
0.5143
0.2694
0.1153
0.1520
0.2430
0.4240
0.3920
0.1920
0.1340
0.1980
0.3340
0.4080
0.2920
0.1630
0.1660
0.2575
0.1343
0.1060
0.1450
0.1202
0.1500
0.1200
0.1260
0.1330
0.1430
0.1440
0.1490
0.2190
0.2390
0.3300
0.3170
0.1950
0.2690
0.1390
0.2750
0.2340
0.184

0.1371
0.1424
0.2472
0.3434
0.1220
0.1048
0.1400
0.1950
0.2950
0.2330
0.1130
0.1220
0.1680
0.2450
0.2640
0.1730
0.1180
0.1450
0.1838
0.1067
0.0512
0.1242
0.0546
0.1260
0.0790
0.0880
0.1220
0.1250
0.0970
0.1300
0.1860
0.1990
0.2340
0.1730
0.1730
0.1420
0.1030
0.1730
0.1390
0.131

Thickness

P

T

Contact

( m)

(bar)

( C)

Time (min)

120
120
120
120
120
120
120
120
120
120
120
120
120
120
120
120
120
120
120
110
110
110
110
110
110
110
110
110
110
110
110
110
110
110
110
110
110
110
110
110

45
45
45
45
45
45
45
45
45
45
45
45
45
45
45
45
45
45
45
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44

60
60
60
60
60
60
60
60
60
60
60
60
60
60
60
60
60
60
60
73
73
73
73
73
73
73
73
73
73
73
73
73
73
73
73
73
73
73
73
73

0.0071
0.0054
0.0429
0.0855
0.0737
0.0053
0.0060
0.0240
0.0645
0.0795
0.0395
0.0060
0.0150
0.0445
0.0720
0.0595
0.0225
0.0105
0.0368
0.0138
0.0274
0.0104
0.0328
0.0120
0.0205
0.0190
0.0055
0.0090
0.0235
0.0095
0.0165
0.0200
0.0480
0.0720
0.0110
0.0635
0.0180
0.0510
0.0475
0.027

Once demonstrated by TEM results that the particles were coated and an average
coating thickness was estimated, the next step was to study the morphology of the
coating, and this was obtained from AFM. The atomic force microscope (AFM) is a
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high-resolution type of scanning probe microscope (the term 'microscope' in the name is
actually a misnomer because it implies looking, while in fact the information is gathered
by "feeling" the surface with a mechanical probe). The AFM is one of the foremost tools
for imaging, measuring and manipulating matter at the nanoscale.
This analysis technique was chosen because AFM provides a true threedimensional surface profile. Additionally, samples viewed by AFM do not require any
special treatments (such as metal/carbon coatings on SEM) that in this case would
irreversibly change the sample, making it impossible to study the true morphology of the
coating material.
In Figures 6.20 and 6.21, the roughness of uncoated and coated CaO particles
sample are compared, showing that once coated, the particle surface is smoother, with
roughness changing from 34.548 nm for the uncoated CaO particle to 2.660 nm for the
encapsulated particle.
Figures 6.22 and 6.23 (Height and Phase) for the uncoated and encapsulated CaO
particles, are another evidence of the encapsulating process, since the uncoated particles
present a crystal shape structure and the encapsulated ones have a rounded coated shape,
confirming the results obtained by the TEM, where complete encapsulated particles were
found. The Section Analysis presented in Figures 6.24 and 6.25 show particles with
diameters of less than one micron, confirming the particle sizes obtained with TEM and
SEM, as well as differentiating the external angular crystal shape of the uncoated
particles and the rounded surface of the coated ones.
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Figure 6.20. Uncoated CaO Roughness Analysis.

Figure 6.21. Coated CaO Roughness Analysis.
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Figure 6.22. Uncoated CaO Height and Phase.

Figure 6.23. Coated CaO Height and Phase.
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Figure 6.24. Uncoated CaO Section Analysis.

Figure 6.25. Coated CaO Section Analysis.
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6.5. Coating Analysis and Characterization
As mentioned previously, there is no analytical data published about this
particular Chitosan Oligosaccharide Lactate; for this reason some characterization was
needed. In order to determine if the encapsulating process was causing some changes to
the polymer, all analytical tests were performed before and after processing.
FTIR analyses were performed to four Chitosan samples of different molecular
weights and the Oligosaccharide Lactate before and after the encapsulating process, to
determine if there were any changes on polymer. Figure 6.26 shows that all the plots are
similar, confirming that all the Chitosan peaks were present before and after the
encapsulation process.
Wavelenght (cm-1)
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MMW

Figure 6.26. FTIR Plot for Chitosan Oligosaccharide Lactate. (OL Sigma).
Before and after processing is shown, as well as Chitosan Low Molecular Weight (LMW)
and Medium Molecular Weight (MMW).
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The -NH deformations were in the 1600 cm-1 (1539 cm-1 amine and 1635 cm-1
amide) range. The -CO band was at 1074 cm-1, stretching deformation -CH was at
2920-2945 cm-1, -OH was at 3435 cm-1, and -CN was at 1153 cm-1. These were all
similar to the ones found in the literature reviewed (Cardenas 2004, Jang 2003 and Zhou
2002).
The only difference observed was that the processed Oligosaccharide Lactate
spectrum had two peaks seeming to be stronger, one at 3435 cm-1, that corresponded to OH deformations, which could be an indication of some water absorbed in the Chitosan;
and the other one was around 1060cm-1, for the sulfoxide group, indicating that some
DMSO remained absorbed in the polymer. However this peak overlapped with the -CO
band at 1074 cm-1 and -CN at 1153 cm-1.
Using another analysis method, a DSC-TGA device was used to characterize the
polymers, by measuring both heat flow and weight changes in a material as a function of
temperature on time in a controlled atmosphere. This is a very useful technique because
the information obtained allows differentiation between endothermic and exothermic
events which have no associated weight loss (e.g. melting, crystallization, glass
transition) and those which involve a weight loss (e.g. degradation).
In Figure 6.27, a DSC-TGA for Chitosan Oligosaccharide Lactate before
processing is shown, where a phase change or glass transition temperature was observed
at 106.1 C (no weight loss) and decomposition was seen at 148.96 C accompanied by a
weight loss of 21.16%. Glass transition temperatures have been reported by Y. Dong
2004 for higher molecular weights Chitosans (450,000 Da) around 130-150 C, but no
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data was found for Chitosan Oligosaccharide Lactate. Not even the provider (Sigma
Aldrich) had this data available in order to compare the results.
Figure 6.28 shows a DSC-TGA for the processed Chitosan Oligosaccharide
Lactate, where decomposition at 125.8 C accompanied by a weight loss of 49.92% was
observed. These results indicate that the original polymer was more stable and this is
probably a consequence of the water and DMSO absorbed by the Chitosan during
processing or manipulation, as indicated by the FTIR (increase of -OH 3435 cm-1 peak)
and the NMR tests presented next, and confirmed by studies done by Ratajska on water
soluble Chitosan.

Figure 6.27. DSC-TGA for Chitosan Oligosaccharide Lactate.
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Figure 6.28. DSC-TGA for Processed Chitosan Oligosaccharide Lactate.

From a theoretical proton NMR of the monomer made in ChemDraw from
CambridgeSoft, which is generally a good estimate, we can see the expected peaks in
Figure 6.29.
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Figure 6.29. Proton NMR for Chitosan Monomer (ChemDraw).

The NMR done at Inova-400 (Figure 6.30) looks pretty well resolved for the
peaks of the pure Chitosan Oligosaccharide Lactate, if compared with the NMR of the
monomer made with ChemDraw. The DMSO peak came around 2.5-2.62 ppm. In
addition, there was always water absorbed by the DMSO and it appeared around 3.3 ppm.
In Figure 6.31, a Proton NMR of the processed Chitosan Oligosaccharide Lactate
is presented and it can be seen is that, although almost all DMSO was extracted from the
sample (SEM-EDS data), there was still some DMSO present. Also, the large peak
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between 2-3 ppm was residual DMSO and the other large peak between 3-4 ppm was
water, probably absorbed from the environment, since the sample and DMSO are highly
hygroscopic. This caused some of the peaks shifting to 5-6 ppm and the rest of the peaks
were buried under DMSO and water peaks, since the encapsulation process described did
not change the chemical structure of the polymer.

Figure 6.30. Proton NMR Pure Chitosan Oligosaccharide Lactate.
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Figure 6.31. Proton NMR Processed Chitosan Oligosaccharide Lactate.
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CHAPTER 7
CONCLUSIONS AND RECOMMENDATIONS

Chitosan Oligosaccharide Lactate is a relatively new biopolymer with a low
molecular weight (5000Da), when compared with the other members of the Chitosan
family where the molecular weight ranges 50,000 to 375,000 Da. This specific
characteristic makes Chitosan Oligosaccharide Lactate soluble at regular mucus pH 6.5,
showing potential application in the pharmaceutical and food industries. What was found
during this research is that it is not soluble on DCM, chloroform, acetone, ethanol or pure
supercritical CO2, but it is highly soluble in water and DMSO. DMSO, being readily
accepted for targeted delivery, can be used as a cosolvent in supercritical procedures.
The main objective of this research was to perform the encapsulation of fine dry
powders using supercritical CO2. This necessitated basic information on phase behavior
and solubility for the system DMSO-CO2. The experimental effort to date had focused on
high DMSO concentrations used for antisolvent procedures with limited use for DMSO
as a cosolvent in encapsulation procedures. Cloud point data was generated for the
system DMSO-CO2 in a temperature range of 314.2 K to 328.2 K and pressures from
89 to 133.5 bars and DMSO molar fractions between 5 to 10%. The standard deviation
based on the five readings made for each data point is less than one bar, indicating that
this experimental method is accurate. The results that were obtained line up with existent
literature data reported by Rajasingam 2004, Gonzalez 2002 and Kordikowski 1995,
154

observing some variations ( 4 bar) that can be attributed to the different experimental
methods designed to work with DMSO concentrations over 10% molar basis.
Chitosan-DMSO-CO2 cloud point and solubility data was generated in a
temperature range of 308.2 K to 318.2 K and pressures from 92.4 to 156.7 bars with a
standard deviation for each data point of less than one bar. This is an important
contribution from this research, since there was previously no information available for
this system. Furthermore, as is well known, modeling the behavior of a supercritical
mixture including a polymer is exceedingly difficult, since polymers are substances
composed of many single molecules or repeating units (monomers) connected by
covalent chemical bonds, interacting among themselves and the solvents used at
supercritical conditions.
From the solubility experiments, it can be stated that at isothermal conditions the
Chitosan solubility increases proportionally with the pressure; and at constant pressure
the solubility decreases with temperature increments. This is a general effect that is
suitable to the short-range attractive forces between solvent and solute. The solubility of a
low-volatile solute, like Chitosan, is enhanced as the density of the volatile solvent (CO2)
increases, as a consequence of temperature drop in an isobaric process or pressure rise in
an isothermal process.
The fact that DMSO solubility in supercritical CO2 is high compared to the
solubility of Chitosan Oligosaccharide Lactate in SCCO2 was the reason to try a
temperature change at isobaric conditions to disrupt the equilibrium of this ternary
system. The experimental work performed establishes that by increasing the temperature
at constant pressure, the solubility of the Chitosan decreases, causing it to precipitate over
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the particles that need to be encapsulated while the DMSO stays solubilized in the
SCCO2.
Fluidization of CaO and TiO2 particles with diameters under one micron was
achieved in a mini fluidized bed (volume = 60 ml) with SCCO2. The average CO2 mass
flow used to fluidize these particles was 2 to 5g/min, calculated with Wen & Yu 1966, as
recommended by Carsten Vogt, 2005.
The performance of this encapsulation method for dry powders particles was
proved by encapsulating calcium oxide (CaO, non porous) and titanium dioxide (TiO2,
porous) particles with diameters under one micron using Chitosan Oligosaccharide
Lactate.
This research confirms FTIR and EDS as valuable techniques to verify the
presence of Chitosan in the encapsulated particle and also shows that almost all DMSO
was removed during extraction. TEM analysis provided visual confirmation that CaO and
TiO2 particles of 1 micron or less were encapsulated with a thickness of 5 nm or less, and
these results coincided with SEM and AFM analysis.
The experimental data obtained validates the fact that solubility is a function of
pressure and temperature. Pressure increments at constant temperature cause coating
thickness augmentation and coverage improvement as a logical consequence of solubility
enhancement. On the other hand, temperature increments diminish the solubility of the
polymer, causing its rapid precipitation, which is desirable since this encapsulation
method is based on temperature perturbation. However, when not controlled the polymer
precipitates too fast, and if contact time was not enough for the supercritical mix to get
adsorbed over the particles, it results in surface agglomeration and a poor encapsulation.
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SEM samples of 477 to more than 900 particles provided a particle size
distribution, where more than 90% of the CaO and TiO2 particles had been confirmed to
have a diameter under one micron.
AFM showed particle roughness of 2-4 nm for the encapsulated sample and 36 to
46 nm or higher for uncoated ones, proving the particles were encapsulated, since the
surface is smoother after the coating is applied, also the uncoated particles presented a
crystal angular shape structure when compared to the encapsulated ones with a rounded
shape.
FTIR analyses were performed on four Chitosan samples of different molecular
weights and the Oligosaccharide Lactate before and after the encapsulating process. All
the plots are similar, confirming the presence of Chitosan before and after the
encapsulation process.

The only difference observed is that the processed

Oligosaccharide Lactate spectrum has two peaks seeming to be stronger, one at 3435cm-1,
that corresponds to

-OH deformations (which can be an indication of some water

absorbed in the Chitosan) and the other one at around 1060cm-1 for the sulfoxide group
(indicating that some DMSO remains absorbed in the polymer). However, this peak
overlaps with the -CO band at 1074 cm-1 and -CN at 1153 cm-1.
DSC-TGA analysis performed on Chitosan Oligosaccharide Lactate indicates that
the original polymer appears to be more thermally stable and this is probably a
consequence of the water adsorbed by the Chitosan during or after processing, as
confirmed by the NMR tests. DSC-TGA for Chitosan Oligosaccharide Lactate before
processing shows a phase change or glass transition temperature at 106.1 C (no weight
loss) and decomposition at 148.96 C, accompanied by a weight loss of 21.16%, while
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processed Chitosan Oligosaccharide Lactate had decomposition at 125.8

C,

accompanied by a weight loss of 49.92%.
In conclusion, the solubility data and encapsulation results obtained from this
research are valuable as new information. This new data can be the starting point for
many other research works, including experimental and modeling. It was proven
experimentally that Chitosan Oligosaccharide Lactate can be solubilized in supercritical
carbon dioxide using DMSO as a cosolvent (5-10%) at temperatures between 308.2 K to
318.2 K and pressures from 92.4 to 156.7 bars. This information was used to coat CaO
and TiO2 particles (0.2-2

m) at 92-156 bar and 308-318 K, using a temperature

perturbation technique in a fluidized bed.
The mass balance presented in Appendix I indicates that the solubility decreases
inside the encapsulation cell, as the temperature was raised at a constant pressure to
promote the polymer precipitation. The results from Tables I.3 and I.4 indicate that the
volume of SCCO2 used to remove DMSO was higher than required, which could cause
Chitosan removal, reducing encapsulant thickness.
The results obtained during this experimental research work are encouraging and
for this reason some improvements are recommended for future work. In order to obtain
more experimental data in less time from the dynamic solubility set-up, it would be
useful to have the solubility cell and the mixer enclosed in an oven instead of the water
bath, as well as having a densitometer connected to the extraction cell.
The encapsulation cell used was a modified Jerguson gauge, which included some
Teflon baffles especially designed to avoid disruption of the flow profile. These inserts
had to be readjusted after every single experiment, taking at least eight hours before the
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cell could be operated again. For this reason, redesigning and building the body of the
cell as one solid piece should be considered, as well as an easy opening and closing
system. Having a full body Safire cell on the solubility set-up would make it possible to
obtain all the phase transitions for multi-component mixtures, facilitating future modeling
attempts for this and other supercritical systems.
Due to the hygroscopic nature of Chitosan Oligosaccharide Lactate, some
agglomeration could be attributed to moisture pick-up over time; for future experiments it
is recommended to store samples in absolute dry conditions.
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Appendix A. Supercritical Encapsulation Techniques Literature
Particle Size
Reference

Process

(μm)

Coating
Core
Solubility Solubility

Comments
-

Bleich J., 1996

Chapttopadhyay P.,
2005

ASES

SFEE

<50

0.2-1

No

No

No

No

Elva1ssore Nicola,
2001

SAS

0.5-2

No

No

Falk Rick, 1997

PCA

0.2-1

No

No

Glebov Evgeni M.,
2001

RESS

20

Yes

-

No

-
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SCCO2
Core particles: hyoscine butylbromide, indomethacin, piroxican
and thymopentin.
Coating material: PLA.
Particle size: 10-90 μm.
SCCO2
Core particles: indomethacin and ketoprofen.
Coating material: Eudagrid and PLA.
Continuous and batch process by supercritical carbon dioxide
extraction of oil in water (o/w) emulsions.
Final particle size 200 and 1000 nm.
SCCO2
Core particles: insulin.
Coating material: PLA
Cosolvents: DCM, DMSO.
Particle size: 0.5 to 2 μm.
SCCO2
Core particles: Gentamycin, naloxone, and naltrexone.
Coating material: PLA.
Hydrophobic ion pairing (HIP) technique was used.
Particle size: 0.2-1.0 m.
SCCO2
Core particles: Al, Mg powders (20 μm).
Coating material: poly(vinylidene fluoride) and poly(4vinylbiphenyl) (PVB) were used.
Average thicknesses of the films deposited on metal powders
were in the range of 1-30 nm.

Appendix A (Continued)
Particle Size

Coating
Core
Solubility Solubility

Reference

Process

Hertz Audrey,
2006

RESS,
Polymerization

0.03-0.3

Yes

No

Kim Jong-Hyun,
1996

RESS

10-90

Yes

Yes

Kröber H, 2005

RESS

7.39-124.6

Yes

No

Matsuyama
Kiyoshi, 2003

RESS-N

14.6

Yes

No

Mishima Kenji,
2000

Pessey V., 2000

(μm)

Comments
-

RESS-N

SCF- Reaction

6-62

2-3

Yes

Yes

No

No
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-

SCCO2
The core material: YSZ particles.
Coating material MMA and PMMA.
PDMS-g-PA was used as surfactant.
SCCO2
Core particles: naproxen.
Coating material: poly-(L-lactic acid) (L-PLA).
Particle size: 10-90 μm.
Agglomeration was constant in almost all the experiments.
SCCO2.
Glass beads were coated with stearyl alcohol.
Smooth coating, thickness 1-8 m.
Coated particle size range is 70-125 m.
SCCO2
Core material: p-acetamidophenol, acetylsalicylic acid,
1,3-dimethylxanthine, flavone, and 3-hydroxyflavone.
Coating material PEG, PMMA, PLA, PGLA and PPGPEG.
SCCO2
Core material: lysozyme (24 m) and lipase (19 m).
Coating material PEG, PMMA, PLA, PGLA and PPGPEG.
SCCO2
Core particles: Ni (3 m) and SmCo5 (10 m)
Coating: Cu
The thickness on Ni gave values from 0.2 to 1 m.

Appendix A (Continued)
Particle Size
Reference

Process

(μm)

Coating
Core
Solubility Solubility

Comments
-

Ribeiro Dos
Santos, 2002

Sun Ya-Ping, 1998

Sunol A.K, 1998

Gradual P-T
drop

RESS

T antisolvent

125-500

0.0033

30-500

Yes

Yes

Yes

No

No

No

-

SCCO2.
BSA microparticles coated with Gelucire 50/02 or Dynasan
114.
Dynasan 114 crystallizes, was not a good coating.
Coating was not perfectly uniform.
Coated particle size range is 543 m.

-

SCNH3
Core particles: cadmium sulfide (33 Å)
Coating material: Poly(N-vinyl-2-pyrrolidone).

-

SCCO2
Core particles: sodium chloride (30-500 μm) and
ammonium nitrate.
Coating material: HTPB.
Film thicknesses as low as 0.2 micron.

-

Thies C., 2003

Tsutsumi Atsushi,
1995

Gradual P-T
drop

RESS

500

55.6

Yes

Yes

No

No
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-

SCCO2.
BSA crystals and sugar spheres as core particles coated with
Gelucire 50/02 and Trimyristin.
Trimyristin crystallizes, was not a good coating.
Insoluble biomolecules less prone to denaturizing in process
like this.
Coated particle size range is 500 m.
SCCO2.
Spherical catalyst particles were coated with paraffin.
Average particle size 56 μm.
Coating thickness below 0.5 m.

Appendix A (Continued)
Particle Size
Reference

Process

(μm)

RESS,
Impinging

0.02-1

Wang Ting-Jie,
2001

RESS

130

RESS

Comments
-

Tsutsumi Atsushi,
2003

Wang Yulu, 2002

Coating
Core
Solubility Solubility

315-500

Yes

Yes

Yes

No
-

No

-

No

Wang Yulu, 2004

SAS

0.016, 0.020,
0.6

No

No

Wang Yulu, 2005

SAS

0.5

No

No

Young Timothy
J., 1999

PCA

5-70

No

No

-

173

SCCO2
Core particles: silica particles (1μm) and titanium dioxide (20
nm) were used.
Coating material was paraffin.
Thickness of the paraffin layer was around 50–60 nm.
SCCO2, paraffin was used as a binder.
Fine particles of SiO2 (d= 1μm) as coating material and glass
beads as core particle (d=130 μm).
SCCO2.
PVCVA and HPC were used as coating.
The host particles were glass beads, 315 and 500 m.
The average coating thickness was about 0.8 μm, some
agglomeration and uneven coating was observed.
SCCO2
Core particles: silica nanoparticles (hydrophobic and
hydrophilic).
Coating material: Eudragit.
Coated particle: 600 nm.
Coating thickness: 75 nm.
SCCO2
Core particles: silica particles (0.5 μm)
Coating material: PLGA.
SCCO2
Core particles: Lysozyme (1-10 μm).
Coating material was l-PLA or PGLA.
Particle size: 5- 70 μm.

Appendix A (Continued)
Particle Size
Reference

Process

(μm)

Coating
Core
Solubility Solubility

Comments
-

Yuea Baohua,
2004

Dispersion
polymerization

12

Yes

No

-

BSA: Bovine serum albumin
CdS: cadmium sulfide
CF3COCH=C(O)-CF3]2Cu: bis-(hexafluoroacetylacetonate)copper(II)
L-PLA: Poly-L-lactide
PEG: Poly(ethylene glycol)
PDMS-g-PA: poly(dimethylsiloxane)-grafted-polyacrylate
PMMA: Poly(methyl methacrylate)
PPG:Poly(propylene glycol)
PS: Poly(styrene)
PVB: poly(4-vinylbiphenyl)
PVDF: poly(vinylidene fluoride)
SmCo5: Samarium cobalt
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SC CO2.
DCR particles were encapsulated with PMMA
and PVP.
Useful when a monomer can be used as a
cosolvent.
Valuable to make small particles, 12 m.
Minor particle agglomeration.

Appendix B. Supercritical Encapsulation Patents Literature
Author
Akihisa N., Eiichi U., Chiaki
N. (2005)
Benoit J. P., Richard J., Thies
C. (1996)
Benoit J. P. , Rolland H., Thies
C., Van de Velde V. (1996)
Benoit J. P. , Rolland H., Thies
C., Van de Velde V. (2000)

Patent #
JP 2005232053

Brunner G. and Werther J.
(2006)

EP 1731219

Buerger A., Raschck T., Voigt
N., Schwanke F. (2003)
Cunningham M. F., Mahabadi
H. K. (1996)

WO 03075881

Dalian Medicine Institute
(1998)
Kobe Steel Ltd. (1993)
Krause H., Niehaus M., Teipel
U. (1998)
Mishima K. (1999)

CN 1221607

Mishima K., Yamaguchi S.
Umemoto H., (1996)

JP 8104830

FR 2753639
WO 96/13136
EP 0706821
WO 96/11055
US 6087003

US 5514514

J 05057166
DE 19711393
JP 11197494

Method
Formulation of liposome-charged particles with a lipid film using SCCO2 in a RESS
process.
A suspension of the active substance and a polar polymer in an organic solvent were
precipitated with SCCO2 using a SAS process.
Particles were coated in a stirred vessel by precipitating the dissolved coating with T
and P changes.
Solid particles were coated by using SCCO2 and a coated material dissolved thereon.
The pressure or temperature of the system is adjusted in such a way as to cause
controlled precipitation of the coating material.
Process for encapsulating organic substances in particle form by spraying an inert
supercritical carrier gas together with the coating material into a high pressure
fluidized bed contained in an autoclave.
Coating method for cosmetic application using a wax coating in a SCF fluidized bed.
Preparation of carrier powder polymer coatings which includes the supercritical
polymerization of a monomer and surfactant in a SCF to form a porous polymer,
after which a second polymer is incorporated.
Lipoplast particles were coated with liposoluble medicines in a SCCO2 environment
by the increase of T and decrease of P.
RESS process where core, coating material and SCCO2 form a homogeneous system.
Coated 100 m particle with a coating agent dissolved in SCCO2 using RESS in a
fluidized bed.
Production of organic-inorganic microcapsules using SCCO2 RESS process.
Patented the formation of micro-spheres by spraying a suspension of flavonoids in a
supercritical solution of the polymer and a cosolvent at atmospheric pressure.
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Author
Mishima K., Mitani H. (1999)

Patent #
JP11047681

Mishima K., Matsuyama K.
(2006)
Perrut M. (2001)

KR 20060125871

Pessey V., Cansell F.,
Chevalier B., Weill F.,
Etourneau J. (1999)
Shine A., Gelb J. (1997)

FR 9904175

Subramanian B., Said S.,
Rajewski R. A., Stella V.
(1997)
Subramanian B., Saim S.,
Rajejewski R. A., Stella V.
(1998)
Sunol A. K. (1997)

WO 97/31691

Wang Y., Pfeffer R., Dave R.
(2004)
Wang Y., Pfeffer R., Dave R.
(2009)
Yunquing K., Guangfu Y.,
Yandong Y.‟ Zhongbing H.‟
Xiaoming L. (2008)

WO2001049407

WO 98/15348

Method
Inorganic particles were coated with PEG using SCCO2 in a RESS process, where
the core and coating materials were solubilized in the SCF by using a cosolvent.
A method for producing fine particles using rapid expansion into poor solvent from
supercritical fluid.
Method for collecting and particles encapsulation using a coating agent and particles
dispersed in a SCF by RESS.
Coating of metallic particles was obtained by thermal decomposition of the coating
material in a high pressure cell.
Microencapsulation of a core material by swelling a polymer coating with a SCF,
followed by a RESS process.
An ASES process was patented where a solution with the coating agent was sprayed
over the fluidized core particles.

US5833891

Method for particle precipitation and subsequence coating using a SCF with an
antisolvent technique.

US 0062332
WO2004091571

Using a temperature swing, the polymer coating was precipitated over the insoluble
particle core.
Preparation of coated nanoparticles with SCCO2 antisolvent method.

US 7537803

Polymer coating/encapsulation using supercritical antisolvent process.

EP 1731219

Preparation of praclitaxel carried medicine sustained-release microsphere by
supercritical fluid technique.
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Appendix C. Operating the Phase Analyzer
1. Start Up
a) Turn on syringe pump cooler.
b) Let the cooler temperature reach at least –3oC before beginning experiments.
c) Turn on syringe pump controller.
d) Turn on syringe pump.
e) Open the valve on the CO2 tank.
f) Open the inlet valves into the syringe pump and check that the outlet valves
(syringe pump) are closed.
g) Press REFILL on the syringe pump controller to fill the syringe pump, select
pump A or B, flow rate no higher than 5 ml/min.
h) When the syringe pump is full, press STOP on the syringe pump controller, then
press pump A or B (depending on which pump you are working with).
i) Close the inlet valves on the syringe pump.
j) Turn on the TV and put in a video for recording purposes.
k) Turn on the phase analyzer controller.
l) Turn on the magnetic stirrer on the phase analyzer.
m) Press the Video Input Button on the phase analyzer controller to get video feed
into the TV.
n) To make a temperature set point for experiment runs, press the down arrow on the
phase analyzer controller to SPM Settings.
o) Once blinker is on SPM Settings press the Enter Button.
p) Enter the temperature at which you want to run experiments.
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q) Press the Enter Button and then press the Escape Button to return to the main
menu of the phase analyzer controller.
r) To enter sample numbers, go to Sample on the phase analyzer, then enter sample
numbers. Press the Enter Button, then input whatever sample number you want.
s) Press the Enter Button after designating a sample number for your experiment.

2. Running Experiments
a) Weigh solid sample and record the mass, or measure out liquid sample and record
the volume.
b) Unscrew the magnetic stirrer from the phase analyzer.
c) Put liquid/solid sample into the solubility cell.
d) Put the magnetic stirrer back on the phase analyzer and tighten it.
e) Make sure the outlet valve on the phase analyzer is closed.
f) Open the outlet valves on the syringe pump.
g) On the syringe pump controller, press RUN. Make sure the flow rate is 1 ml/min.
h) Open the inlet valve of the phase analyzer slowly to let CO2 into the solubility cell
until a pressure of 5-7 bar is reached, then close the inlet valve of the phase
analyzer and open the outlet valve slowly to release the air trapped in the cell.
Repeat this process 10 times, and check that the cell outlet valve remains closed
after every purge.
i) After the air purging is done, stop the syringe pump and take notes about the
pressure and volume at the syringe pump controller.
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j) Now press RUN on the syringe pump controller and open the cell inlet valve to
fill up the cell with CO2. Recommended flow rate is 1-3 ml/min. volume with the
manual pump (this will take a few minutes depending on the pressure required).
k) The temperature recommended to fill up the cell is room temperature. Once the
cell is full, the temperature can be adjusted.
l) Once the required pressure is reached, press STOP on the syringe pump
controller. Close both outlet valves to syringe pump and close the phase analyzer
inlet valve.
m) Stop the syringe pump flow rate – close both outlet valves to syringe pump.
n) Record the final pressure and temperature at the syringe pump controller (this data
is needed to calculate the amount of CO2 used in the experiment).
o) Adjust temperature (START UP procedure n to q) and press the HEAT ON button
on the phase analyzer controller to bring the cell up to the experiment
temperature.
p) Adjust volume by turning the manual pump.
q) Once the operation conditions for the experiment are reached, unlock the hinge on
the phase analyzer and shift the phase analyzer until it is horizontal or slightly
past horizontal to get some sample in the camera‟s view cell. If the sample is a
solid you should see some solid in the window. If the sample is liquid a liquidliquid interface should be visible in cell window.
r) Wait at least 3h for the system to stabilize.
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s) Record the pressure on the phase analyzer and the manual pump as well as the
temperature.
t) Watch the sample while increasing the pressure to determine if it has dissolved
into the CO2.
u) Once no solid or no liquid-liquid interface is detected (turn on the magnetic stirrer
for a few seconds to make sure). Record this pressure on the phase analyzer, the
manual pump gauge, and the volume of the cell.
v) If more than one phase is observed, increase the pressure by turning the manual
pump to the right.
w) Watch the sample while increasing the pressure to determine if it has dissolved
into the CO2.
x) Decrease the pressure drastically by turning the manual pump to the left until a
cloud point is observed.
y) Record this pressure on the phase analyzer, the manual pump gauge, and the
volume of the cell.
z) Continue increasing and decreasing the pressure as described above for precision
purposes to get 5 points to average out for calculations. Record pressures and
volumes properly. (It might also be wise to indicate 1 phase or 2 phases for each
pressure and volume as well).
aa) Change the temperature, let the system stabilize and re-run the experiment at the
new operation conditions.
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3. Clean Up
Once the experiment is done and data is gathered, the system needs to be cleaned
before any other experiment can be run.
a) Stop recording the experiment.
b) Press the Heat-Off Button on phase analyzer controller. Let the cell cool to room
temperature. It will take a while for the cell to return to room temperature,
depending on the experiment temperature used.
c) Unlock pivot and put cell into upright position.
d) Open the phase analyzer outlet valve slowly to vent the pressure. Opening the
outlet valve too fast will result in clogging the outlet valve.
e) Unplug the magnetic stirrer and carefully unscrew the cap (the cell may still be
pressurized even if phase analyzer controller says 0 bar).
f) Collect the remaining sample inside the cell.
g) Disconnect and remove the lamp, camera, thermocouples, inlet and outlet valves,
and the pressure gauge on the phase analyzer.
h) Carefully unscrew the solubility cell from the phase analyzer (do not twist the
heaters‟ wires connected to the cell).
i) Clean the cell using an appropriate solvent and a q-tip, so as not to scratch the
wall‟s surface.
j) Remove O-rings from the bottom of the solubility cell and wash them thoroughly
with the appropriate solvent.
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k) Remove frit from phase analyzer or the solubility cell carefully (depending on
which frit you use – fixed frit is in the cell, the movable frit is screwed onto the
piston) and rinse thoroughly with the solvent.
l) Clean out the inlet and outlet valves of the phase analyzer with the solvent.
m) Wash the magnetic stirrer with the solvent.
n) Clean each component with compressed nitrogen as well (this aids in removing
very fine solid particles).
o) Reassemble the system and refill the phase analyzer with pure CO2 or the mix
solvent- CO2.
p) Proceed to run the system at the same operation conditions (pressure and
temperature) of the experiment in order to dissolve any remaining solute.
q) This cleaning procedure should be done as many times as needed, until no solute
(liquid or solid) stays inside the phase analyzer.

4. Shut Down
Once the cleaning process is done, follow the instructions to shut down the
system.
a) Press the Heat-Off Button on phase analyzer controller. Let the cell cool to room
temperature.
b) Open the phase analyzer outlet valve slowly to vent the pressure.
c) Open the syringe pump outlet valves to vent the remaining CO2 through the phase
analyzer.
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d) Turn off the syringe pump.
e) Turn off the syringe pump controller.
f) Turn off the cooler.
g) Return the manual pump displacement to zero.
h) Turn off the TV.

5. Reassembly
a) Put frit back into place (into the solubility cell or onto the piston, depending on
which one you use).
b) Put both O-rings back into place on the bottom of the solubility cell.
c) Carefully tighten the solubility cell back onto the phase analyzer.
d) Install and connect the lamp, camera, thermocouples, inlet and outlet valves, and
pressure gauge on the phase analyzer.
e) Carefully screw magnetic stirrer cap back on top of the phase analyzer.
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Appendix D. Operating the Dynamic Solubility Set-Up
1. Glassware Pre-Treatment
a) Prepare a 5% solution of HMDS in dichloromethane (DCM).
b) Fill the glassware and soak the glass wool with this solution.
c) Put on the oven at 250 C for 1 hr.
d) Wait for cool down, pass some DCM and let it dry.

2. Start Up
a) Turn on the syringe pump cooler (Lauda Ecoline RE120), the immersion
circulator (Model 7300, Fisher) at the water bath and the heating tape over the
back pressure regulator.
b) Let the cooler temperature reach at least –3oC before beginning experiments.
c) Turn on syringe pump controller.
d) Turn on syringe pump.
e) Open the valve on the CO2 tank.
f) Open the inlet valves into the syringe pump and check that the outlet valves
(syringe pump) are closed.
g) Press REFILL on the syringe pump controller to fill the syringe pump, select
pump A or B, flow rate no higher than 5 ml/min.
h) When the syringe pump is full, press STOP on the syringe pump controller, then
press pump A or B (depending on which pump you are working with).
i) Close the inlet valves on the syringe pump.
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3. Running Experiment
a) Weigh solid sample and record the mass.
b) Weigh the extraction cell by itself.
c) Prepare the cell as follows: first place a piece of stainless steel mesh at the bottom
of the cell, then put in a layer of the treated glass wool, followed by the weighted
solute. Before closing the cell, place at the closing top of it the metallic mesh and
then another glass wool layer. The cell should be tight over the wise to assure a
tight fit.
d) Weigh the loaded cell.
e) Place the extraction cell in the system.
f) Set the working pressure on the BPR using the nitrogen tank.
g) Open the outlet valves on the syringe pump.
h) Check for leaks through all the system.
i) Set the set-up to run through the bypass line until the operation conditions are
reached (T and P).
j) On the syringe pump controller, press RUN and wait until the required pressure is
reached (100-120 bar). Make sure the flow rate is 1 ml/min.
k) Turn on the HPLC pump.
l) Press the DIRECT button.
m) Select the appropriate component line (A, B, C or D) and fix the flow rate at the
HPLC pump. Press ENTER.
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n) Run the pumps for 2 to 3 h until the conditions (T and P) are stable. The
supercritical mix will be passing through the bypass section until the system
reaches the equilibrium.
o) Switch the supercritical mix to the extraction cell.
p) Set the collection vessel with a measured volume of DI water.
q) Register P and T at the system.
r) Start the Wet Test Meter.
s) Register the volume, pressure and temperature in the ISCO pump.
t) Collect samples for a period of 4 h.
u) Stop both pumps after the collection period.
v) Register P, T and volume in the ISCO pump.
w) Register total CO2 volume and T in the Wet Test Meter.

4. Clean Up
a) Change the collection vessel.
b) Switch the flow through the bypass section.
c) Run the HPLC pump for 1 h (1ml/min), and then stop it.
d) Run the ISCO pump for 2 h with a flow rate higher than the one used for the
extraction process (5 ml/min).
e) After one hour switch back the CO2 flow to the extraction cell in order to
eliminate residual DMSO.
f) Open the cell and remove the glass wool and metallic mesh from both ends.
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g) Clean the cell with water, followed by alcohol.
h) Use nitrogen to dry the cell.

5. Shut Down
a) Stop the ISCO pump.
b) Turn off the water heater and let the system cool down.
c) Release the system‟s pressure.
d) Turn off the pump‟s chiller.
e) Turn off the pumps.
f) Unscrew the extraction cell carefully and let it dry completely.
g) Weigh the dry cell.

6. Reassembly
a) Change the Teflon tape in all the cell connections.
b) Check that the cell is clean and completely dry.
c) Put together the extraction cell following the same procedure (a, b, c and d)
explained in the Running Experiment section.
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Appendix E. Operating the Encapsulation Set-Up
1. Start Up
a) Turn on the pump chiller, the heater at the insulation box and the heating tape
over the back pressure regulator (BPR).
b) Set the pressure at the back pressure regulator.
c) Turn on the camera and the light inside the insulation box.
d) Let the chiller temperature reach at least 0oC before starting the pump.
e) Turn on the continuous pump.
f) Check that the outlet valve of the pump is closed.
g) Open the valve on the CO2 tank.
h) Press F2 on the pump controller, select E (flow) and then input the flow rate
(usually start with 4g/min). Increase the flow rate by pressing F2 and then E, set
desired flow rate, ENTER; use 5g/min increments until the operation condition is
reached.
i) Very slowly, open the outlet valve on the high pressure pump.
j) Turn on the heating tape over the coating cell.
k) Check for leaks, and wait until the operation conditions are reached and the
particles to be coated are fluidizing inside the cell.

2. Running Experiment
a) Weigh solid to be coated and record the mass.
b) Load the coating cell with the solid sample.
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c) Place the coating cell in the system.
d) Follow the START UP procedure.
e) Turn on the WTM. Using a stop watch, start the time and the WTM
simultaneously.
f) Turn on the HPLC pump.
g) Press the DIRECT button.
h) Select the appropriate component line (A, B, C or D) and fix the flowrate at the
HPLC pump. Press ENTER.
i) Open the outlet valve of the HPLC pump, when the pressure in the HPLC
controller slightly exceeds the pressure in the coating system.
j) Run the HPLC pump for 10 to 20 min (depending on the coating required).
k) Close the outlet valve on the HPLC pump. Change the flow rate to zero, and then
press ENTER to stop the coating mix flow.
l) Set the collection vessel with a measured volume of DI water.
m) Register P and T at the system.
n) Register the flow rate and pressure in the continuous pump.
o) Collect water samples every hour and take it to the UV, until all the DMSO is
extracted from the coating cell.
p) Stop pumping CO2 after the collection period.
q) Register total CO2 volume and T in the Wet Test Meter.
r) Register T1 (cell inlet temperature), T2 (cell outlet temperature) and T4 (box
temperature).
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3. Clean Up
After stopping the CO2 pump continue with the cleaning procedure.
a) Turn off the heater at the insulation box and the heating tape of the coating cell.
b) Release the pressure of the system using the BPR until atmospheric pressure is
reached.
c) Separate the coating cell from the CO2 line and the coating line.
d) Run the HPLC pump with DMSO for twenty minutes using a flow rate of 5
ml/min through the coating line, to dissolve remaining polymer and avoid
clogging.
e) Open the cell and remove the coated material and put into the desiccator.
f) Clean the cell with a dry cloth, and then use nitrogen to blow away the remaining
powder.

4. Shut Down
a) Turn off the pump chiller, the heating tape over the BPR, the camera and the TV
monitor.
b) Close the valves of the CO2 and N2 tanks.
c) Check that all the manometers or pressure indicators show atmospheric pressure,
and then turn off both pumps.
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5. Reassembly
a) Prepare the coating vessel as follows: put the central chamber over one of the side
windows-cover set, load the cell with the weighted core material, place the other
window and cover over the central chamber. Using a torque wrench, tighten nuts
in 5 ft.lb increments following the tightening sequence in Figure E.1, until the
torque value of 30ft.lb is reached.

Figure E.1. Nut Tightening Sequence.

b) Set the loaded coating cell inside the insulation box.
c) Tighten the ¼ inlet and outlet CO2 connections of the cell to the CO2 line.
d) Tighten the 1/16 inlet coating connection of the cell to the HPLC line.
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Appendix F. Fluidization Calculations
Using the correlation established for Wen and Yu in 1966 for 0.001 < Re < 4000,
the minimum fluidization velocity was calculated:

Re

um f dp

CO 2

3 3.7

2

d 3p
0.0 4 0 8

CO 2

CO 2

Ca O
2
CO 2

CO 2

g

0. 5

3 3.7

(1)

As an example for the calculations, the operation conditions considered were
P=100 bar and T = 320 K. At these conditions from the IUPAC table, the molar volume
for carbon dioxide is 97.919 cm3/mol, and the viscosity is 3.26 K/m s. As the molecular
weight of the carbon dioxide was 44, the density at the base operation conditions was
449.35 Kg/m3.
As was presented in Chapter 4 in Table 4.6, the density of the calcium oxide was
3300Kg/m3, for the calculations presented next, the size particle considered was 5 micron
or 5 x 10-6 m.
Using equation 1, the Reynolds number obtained was 0.001, then solving for the
minimum fluidization velocity, umf:
u mf

Re

CO2

dp

CO2

(2)

The minimum fluidization velocity obtained was 1.3 x10-5 m/s. The CO2 pump
input data units were grams/minute (g/min), then using the inlet transversal area on the
encapsulation cell and the density of the CO2 at the conditions inside the pump the
required flow was calculated.
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A 2.6 5x1 0 4 m2
Vm f A u m f 2.6 5x1 0 4 m2 1.3x1 0 5 m / s 3.4 4x1 0 9 m3 / s
CO 2

989.1Kg/ m3

Mmf 3.44x10 9

(100bar, 270 K)

m3
Kg 1000g 60s
g
989.1 3 .
0.2
s
m 1Kg 1min
min

Next, the minimum mass fluidization mass flow ( M mf ) was obtained from umf,
which is known as the minimum fluidization velocity. This is also sometimes referred to
as the velocity at incipient fluidization ("incipient" means "about to begin"). After this,
the flow rate was limited on one side by umf (minimum flow) and on the other side by the
terminal (ut) or free fall velocity of the particles (maximum flow).

ut

4 g dp
3

CaO
CO2

Cd,spheri cal

24
Rep

Cd,spher i cal

10
Re1p/ 2

CO2

(3)

Cd

for Rep

(4)

0.4

(5)

for 0.4 Re p 500

Replacing these values of the drag coefficient Cd in equation 3 the following
expressions were obtained:

u t ,spher i cal

u t ,s phe r i c a l

g

CaO

CO 2

18
4
225

d2p

for Re p

0.4

(6)

CO 2

2
Ca O

CO 2
CO 2

g2

1/ 3

CO 2
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For the Reynolds number of 0.001, the terminal velocity was calculated with
equation 6, and the value obtained was 6.36x10-4 m/s. Following the same procedure
explained previously to calculate the volumetric flow and mass flow, the results obtained
were:
Vt

1.69x10 7 m 3 / s

Mt

10 g / min

The same calculations were done for the TiO2, but in this case the value of density
of the calcium oxide of 3300Kg/m3 was substituted by the density of titanium dioxide of
4200 Kg/m3.
Assuming spherical particles for an average pressure of 100 bar, the values
obtained are shown in Tables F.1 and F.2.
Table F.1. Flow Required to Fluidize CaO 2 m and 5 m Particles.
T ( C) M mf

37
38
39
40
41
42
43
44
45
46
47

(g/min)

Mt

(g/min)

M mf

(g/min)

Mt

(g/min)

M mf

(g/min)

Mt

(g/min)

0.5 m

0.5 m

2 m

2 m

5 m

5 m

1.87E-03
1.90E-03
1.92E-03
1.94E-03
1.96E-03
1.97E-03
1.99E-03
2.00E-03
2.02E-03
2.03E-03
2.04E-03

0.82
0.84
0.86
0.88
0.90
0.92
0.94
0.95
0.97
0.99
1.00

0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03

3.28
3.37
3.45
3.53
3.60
3.67
3.74
3.81
3.88
3.94
4.00

0.19
0.19
0.19
0.19
0.20
0.20
0.20
0.20
0.20
0.20
0.20

8.20
8.41
8.62
8.81
9.00
9.19
9.36
9.53
9.69
9.85
10.00
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Table F.2. Flow Required to Fluidize TiO2 1 m and 2 m Particles.
T ( C) M mf

37
38
39
40
41
42
43
44
45
46
47

(g/min)

Mt

(g/min)

M mf

(g/min)

Mt

(g/min)

M mf

(g/min)

Mt

(g/min)

0.5 m

0.5 m

1 m

1 m

2 m

2 m

2.52E-03
2.54E-03
2.56E-03
2.58E-03
2.60E-03
2.62E-03
2.63E-03
2.65E-03
2.66E-03
2.67E-03
2.69E-03

1.00
1.02
1.05
1.07
1.09
1.11
1.13
1.15
1.17
1.18
1.20

0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01

2.00
2.05
2.09
2.13
2.18
2.22
2.26
2.30
2.33
2.37
2.40

0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04

3.99
4.09
4.18
4.27
4.35
4.44
4.51
4.59
4.66
4.74
4.81

As can be seen from the tables, operating at constant pressure even a T of 10 C
did not cause major adjustments on the CO2 flow rate required to fluidize the particles,
compared to the effect of particle size. As the samples presented a variable particle size
which facilitates the fluidization, the best results were obtained for 2-5 g CO2/min.
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Appendix G. UV Calibration
The first set of UV analysis consisted of running the UV with an empty
disposable cuvette and two different solutions (Chitosan-DMSO-water solution in a
quartz cuvette and water-Chitosan in a quartz cuvette (Figure G.1)). The idea of these
measurements was to determine first if a disposable (PMMA) or quartz cuvette should be
used for Chitosan determination, and the answer for this was any of them, since the
Chitosan peak shows at 294 nm where there is no interference of the cuvette materials at
this wavelength. Then as the disposable cuvettes were more accessible and were proven
not to interfere with the samples, these were chosen.

Cuvette Evaluation for Water-DMSO-Chitosan System

3

Absorbance

2

1

0
190

240

290

340

Wavelength (nm)
Chitosan in water 1.45mg/ml in Quartz cuvette
Chitosan in water 1.45mg/ml + 5microL DMSO in Quartz cuvette
Chitosan in water 1.45mg/ml + 15microL DMSO in Quartz cuvette
Empty PMMA cuvette vs air

Figure G.1. Cuvette Evaluation for Water-DMSO-Chitosan System.

196

390

Appendix G (Continued)
The next set of experiments consisted in running two solutions of ChitosanDMSO-water and changing the DMSO concentration in order to observe any interference
on the Chitosan determination. Chitosan has two peaks, one at 195 nm and another at 294
nm. The first one cannot be used because it saturates the instrument and overlaps with the
DMSO peak. Due to these results, Chitosan concentration will be obtained from the peak
at 294 nm, since DMSO and Chitosan peaks in the region 195-245 nm cannot be deconvoluted, and UV cannot be used to determine DMSO concentration.
Finally, a set of Chitosan-water solutions were prepared in order to construct a
calibration curve using disposable cuvettes, as was proven that neither the DMSO nor the
cuvette material represent an interference
forDatathis
analysis.
UV Calibration
Chitosan-Water
0.25

0.2

Absorbance

0.15

0.1

0.05

0
200

250

300

350

400

450

-0.05

Wavelength (nm)
0.01mg/ml

0.05mg/ml

0.1mg/ml

0.2mg/ml

0.3mg/ml

0.4mg/ml

Reference Peak

Figure G.2. UV Spectra for Chitosan-Water Solutions. Reference peak 294 nm.
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Figure G.2 shows the UV plots and an absorption band at 294 nm for all
Chitosan-Water solutions prepared to build a calibration curve based on Chitosan
absorption. This curve is required in order to determine the Chitosan concentration on the
solution collected at the end of the dynamic solubility set-up.
The UV spectrum for Chitosan reported in the bibliography (Muzzarelli 1973,
Siokonkowska 2004, Guanghan 2006) mention absorption bands of 250nm, 278nm,
280nm, 295nm depending on the molecular weight and the UV exposure of the sample,
given that the chromophores responsible for the UV absorption are related to the carbonyl
and amino groups in the Chitosan (Andrady 1996).
With the readings obtained at the absorption band of 294 nm for six different
solutions of Chitosan-Water, a calibration curve was built; this data is presented as a
linear relation in Figure G.3.
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Calibration Data Chitosan Water (294 nm)

0.5

Concentration (mg/ml)

0.4
y = 2.1763x - 0.0101
R2 = 0.9865
0.3

0.2

0.1

0.0
0

0.02

0.04

0.06

0.08

0.1

0.12

0.14

0.16

0.18

0.2

Absorbance

Figure G.3. Calibration Curve for Chitosan-Water Solutions Wavelength 294nm.
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Appendix H. Quantification of Carbon Dioxide During Solubility Experiments
The amount of carbon dioxide used during the solubility experiments was
determined in two different ways: by using the Improved Rackett Equation (IRE) and by
direct measurement with a Wet Test Meter (WTM).
When running solubility experiments, the carbon dioxide was fed into the system
with a syringe pump. The body or tank of the pump was kept at a constant temperature of
-3 C (270.15 K) and the controller of the pump had a screen reporting temperature,
pressure and volume readings in the syringe tank at all the times, providing a way to
measure the amount of carbon dioxide in the feed.
The Improved Rackett Equation (IRE) can be written as:

(1)

This is a simple equation. No arbitrary constants are required and the only
information needed is the critical properties of the substance to be evaluated. In addition,
this equation has been reported to be able to predict reasonable results between the triple
point and the critical point for most substances (Spencer, 1972).
By using the subsequent data and IRE the moles of CO2 fed to the system were
calculated as follows.
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Table H.1. Data for IRE Calculations.
Experimental Data

Constants and CO2 Critical Properties

Tpump = -3 C= 270.15 K
R= 83.1447
VCO2 (l) = 360.28cm3 (vol. of liquid carbon
Pc= 73.7 bar
dioxide in the syringe pump at -3C)

Tc= 304.18K
Zc= 0.2736

(2)
The experimental data obtained from the dynamic set-up calculated using the IRE
is presented in table H2.
Table H.2. CO2 Feed from IRE Calculations.
Tpump ( C)

Tpump ( K)

VCO2,l (cm3)

1/ (cm3/mol)

NCO2

-3.00
-3.00
-3.00
-3.00
-3.00
-3.00
-3.00
-3.00

270.15
270.15
270.15
270.15
270.15
270.15
270.15
270.15

360.28
315.00
288.18
299.15
295.00
278.00
235.00
365.00

46.91
46.91
46.91
46.91
46.91
46.91
46.91
46.91

7.68
6.72
6.14
6.38
6.29
5.93
5.01
7.78

After passing through the solubility set-up, the carbon dioxide was released in its
gas phase and the volume of the gas released was measured with a Wet Test Meter
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located at the end of the experimental system. While the experiment was run, the total
operation time as well as the room temperature was registered, so by considering it as an
ideal gas, the moles of CO2 released could be easily calculated.

(3)
The experimental data obtained from the dynamic set-up calculated using the
WTM is presented in table H3.
Table H.3. CO2 Feed from WTM Measurements.
TWTM ( C)

TWTM ( K)

VWTM (cm3) NCO2

24.40
25.40
25.00
24.20
24.00
24.50
26.20
25.20

297.55
298. 55
298.15
297.35
297.15
297.65
299.35
298.35

190323.60
172111.80
153456.00
154769.60
158895.30
146790.00
125334.50
192015.40
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7.70
6.94
6.19
6.26
6.43
5.93
5.04
7.74

Appendix I. Quantification of Chitosan and DMSO During Encapsulation Experiments
The polymer used in this research, Chitosan Oligosaccharide Lactate, is soluble in
DMSO at room temperature for concentrations not higher than 17% w/w, as presented in
Chapter 6. Accordingly, it was more practical to prepare the liquid solutions of DMSOChitosan previous to starting the encapsulation experiments, and the feed composition for
these components was determined from the feed rate set on the HPLC pump, the
concentration of the solution and the operation time. The other component for the
encapsulation mixture was the carbon dioxide, and the feed information was obtained
from the continuous pump.

Table I.1. Feed Composition for Encapsulation Experiments
System

Encapsulation Operation Conditions

Feed Composition

Component

P (bar)

T (ºC)

t (min) Core (g)
Chitosan (g)
DMSO (g)

CO2 (g)

CaO

111.0

48.9

30

0.10

0.10

5.50

60

CaO

119.0

41.9

50

0.30

0.14

15.85

96

CaO

119.8

44.8

45

0.20

0.14

14.86

90

TiO2

110.0

45.0

73

0.20

0.21

12.00

146

TiO2

120.0

44.0

60

0.20

0.09

22.00

80

In order to be able to explain the encapsulation mechanism evaluating the effect
of the feed composition and the operation conditions, the predicted amount of Chitosan
and DMSO that could precipitate in the encapsulation cell was estimated by using the
following expression:
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Pm

Sf

Sc T ,P

F
t

(1)

where:
Pm: precipitated material (g)
Sf: Solubility in the feed
Sc: Solubility in the bed (from solubility experimental data)
F: Feed rate (g/min)
t: contact time (min)
Based on the solubility data obtained experimentally for the system ChitosanDMSO-SCCO2, the feed composition and the operation conditions evaluated in the
encapsulation the estimated amount of material precipitated inside the cell is presented in
the following tables.
Table I.2. Chitosan Mass Balance from Solubility Data
Encapsulation Operation Conditions

Composition
Chitosan

Feed

Cell

Precipitate

(g)

Sf

Sc

Pm (g)

30

0.10

1.5243E-3

9.7800E-6

1.5146E-4

41.9

50

0.14

1.2858E-3

2.3100E-5

1.8183E-4

119.8

44.8

45

0.14

1.2858E-3

1.2900E-5

1.7185E-4

110.0

45.0

73

0.21

2.2480E-3

1.0000E-5

4.6999E-4

120.0

44.0

60

0.10

5.2848E-4

1.2917E-5

4.6401E-5

P (bar)

T (ºC)

t (min)

111.0

48.9

119.0
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Table I.3. DMSO Mass Balance from Solubility Data at the Cell
Encapsulation Operation Conditions

Composition
DMSO

Feed

Cell

Precipitate

(g)

Sf

Sc

Pm (g)

30

5.50

1.0701E-1

8.3869E-2

1.2726E-1

41.9

50

15.85

1.4149E-1

1.0700E-1

5.4657E-1

119.8

44.8

45

14.86

1.4200E-1

1.4149E-1

7.5326E-3

110.0

45.0

73

12.00

1.4136E-1

1.1000E-1

3.7628E-1

120.0

44.0

60

22.00

1.4215E-1

1.4157E-1

1.2926E-1

P (bar)

T (ºC)

t (min)

111.0

48.9

119.0

Table I.4. Mass Balance from Solubility Data DMSO Removal
Encapsulation Operation Conditions

Composition
CO2

Feed

Cell

Removed

(g/min)

Sf

Sc

Pm (g)

120

20

1.1000E-1

1.0700E-1

7.20

41.9

40

40

1.6210E-1

1.0700E-1

8.82

119.8

44.8

240

25

1.6000E-1

1.4200E-1

10.80

110.0

45.0

180

15

1.4000E-1

1.1000E-1

8.10

120.0

44.0

180

20

1.6000E-1

1.4157E-1

6.64

P (bar)

T (ºC)

t (min)

111.0

48.9

119.0

The results obtained from the mass balances presented in these tables indicates
that the solubility decreased inside the encapsulation cell, which is completely
reasonable, and the temperature was raised at a constant pressure (Encapsulation
Operation Conditions) to promote the polymer precipitation. The results from Table I.4
indicate that the volume of SCCO2 used to remove DMSO was higher than required,
which could cause Chitosan removal, reducing encapsulant thickness. For example, the
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SCCO2 injected in the cell at 111 bar and 48.9ºC was enough to remove 7.2g of this
chemical under these operation conditions, and the amount of DMSO inside the cell
before its removal was 0.11g.
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